id	sid	tid	token	lemma	pos
ajlm-2912	1	1	abstract	abstract	ADJ
ajlm-2912	1	2	introduction	introduction	NOUN
ajlm-2912	1	3	methods	method	NOUN
ajlm-2912	1	4	results	result	VERB
ajlm-2912	1	5	discussion	discussion	NOUN
ajlm-2912	1	6	acknowledgements	acknowledgement	NOUN
ajlm-2912	1	7	references	reference	NOUN
ajlm-2912	1	8	about	about	ADP
ajlm-2912	1	9	the	the	DET
ajlm-2912	1	10	author(s	author(s	NOUN
ajlm-2912	1	11	)	)	PUNCT
ajlm-2912	1	12	astha	astha	PROPN
ajlm-2912	1	13	goyal	goyal	PROPN
ajlm-2912	1	14	department	department	PROPN
ajlm-2912	1	15	of	of	ADP
ajlm-2912	1	16	biochemistry	biochemistry	NOUN
ajlm-2912	1	17	,	,	PUNCT
ajlm-2912	1	18	faculty	faculty	NOUN
ajlm-2912	1	19	of	of	ADP
ajlm-2912	1	20	medicine	medicine	NOUN
ajlm-2912	1	21	and	and	CCONJ
ajlm-2912	1	22	health	health	NOUN
ajlm-2912	1	23	sciences	science	NOUN
ajlm-2912	1	24	,	,	PUNCT
ajlm-2912	1	25	sgt	sgt	PROPN
ajlm-2912	1	26	university	university	PROPN
ajlm-2912	1	27	,	,	PUNCT
ajlm-2912	1	28	gurugram	gurugram	PROPN
ajlm-2912	1	29	,	,	PUNCT
ajlm-2912	1	30	india	india	PROPN
ajlm-2912	1	31	sanjiv	sanjiv	PROPN
ajlm-2912	1	32	k.	k.	PROPN
ajlm-2912	1	33	bansal	bansal	PROPN
ajlm-2912	1	34	department	department	PROPN
ajlm-2912	1	35	of	of	ADP
ajlm-2912	1	36	biochemistry	biochemistry	NOUN
ajlm-2912	1	37	,	,	PUNCT
ajlm-2912	1	38	faculty	faculty	NOUN
ajlm-2912	1	39	of	of	ADP
ajlm-2912	1	40	medicine	medicine	NOUN
ajlm-2912	1	41	and	and	CCONJ
ajlm-2912	1	42	health	health	NOUN
ajlm-2912	1	43	sciences	science	NOUN
ajlm-2912	1	44	,	,	PUNCT
ajlm-2912	1	45	sgt	sgt	PROPN
ajlm-2912	1	46	university	university	PROPN
ajlm-2912	1	47	,	,	PUNCT
ajlm-2912	1	48	gurugram	gurugram	PROPN
ajlm-2912	1	49	,	,	PUNCT
ajlm-2912	1	50	india	india	PROPN
ajlm-2912	1	51	shikhar	shikhar	PROPN
ajlm-2912	1	52	ganjoo	ganjoo	PROPN
ajlm-2912	1	53	department	department	PROPN
ajlm-2912	1	54	of	of	ADP
ajlm-2912	1	55	dermatology	dermatology	NOUN
ajlm-2912	1	56	,	,	PUNCT
ajlm-2912	1	57	faculty	faculty	NOUN
ajlm-2912	1	58	of	of	ADP
ajlm-2912	1	59	medicine	medicine	NOUN
ajlm-2912	1	60	and	and	CCONJ
ajlm-2912	1	61	health	health	NOUN
ajlm-2912	1	62	sciences	science	NOUN
ajlm-2912	1	63	,	,	PUNCT
ajlm-2912	1	64	sgt	sgt	PROPN
ajlm-2912	1	65	university	university	PROPN
ajlm-2912	1	66	,	,	PUNCT
ajlm-2912	1	67	gurugram	gurugram	PROPN
ajlm-2912	1	68	,	,	PUNCT
ajlm-2912	1	69	india	india	PROPN
ajlm-2912	1	70	citation	citation	PROPN
ajlm-2912	1	71	goyal	goyal	PROPN
ajlm-2912	1	72	a	a	PROPN
ajlm-2912	1	73	,	,	PUNCT
ajlm-2912	1	74	bansal	bansal	NOUN
ajlm-2912	1	75	sk	sk	NOUN
ajlm-2912	1	76	,	,	PUNCT
ajlm-2912	1	77	ganjoo	ganjoo	NOUN
ajlm-2912	1	78	s.	s.	PROPN
ajlm-2912	1	79	oxidative	oxidative	VERB
ajlm-2912	1	80	stress	stress	NOUN
ajlm-2912	1	81	in	in	ADP
ajlm-2912	1	82	acne	acne	NOUN
ajlm-2912	1	83	vulgaris	vulgaris	NOUN
ajlm-2912	1	84	of	of	ADP
ajlm-2912	1	85	varying	vary	VERB
ajlm-2912	1	86	severities	severity	NOUN
ajlm-2912	1	87	in	in	ADP
ajlm-2912	1	88	india	india	PROPN
ajlm-2912	1	89	.	.	PUNCT
ajlm-2912	2	1	afr	afr	PROPN
ajlm-2912	2	2	j	j	PROPN
ajlm-2912	2	3	lab	lab	PROPN
ajlm-2912	2	4	med	med	PROPN
ajlm-2912	2	5	.	.	PUNCT
ajlm-2912	3	1	2025;14(1	2025;14(1	NUM
ajlm-2912	3	2	)	)	PUNCT
ajlm-2912	3	3	,	,	PUNCT
ajlm-2912	3	4	a2912	a2912	PROPN
ajlm-2912	3	5	.	.	PUNCT
ajlm-2912	3	6	https://doi.org/10.4102/ajlm.v14i1.2912	https://doi.org/10.4102/ajlm.v14i1.2912	PROPN
ajlm-2912	3	7	original	original	ADJ
ajlm-2912	3	8	research	research	NOUN
ajlm-2912	3	9	oxidative	oxidative	ADJ
ajlm-2912	3	10	stress	stress	NOUN
ajlm-2912	3	11	in	in	ADP
ajlm-2912	3	12	acne	acne	NOUN
ajlm-2912	3	13	vulgaris	vulgaris	NOUN
ajlm-2912	3	14	of	of	ADP
ajlm-2912	3	15	varying	vary	VERB
ajlm-2912	3	16	severities	severity	NOUN
ajlm-2912	3	17	in	in	ADP
ajlm-2912	3	18	india	india	PROPN
ajlm-2912	3	19	astha	astha	PROPN
ajlm-2912	3	20	goyal	goyal	PROPN
ajlm-2912	3	21	,	,	PUNCT
ajlm-2912	3	22	sanjiv	sanjiv	PROPN
ajlm-2912	3	23	k.	k.	PROPN
ajlm-2912	3	24	bansal	bansal	PROPN
ajlm-2912	3	25	,	,	PUNCT
ajlm-2912	3	26	shikhar	shikhar	PROPN
ajlm-2912	3	27	ganjoo	ganjoo	PROPN
ajlm-2912	3	28	received	receive	VERB
ajlm-2912	3	29	:	:	PUNCT
ajlm-2912	3	30	20	20	NUM
ajlm-2912	3	31	june	june	PROPN
ajlm-2912	3	32	2025	2025	NUM
ajlm-2912	3	33	;	;	PUNCT
ajlm-2912	3	34	accepted	accept	VERB
ajlm-2912	3	35	:	:	PUNCT
ajlm-2912	3	36	16	16	NUM
ajlm-2912	3	37	oct	oct	PROPN
ajlm-2912	3	38	.	.	PROPN
ajlm-2912	3	39	2025	2025	NUM
ajlm-2912	3	40	;	;	PUNCT
ajlm-2912	3	41	published	publish	VERB
ajlm-2912	3	42	:	:	PUNCT
ajlm-2912	3	43	29	29	NUM
ajlm-2912	3	44	nov	nov	NOUN
ajlm-2912	3	45	.	.	PROPN
ajlm-2912	3	46	2025	2025	NUM
ajlm-2912	3	47	copyright	copyright	NOUN
ajlm-2912	3	48	:	:	PUNCT
ajlm-2912	3	49	©	©	PROPN
ajlm-2912	3	50	2025	2025	NUM
ajlm-2912	3	51	.	.	PUNCT
ajlm-2912	4	1	the	the	DET
ajlm-2912	4	2	author(s	author(s	PROPN
ajlm-2912	4	3	)	)	PUNCT
ajlm-2912	4	4	.	.	PUNCT
ajlm-2912	5	1	licensee	licensee	NOUN
ajlm-2912	5	2	:	:	PUNCT
ajlm-2912	5	3	aosis	aosis	NOUN
ajlm-2912	5	4	.	.	PUNCT
ajlm-2912	6	1	this	this	DET
ajlm-2912	6	2	work	work	NOUN
ajlm-2912	6	3	is	be	AUX
ajlm-2912	6	4	licensed	license	VERB
ajlm-2912	6	5	under	under	ADP
ajlm-2912	6	6	the	the	DET
ajlm-2912	6	7	creative	creative	ADJ
ajlm-2912	6	8	commons	common	NOUN
ajlm-2912	6	9	attribution	attribution	NOUN
ajlm-2912	6	10	4.0	4.0	NUM
ajlm-2912	6	11	international	international	NOUN
ajlm-2912	6	12	(	(	PUNCT
ajlm-2912	6	13	cc	cc	NOUN
ajlm-2912	6	14	by	by	ADP
ajlm-2912	6	15	4.0	4.0	NUM
ajlm-2912	6	16	)	)	PUNCT
ajlm-2912	6	17	license	license	NOUN
ajlm-2912	6	18	(	(	PUNCT
ajlm-2912	6	19	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
ajlm-2912	6	20	)	)	PUNCT
ajlm-2912	6	21	.	.	PUNCT
ajlm-2912	7	1	abstract	abstract	ADJ
ajlm-2912	7	2	background	background	NOUN
ajlm-2912	7	3	:	:	PUNCT
ajlm-2912	7	4	acne	acne	NOUN
ajlm-2912	7	5	vulgaris	vulgaris	NOUN
ajlm-2912	7	6	is	be	AUX
ajlm-2912	7	7	a	a	DET
ajlm-2912	7	8	common	common	ADJ
ajlm-2912	7	9	inflammatory	inflammatory	ADJ
ajlm-2912	7	10	skin	skin	NOUN
ajlm-2912	7	11	disease	disease	NOUN
ajlm-2912	7	12	with	with	ADP
ajlm-2912	7	13	a	a	DET
ajlm-2912	7	14	multifactorial	multifactorial	ADJ
ajlm-2912	7	15	pathogenesis	pathogenesis	NOUN
ajlm-2912	7	16	.	.	PUNCT
ajlm-2912	8	1	although	although	SCONJ
ajlm-2912	8	2	the	the	DET
ajlm-2912	8	3	pathophysiology	pathophysiology	NOUN
ajlm-2912	8	4	of	of	ADP
ajlm-2912	8	5	acne	acne	NOUN
ajlm-2912	8	6	has	have	AUX
ajlm-2912	8	7	been	be	AUX
ajlm-2912	8	8	linked	link	VERB
ajlm-2912	8	9	to	to	ADP
ajlm-2912	8	10	free	free	ADJ
ajlm-2912	8	11	radical	radical	ADJ
ajlm-2912	8	12	-	-	PUNCT
ajlm-2912	8	13	mediated	mediate	VERB
ajlm-2912	8	14	responses	response	NOUN
ajlm-2912	8	15	,	,	PUNCT
ajlm-2912	8	16	it	it	PRON
ajlm-2912	8	17	is	be	AUX
ajlm-2912	8	18	still	still	ADV
ajlm-2912	8	19	unknown	unknown	ADJ
ajlm-2912	8	20	how	how	SCONJ
ajlm-2912	8	21	these	these	DET
ajlm-2912	8	22	reactions	reaction	NOUN
ajlm-2912	8	23	trigger	trigger	VERB
ajlm-2912	8	24	the	the	DET
ajlm-2912	8	25	disease	disease	NOUN
ajlm-2912	8	26	’s	’s	PART
ajlm-2912	8	27	progression	progression	NOUN
ajlm-2912	8	28	.	.	PUNCT
ajlm-2912	9	1	objective	objective	NOUN
ajlm-2912	9	2	:	:	PUNCT
ajlm-2912	9	3	this	this	DET
ajlm-2912	9	4	study	study	NOUN
ajlm-2912	9	5	aimed	aim	VERB
ajlm-2912	9	6	to	to	PART
ajlm-2912	9	7	evaluate	evaluate	VERB
ajlm-2912	9	8	the	the	DET
ajlm-2912	9	9	status	status	NOUN
ajlm-2912	9	10	and	and	CCONJ
ajlm-2912	9	11	role	role	NOUN
ajlm-2912	9	12	of	of	ADP
ajlm-2912	9	13	oxidative	oxidative	ADJ
ajlm-2912	9	14	stress	stress	NOUN
ajlm-2912	9	15	in	in	ADP
ajlm-2912	9	16	patients	patient	NOUN
ajlm-2912	9	17	with	with	ADP
ajlm-2912	9	18	acne	acne	NOUN
ajlm-2912	9	19	vulgaris	vulgaris	NOUN
ajlm-2912	9	20	,	,	PUNCT
ajlm-2912	9	21	and	and	CCONJ
ajlm-2912	9	22	to	to	PART
ajlm-2912	9	23	find	find	VERB
ajlm-2912	9	24	a	a	DET
ajlm-2912	9	25	potential	potential	ADJ
ajlm-2912	9	26	correlation	correlation	NOUN
ajlm-2912	9	27	with	with	ADP
ajlm-2912	9	28	varying	vary	VERB
ajlm-2912	9	29	clinical	clinical	ADJ
ajlm-2912	9	30	severities	severity	NOUN
ajlm-2912	9	31	.	.	PUNCT
ajlm-2912	10	1	methods	method	NOUN
ajlm-2912	10	2	:	:	PUNCT
ajlm-2912	10	3	an	an	DET
ajlm-2912	10	4	observational	observational	ADJ
ajlm-2912	10	5	cross	cross	ADJ
ajlm-2912	10	6	-	-	ADJ
ajlm-2912	10	7	sectional	sectional	ADJ
ajlm-2912	10	8	study	study	NOUN
ajlm-2912	10	9	was	be	AUX
ajlm-2912	10	10	conducted	conduct	VERB
ajlm-2912	10	11	amongst	amongst	ADP
ajlm-2912	10	12	200	200	NUM
ajlm-2912	10	13	subjects	subject	NOUN
ajlm-2912	10	14	(	(	PUNCT
ajlm-2912	10	15	50	50	NUM
ajlm-2912	10	16	in	in	ADP
ajlm-2912	10	17	each	each	DET
ajlm-2912	10	18	grade	grade	NOUN
ajlm-2912	10	19	of	of	ADP
ajlm-2912	10	20	acne	acne	NOUN
ajlm-2912	10	21	vulgaris	vulgaris	NOUN
ajlm-2912	10	22	:	:	PUNCT
ajlm-2912	10	23	grades	grade	NOUN
ajlm-2912	10	24	1	1	NUM
ajlm-2912	10	25	,	,	PUNCT
ajlm-2912	10	26	2	2	NUM
ajlm-2912	10	27	,	,	PUNCT
ajlm-2912	10	28	3	3	NUM
ajlm-2912	10	29	,	,	PUNCT
ajlm-2912	10	30	and	and	CCONJ
ajlm-2912	10	31	4	4	NUM
ajlm-2912	10	32	)	)	PUNCT
ajlm-2912	10	33	and	and	CCONJ
ajlm-2912	10	34	50	50	NUM
ajlm-2912	10	35	controls	control	NOUN
ajlm-2912	10	36	aged	age	VERB
ajlm-2912	10	37	18	18	NUM
ajlm-2912	10	38	to	to	PART
ajlm-2912	10	39	45	45	NUM
ajlm-2912	10	40	years	year	NOUN
ajlm-2912	10	41	,	,	PUNCT
ajlm-2912	10	42	between	between	ADP
ajlm-2912	10	43	01	01	NUM
ajlm-2912	10	44	july	july	PROPN
ajlm-2912	10	45	2023	2023	NUM
ajlm-2912	10	46	and	and	CCONJ
ajlm-2912	10	47	30	30	NUM
ajlm-2912	10	48	june	june	PROPN
ajlm-2912	10	49	2024	2024	NUM
ajlm-2912	10	50	at	at	ADP
ajlm-2912	10	51	sgt	sgt	PROPN
ajlm-2912	10	52	university	university	PROPN
ajlm-2912	10	53	,	,	PUNCT
ajlm-2912	10	54	faculty	faculty	NOUN
ajlm-2912	10	55	of	of	ADP
ajlm-2912	10	56	medicine	medicine	NOUN
ajlm-2912	10	57	and	and	CCONJ
ajlm-2912	10	58	health	health	NOUN
ajlm-2912	10	59	sciences	sciences	PROPN
ajlm-2912	10	60	,	,	PUNCT
ajlm-2912	10	61	gurugram	gurugram	PROPN
ajlm-2912	10	62	,	,	PUNCT
ajlm-2912	10	63	india	india	PROPN
ajlm-2912	10	64	.	.	PUNCT
ajlm-2912	11	1	the	the	DET
ajlm-2912	11	2	analysis	analysis	NOUN
ajlm-2912	11	3	included	include	VERB
ajlm-2912	11	4	superoxide	superoxide	NOUN
ajlm-2912	11	5	dismutase	dismutase	NOUN
ajlm-2912	11	6	(	(	PUNCT
ajlm-2912	11	7	sod	sod	NOUN
ajlm-2912	11	8	)	)	PUNCT
ajlm-2912	11	9	,	,	PUNCT
ajlm-2912	11	10	catalase	catalase	NOUN
ajlm-2912	11	11	(	(	PUNCT
ajlm-2912	11	12	cat	cat	NOUN
ajlm-2912	11	13	)	)	PUNCT
ajlm-2912	11	14	,	,	PUNCT
ajlm-2912	11	15	glutathione	glutathione	NOUN
ajlm-2912	11	16	(	(	PUNCT
ajlm-2912	11	17	gsh	gsh	PROPN
ajlm-2912	11	18	)	)	PUNCT
ajlm-2912	11	19	and	and	CCONJ
ajlm-2912	11	20	malondialdehyde	malondialdehyde	NOUN
ajlm-2912	11	21	(	(	PUNCT
ajlm-2912	11	22	mda	mda	PROPN
ajlm-2912	11	23	)	)	PUNCT
ajlm-2912	11	24	by	by	ADP
ajlm-2912	11	25	using	use	VERB
ajlm-2912	11	26	enzyme	enzyme	NOUN
ajlm-2912	11	27	-	-	PUNCT
ajlm-2912	11	28	linked	link	VERB
ajlm-2912	11	29	immunosorbent	immunosorbent	NOUN
ajlm-2912	11	30	assay	assay	ADJ
ajlm-2912	11	31	kits	kit	NOUN
ajlm-2912	11	32	.	.	PUNCT
ajlm-2912	12	1	a	a	DET
ajlm-2912	12	2	student	student	NOUN
ajlm-2912	12	3	’s	’s	PART
ajlm-2912	12	4	t	t	PROPN
ajlm-2912	12	5	-	-	PUNCT
ajlm-2912	12	6	test	test	NOUN
ajlm-2912	12	7	and	and	CCONJ
ajlm-2912	12	8	pearson	pearson	PROPN
ajlm-2912	12	9	’s	’s	PART
ajlm-2912	12	10	correlation	correlation	NOUN
ajlm-2912	12	11	were	be	AUX
ajlm-2912	12	12	applied	apply	VERB
ajlm-2912	12	13	,	,	PUNCT
ajlm-2912	12	14	and	and	CCONJ
ajlm-2912	12	15	a	a	DET
ajlm-2912	12	16	p	p	NOUN
ajlm-2912	12	17	-	-	PUNCT
ajlm-2912	12	18	value	value	NOUN
ajlm-2912	12	19	of	of	ADP
ajlm-2912	12	20	<	<	X
ajlm-2912	12	21	0.05	0.05	NUM
ajlm-2912	12	22	is	be	AUX
ajlm-2912	12	23	considered	consider	VERB
ajlm-2912	12	24	statistically	statistically	ADV
ajlm-2912	12	25	significant	significant	ADJ
ajlm-2912	12	26	.	.	PUNCT
ajlm-2912	13	1	results	result	NOUN
ajlm-2912	13	2	:	:	PUNCT
ajlm-2912	13	3	the	the	DET
ajlm-2912	13	4	present	present	ADJ
ajlm-2912	13	5	study	study	NOUN
ajlm-2912	13	6	included	include	VERB
ajlm-2912	13	7	50	50	NUM
ajlm-2912	13	8	healthy	healthy	ADJ
ajlm-2912	13	9	controls	control	NOUN
ajlm-2912	13	10	:	:	PUNCT
ajlm-2912	13	11	29	29	NUM
ajlm-2912	13	12	women	woman	NOUN
ajlm-2912	13	13	and	and	CCONJ
ajlm-2912	13	14	21	21	NUM
ajlm-2912	13	15	men	man	NOUN
ajlm-2912	13	16	,	,	PUNCT
ajlm-2912	13	17	with	with	ADP
ajlm-2912	13	18	a	a	DET
ajlm-2912	13	19	mean	mean	ADJ
ajlm-2912	13	20	age	age	NOUN
ajlm-2912	13	21	of	of	ADP
ajlm-2912	13	22	25.80	25.80	NUM
ajlm-2912	13	23	±	±	NUM
ajlm-2912	13	24	5.45	5.45	NUM
ajlm-2912	13	25	years	year	NOUN
ajlm-2912	13	26	,	,	PUNCT
ajlm-2912	13	27	while	while	SCONJ
ajlm-2912	13	28	the	the	DET
ajlm-2912	13	29	mean	mean	ADJ
ajlm-2912	13	30	age	age	NOUN
ajlm-2912	13	31	of	of	ADP
ajlm-2912	13	32	the	the	DET
ajlm-2912	13	33	cases	case	NOUN
ajlm-2912	13	34	was	be	AUX
ajlm-2912	13	35	26.24	26.24	NUM
ajlm-2912	13	36	±	±	NUM
ajlm-2912	13	37	6.56	6.56	NUM
ajlm-2912	13	38	years	year	NOUN
ajlm-2912	13	39	,	,	PUNCT
ajlm-2912	13	40	with	with	ADP
ajlm-2912	13	41	121	121	NUM
ajlm-2912	13	42	women	woman	NOUN
ajlm-2912	13	43	and	and	CCONJ
ajlm-2912	13	44	79	79	NUM
ajlm-2912	13	45	men	man	NOUN
ajlm-2912	13	46	.	.	PUNCT
ajlm-2912	14	1	acne	acne	NOUN
ajlm-2912	14	2	patients	patient	NOUN
ajlm-2912	14	3	had	have	VERB
ajlm-2912	14	4	considerably	considerably	ADV
ajlm-2912	14	5	higher	high	ADJ
ajlm-2912	14	6	serum	serum	PROPN
ajlm-2912	14	7	mda	mda	PROPN
ajlm-2912	14	8	levels	level	NOUN
ajlm-2912	14	9	than	than	ADP
ajlm-2912	14	10	healthy	healthy	ADJ
ajlm-2912	14	11	controls	control	NOUN
ajlm-2912	14	12	(	(	PUNCT
ajlm-2912	14	13	p	p	X
ajlm-2912	14	14	<	<	X
ajlm-2912	14	15	0.001	0.001	NUM
ajlm-2912	14	16	)	)	PUNCT
ajlm-2912	14	17	.	.	PUNCT
ajlm-2912	15	1	malondialdehyde	malondialdehyde	PROPN
ajlm-2912	15	2	was	be	AUX
ajlm-2912	15	3	highest	high	ADJ
ajlm-2912	15	4	in	in	ADP
ajlm-2912	15	5	grade	grade	NOUN
ajlm-2912	15	6	4	4	NUM
ajlm-2912	15	7	patients	patient	NOUN
ajlm-2912	15	8	(	(	PUNCT
ajlm-2912	15	9	10.61	10.61	NUM
ajlm-2912	15	10	nmol	nmol	NOUN
ajlm-2912	15	11	/	/	SYM
ajlm-2912	15	12	ml	ml	NOUN
ajlm-2912	15	13	±	±	NUM
ajlm-2912	15	14	1.75	1.75	NUM
ajlm-2912	15	15	nmol	nmol	NOUN
ajlm-2912	15	16	/	/	SYM
ajlm-2912	15	17	ml	ml	NOUN
ajlm-2912	15	18	)	)	PUNCT
ajlm-2912	15	19	,	,	PUNCT
ajlm-2912	15	20	while	while	SCONJ
ajlm-2912	15	21	lowest	low	ADJ
ajlm-2912	15	22	mda	mda	PROPN
ajlm-2912	15	23	levels	level	NOUN
ajlm-2912	15	24	were	be	AUX
ajlm-2912	15	25	observed	observe	VERB
ajlm-2912	15	26	in	in	ADP
ajlm-2912	15	27	grade	grade	NOUN
ajlm-2912	15	28	1	1	NUM
ajlm-2912	15	29	acne	acne	NOUN
ajlm-2912	15	30	(	(	PUNCT
ajlm-2912	15	31	5.83	5.83	NUM
ajlm-2912	15	32	nmol	nmol	NOUN
ajlm-2912	15	33	/	/	SYM
ajlm-2912	15	34	ml	ml	PROPN
ajlm-2912	15	35	±	±	NUM
ajlm-2912	15	36	0.60	0.60	NUM
ajlm-2912	15	37	nmol	nmol	NOUN
ajlm-2912	15	38	/	/	SYM
ajlm-2912	15	39	ml	ml	NOUN
ajlm-2912	15	40	)	)	PUNCT
ajlm-2912	15	41	.	.	PUNCT
ajlm-2912	16	1	superoxide	superoxide	NOUN
ajlm-2912	16	2	dismutase	dismutase	NOUN
ajlm-2912	16	3	,	,	PUNCT
ajlm-2912	16	4	cat	cat	NOUN
ajlm-2912	16	5	and	and	CCONJ
ajlm-2912	16	6	gsh	gsh	NOUN
ajlm-2912	16	7	activities	activity	NOUN
ajlm-2912	16	8	were	be	AUX
ajlm-2912	16	9	significantly	significantly	ADV
ajlm-2912	16	10	lower	low	ADJ
ajlm-2912	16	11	in	in	ADP
ajlm-2912	16	12	acne	acne	NOUN
ajlm-2912	16	13	patients	patient	NOUN
ajlm-2912	16	14	in	in	ADP
ajlm-2912	16	15	comparison	comparison	NOUN
ajlm-2912	16	16	to	to	ADP
ajlm-2912	16	17	healthy	healthy	ADJ
ajlm-2912	16	18	controls	control	NOUN
ajlm-2912	16	19	(	(	PUNCT
ajlm-2912	16	20	p	p	X
ajlm-2912	16	21	<	<	X
ajlm-2912	16	22	0.001	0.001	NUM
ajlm-2912	16	23	)	)	PUNCT
ajlm-2912	16	24	.	.	PUNCT
ajlm-2912	17	1	the	the	DET
ajlm-2912	17	2	levels	level	NOUN
ajlm-2912	17	3	of	of	ADP
ajlm-2912	17	4	sod	sod	NOUN
ajlm-2912	17	5	,	,	PUNCT
ajlm-2912	17	6	cat	cat	NOUN
ajlm-2912	17	7	and	and	CCONJ
ajlm-2912	17	8	gsh	gsh	PROPN
ajlm-2912	17	9	decreased	decrease	VERB
ajlm-2912	17	10	as	as	SCONJ
ajlm-2912	17	11	the	the	DET
ajlm-2912	17	12	severity	severity	NOUN
ajlm-2912	17	13	of	of	ADP
ajlm-2912	17	14	disease	disease	NOUN
ajlm-2912	17	15	increased	increase	VERB
ajlm-2912	17	16	,	,	PUNCT
ajlm-2912	17	17	indicative	indicative	ADJ
ajlm-2912	17	18	of	of	ADP
ajlm-2912	17	19	antioxidant	antioxidant	ADJ
ajlm-2912	17	20	defence	defence	NOUN
ajlm-2912	17	21	system	system	NOUN
ajlm-2912	17	22	damage	damage	NOUN
ajlm-2912	17	23	.	.	PUNCT
ajlm-2912	18	1	conclusion	conclusion	NOUN
ajlm-2912	18	2	:	:	PUNCT
ajlm-2912	18	3	these	these	DET
ajlm-2912	18	4	findings	finding	NOUN
ajlm-2912	18	5	provide	provide	VERB
ajlm-2912	18	6	credence	credence	NOUN
ajlm-2912	18	7	to	to	ADP
ajlm-2912	18	8	the	the	DET
ajlm-2912	18	9	link	link	NOUN
ajlm-2912	18	10	between	between	ADP
ajlm-2912	18	11	acne	acne	NOUN
ajlm-2912	18	12	and	and	CCONJ
ajlm-2912	18	13	oxidative	oxidative	ADJ
ajlm-2912	18	14	stress	stress	NOUN
ajlm-2912	18	15	,	,	PUNCT
ajlm-2912	18	16	which	which	PRON
ajlm-2912	18	17	suggests	suggest	VERB
ajlm-2912	18	18	that	that	SCONJ
ajlm-2912	18	19	oxidative	oxidative	ADJ
ajlm-2912	18	20	stress	stress	NOUN
ajlm-2912	18	21	markers	marker	NOUN
ajlm-2912	18	22	could	could	AUX
ajlm-2912	18	23	be	be	AUX
ajlm-2912	18	24	helpful	helpful	ADJ
ajlm-2912	18	25	in	in	ADP
ajlm-2912	18	26	assessing	assess	VERB
ajlm-2912	18	27	the	the	DET
ajlm-2912	18	28	course	course	NOUN
ajlm-2912	18	29	of	of	ADP
ajlm-2912	18	30	acne	acne	NOUN
ajlm-2912	18	31	,	,	PUNCT
ajlm-2912	18	32	and	and	CCONJ
ajlm-2912	18	33	in	in	ADP
ajlm-2912	18	34	outlining	outline	VERB
ajlm-2912	18	35	the	the	DET
ajlm-2912	18	36	patho	patho	ADJ
ajlm-2912	18	37	-	-	PUNCT
ajlm-2912	18	38	physiological	physiological	ADJ
ajlm-2912	18	39	support	support	NOUN
ajlm-2912	18	40	of	of	ADP
ajlm-2912	18	41	the	the	DET
ajlm-2912	18	42	condition	condition	NOUN
ajlm-2912	18	43	.	.	PUNCT
ajlm-2912	19	1	what	what	PRON
ajlm-2912	19	2	this	this	DET
ajlm-2912	19	3	study	study	NOUN
ajlm-2912	19	4	adds	add	VERB
ajlm-2912	19	5	:	:	PUNCT
ajlm-2912	19	6	the	the	DET
ajlm-2912	19	7	study	study	NOUN
ajlm-2912	19	8	suggests	suggest	VERB
ajlm-2912	19	9	that	that	SCONJ
ajlm-2912	19	10	levels	level	NOUN
ajlm-2912	19	11	of	of	ADP
ajlm-2912	19	12	sod	sod	NOUN
ajlm-2912	19	13	,	,	PUNCT
ajlm-2912	19	14	cat	cat	NOUN
ajlm-2912	19	15	,	,	PUNCT
ajlm-2912	19	16	gsh	gsh	PROPN
ajlm-2912	19	17	and	and	CCONJ
ajlm-2912	19	18	mda	mda	PROPN
ajlm-2912	19	19	differ	differ	VERB
ajlm-2912	19	20	significantly	significantly	ADV
ajlm-2912	19	21	in	in	ADP
ajlm-2912	19	22	patients	patient	NOUN
ajlm-2912	19	23	with	with	ADP
ajlm-2912	19	24	acne	acne	NOUN
ajlm-2912	19	25	vulgaris	vulgaris	NOUN
ajlm-2912	19	26	,	,	PUNCT
ajlm-2912	19	27	adding	add	VERB
ajlm-2912	19	28	region	region	NOUN
ajlm-2912	19	29	-	-	PUNCT
ajlm-2912	19	30	specific	specific	ADJ
ajlm-2912	19	31	evidence	evidence	NOUN
ajlm-2912	19	32	from	from	ADP
ajlm-2912	19	33	the	the	DET
ajlm-2912	19	34	indian	indian	ADJ
ajlm-2912	19	35	population	population	NOUN
ajlm-2912	19	36	,	,	PUNCT
ajlm-2912	19	37	addressing	address	VERB
ajlm-2912	19	38	a	a	DET
ajlm-2912	19	39	gap	gap	NOUN
ajlm-2912	19	40	in	in	ADP
ajlm-2912	19	41	the	the	DET
ajlm-2912	19	42	literature	literature	NOUN
ajlm-2912	19	43	on	on	ADP
ajlm-2912	19	44	oxidative	oxidative	ADJ
ajlm-2912	19	45	stress	stress	NOUN
ajlm-2912	19	46	in	in	ADP
ajlm-2912	19	47	dermatological	dermatological	ADJ
ajlm-2912	19	48	conditions	condition	NOUN
ajlm-2912	19	49	in	in	ADP
ajlm-2912	19	50	this	this	DET
ajlm-2912	19	51	demographic	demographic	NOUN
ajlm-2912	19	52	.	.	PUNCT
ajlm-2912	20	1	keywords	keyword	NOUN
ajlm-2912	20	2	:	:	PUNCT
ajlm-2912	20	3	acne	acne	NOUN
ajlm-2912	20	4	vulgaris	vulgaris	NOUN
ajlm-2912	20	5	;	;	PUNCT
ajlm-2912	20	6	biomarkers	biomarker	NOUN
ajlm-2912	20	7	;	;	PUNCT
ajlm-2912	20	8	lipid	lipid	NOUN
ajlm-2912	20	9	peroxidation	peroxidation	NOUN
ajlm-2912	20	10	;	;	PUNCT
ajlm-2912	20	11	oxidative	oxidative	ADJ
ajlm-2912	20	12	stress	stress	NOUN
ajlm-2912	20	13	;	;	PUNCT
ajlm-2912	20	14	superoxide	superoxide	NOUN
ajlm-2912	20	15	dismutase	dismutase	NOUN
ajlm-2912	20	16	.	.	PUNCT
ajlm-2912	21	1	introduction	introduction	NOUN
ajlm-2912	21	2	acne	acne	NOUN
ajlm-2912	21	3	vulgaris	vulgaris	NOUN
ajlm-2912	21	4	(	(	PUNCT
ajlm-2912	21	5	av	av	NOUN
ajlm-2912	21	6	)	)	PUNCT
ajlm-2912	21	7	is	be	AUX
ajlm-2912	21	8	a	a	DET
ajlm-2912	21	9	chronic	chronic	ADJ
ajlm-2912	21	10	skin	skin	NOUN
ajlm-2912	21	11	disease	disease	NOUN
ajlm-2912	21	12	with	with	ADP
ajlm-2912	21	13	an	an	DET
ajlm-2912	21	14	inflammatory	inflammatory	ADJ
ajlm-2912	21	15	condition	condition	NOUN
ajlm-2912	21	16	caused	cause	VERB
ajlm-2912	21	17	by	by	ADP
ajlm-2912	21	18	changes	change	NOUN
ajlm-2912	21	19	in	in	ADP
ajlm-2912	21	20	pilosebaceous	pilosebaceous	ADJ
ajlm-2912	21	21	units	unit	NOUN
ajlm-2912	21	22	.	.	PUNCT
ajlm-2912	22	1	it	it	PRON
ajlm-2912	22	2	is	be	AUX
ajlm-2912	22	3	by	by	ADP
ajlm-2912	22	4	far	far	ADV
ajlm-2912	22	5	the	the	DET
ajlm-2912	22	6	most	most	ADV
ajlm-2912	22	7	common	common	ADJ
ajlm-2912	22	8	of	of	ADP
ajlm-2912	22	9	the	the	DET
ajlm-2912	22	10	several	several	ADJ
ajlm-2912	22	11	cutaneous	cutaneous	ADJ
ajlm-2912	22	12	disorders	disorder	NOUN
ajlm-2912	22	13	that	that	PRON
ajlm-2912	22	14	affect	affect	VERB
ajlm-2912	22	15	people.1	people.1	X
ajlm-2912	22	16	it	it	PRON
ajlm-2912	22	17	is	be	AUX
ajlm-2912	22	18	common	common	ADJ
ajlm-2912	22	19	,	,	PUNCT
ajlm-2912	22	20	not	not	PART
ajlm-2912	22	21	only	only	ADV
ajlm-2912	22	22	in	in	ADP
ajlm-2912	22	23	teenagers	teenager	NOUN
ajlm-2912	22	24	,	,	PUNCT
ajlm-2912	22	25	but	but	CCONJ
ajlm-2912	22	26	also	also	ADV
ajlm-2912	22	27	in	in	ADP
ajlm-2912	22	28	the	the	DET
ajlm-2912	22	29	adult	adult	NOUN
ajlm-2912	22	30	population	population	NOUN
ajlm-2912	22	31	.	.	PUNCT
ajlm-2912	23	1	the	the	DET
ajlm-2912	23	2	global	global	ADJ
ajlm-2912	23	3	burden	burden	NOUN
ajlm-2912	23	4	of	of	ADP
ajlm-2912	23	5	disease	disease	NOUN
ajlm-2912	23	6	estimates	estimate	VERB
ajlm-2912	23	7	that	that	SCONJ
ajlm-2912	23	8	85	85	NUM
ajlm-2912	23	9	%	%	NOUN
ajlm-2912	23	10	of	of	ADP
ajlm-2912	23	11	young	young	ADJ
ajlm-2912	23	12	adults	adult	NOUN
ajlm-2912	23	13	aged	age	VERB
ajlm-2912	23	14	between	between	ADP
ajlm-2912	23	15	12	12	NUM
ajlm-2912	23	16	and	and	CCONJ
ajlm-2912	23	17	25	25	NUM
ajlm-2912	23	18	years	year	NOUN
ajlm-2912	23	19	suffer	suffer	VERB
ajlm-2912	23	20	from	from	ADP
ajlm-2912	23	21	acne	acne	NOUN
ajlm-2912	23	22	,	,	PUNCT
ajlm-2912	23	23	which	which	PRON
ajlm-2912	23	24	can	can	AUX
ajlm-2912	23	25	occur	occur	VERB
ajlm-2912	23	26	in	in	ADP
ajlm-2912	23	27	individuals	individual	NOUN
ajlm-2912	23	28	of	of	ADP
ajlm-2912	23	29	any	any	DET
ajlm-2912	23	30	age	age	NOUN
ajlm-2912	23	31	,	,	PUNCT
ajlm-2912	23	32	race	race	NOUN
ajlm-2912	23	33	,	,	PUNCT
ajlm-2912	23	34	or	or	CCONJ
ajlm-2912	23	35	sex	sex	NOUN
ajlm-2912	23	36	or	or	CCONJ
ajlm-2912	23	37	gender.2,3	gender.2,3	PROPN
ajlm-2912	23	38	approximately	approximately	ADV
ajlm-2912	23	39	20	20	NUM
ajlm-2912	23	40	%	%	NOUN
ajlm-2912	23	41	of	of	ADP
ajlm-2912	23	42	the	the	DET
ajlm-2912	23	43	individuals	individual	NOUN
ajlm-2912	23	44	who	who	PRON
ajlm-2912	23	45	develop	develop	VERB
ajlm-2912	23	46	severe	severe	ADJ
ajlm-2912	23	47	acne	acne	NOUN
ajlm-2912	23	48	end	end	VERB
ajlm-2912	23	49	up	up	ADP
ajlm-2912	23	50	with	with	ADP
ajlm-2912	23	51	scarring	scarring	NOUN
ajlm-2912	23	52	.	.	PUNCT
ajlm-2912	24	1	while	while	SCONJ
ajlm-2912	24	2	white	white	ADJ
ajlm-2912	24	3	people	people	NOUN
ajlm-2912	24	4	are	be	AUX
ajlm-2912	24	5	more	more	ADV
ajlm-2912	24	6	likely	likely	ADJ
ajlm-2912	24	7	to	to	PART
ajlm-2912	24	8	have	have	VERB
ajlm-2912	24	9	mild	mild	ADJ
ajlm-2912	24	10	acne	acne	NOUN
ajlm-2912	24	11	,	,	PUNCT
ajlm-2912	24	12	asian	asian	ADJ
ajlm-2912	24	13	and	and	CCONJ
ajlm-2912	24	14	african	african	ADJ
ajlm-2912	24	15	people	people	NOUN
ajlm-2912	24	16	are	be	AUX
ajlm-2912	24	17	more	more	ADV
ajlm-2912	24	18	likely	likely	ADJ
ajlm-2912	24	19	to	to	PART
ajlm-2912	24	20	acquire	acquire	VERB
ajlm-2912	24	21	severe	severe	ADJ
ajlm-2912	24	22	forms	form	NOUN
ajlm-2912	24	23	.	.	PUNCT
ajlm-2912	25	1	generally	generally	ADV
ajlm-2912	25	2	,	,	PUNCT
ajlm-2912	25	3	hyperpigmentation	hyperpigmentation	NOUN
ajlm-2912	25	4	is	be	AUX
ajlm-2912	25	5	more	more	ADV
ajlm-2912	25	6	common	common	ADJ
ajlm-2912	25	7	in	in	ADP
ajlm-2912	25	8	darker	dark	ADJ
ajlm-2912	25	9	-	-	PUNCT
ajlm-2912	25	10	skinned	skin	VERB
ajlm-2912	25	11	individuals.4	individuals.4	PROPN
ajlm-2912	25	12	four	four	NUM
ajlm-2912	25	13	key	key	ADJ
ajlm-2912	25	14	interrelated	interrelated	ADJ
ajlm-2912	25	15	concepts	concept	NOUN
ajlm-2912	25	16	of	of	ADP
ajlm-2912	25	17	pathogenesis	pathogenesis	NOUN
ajlm-2912	25	18	that	that	PRON
ajlm-2912	25	19	lead	lead	VERB
ajlm-2912	25	20	to	to	ADP
ajlm-2912	25	21	the	the	DET
ajlm-2912	25	22	formation	formation	NOUN
ajlm-2912	25	23	of	of	ADP
ajlm-2912	25	24	av	av	PROPN
ajlm-2912	25	25	are	be	AUX
ajlm-2912	25	26	:	:	PUNCT
ajlm-2912	25	27	increased	increase	VERB
ajlm-2912	25	28	sebaceous	sebaceous	ADJ
ajlm-2912	25	29	gland	gland	NOUN
ajlm-2912	25	30	activity	activity	NOUN
ajlm-2912	25	31	,	,	PUNCT
ajlm-2912	25	32	keratinisation	keratinisation	NOUN
ajlm-2912	25	33	of	of	ADP
ajlm-2912	25	34	the	the	DET
ajlm-2912	25	35	middle	middle	ADJ
ajlm-2912	25	36	part	part	NOUN
ajlm-2912	25	37	of	of	ADP
ajlm-2912	25	38	the	the	DET
ajlm-2912	25	39	infundibulum	infundibulum	NOUN
ajlm-2912	25	40	,	,	PUNCT
ajlm-2912	25	41	bacterial	bacterial	ADJ
ajlm-2912	25	42	colonisation	colonisation	NOUN
ajlm-2912	25	43	,	,	PUNCT
ajlm-2912	25	44	and	and	CCONJ
ajlm-2912	25	45	inflammation	inflammation	NOUN
ajlm-2912	25	46	of	of	ADP
ajlm-2912	25	47	the	the	DET
ajlm-2912	25	48	follicle.5	follicle.5	NOUN
ajlm-2912	25	49	the	the	DET
ajlm-2912	25	50	most	most	ADV
ajlm-2912	25	51	common	common	ADJ
ajlm-2912	25	52	clinical	clinical	ADJ
ajlm-2912	25	53	signs	sign	NOUN
ajlm-2912	25	54	of	of	ADP
ajlm-2912	25	55	av	av	PRON
ajlm-2912	25	56	include	include	VERB
ajlm-2912	25	57	papules	papule	NOUN
ajlm-2912	25	58	,	,	PUNCT
ajlm-2912	25	59	pustules	pustule	NOUN
ajlm-2912	25	60	,	,	PUNCT
ajlm-2912	25	61	nodules	nodule	NOUN
ajlm-2912	25	62	,	,	PUNCT
ajlm-2912	25	63	cysts	cyst	NOUN
ajlm-2912	25	64	,	,	PUNCT
ajlm-2912	25	65	open	open	ADJ
ajlm-2912	25	66	and	and	CCONJ
ajlm-2912	25	67	closed	closed	ADJ
ajlm-2912	25	68	comedones	comedo	NOUN
ajlm-2912	25	69	,	,	PUNCT
ajlm-2912	25	70	and	and	CCONJ
ajlm-2912	25	71	sometimes	sometimes	ADV
ajlm-2912	25	72	,	,	PUNCT
ajlm-2912	25	73	scarring.6	scarring.6	VERB
ajlm-2912	25	74	the	the	DET
ajlm-2912	25	75	genetic	genetic	ADJ
ajlm-2912	25	76	component	component	NOUN
ajlm-2912	25	77	of	of	ADP
ajlm-2912	25	78	acne	acne	NOUN
ajlm-2912	25	79	has	have	AUX
ajlm-2912	25	80	been	be	AUX
ajlm-2912	25	81	supported	support	VERB
ajlm-2912	25	82	by	by	ADP
ajlm-2912	25	83	numerous	numerous	ADJ
ajlm-2912	25	84	studies	study	NOUN
ajlm-2912	25	85	.	.	PUNCT
ajlm-2912	26	1	acne	acne	NOUN
ajlm-2912	26	2	risk	risk	NOUN
ajlm-2912	26	3	can	can	AUX
ajlm-2912	26	4	be	be	AUX
ajlm-2912	26	5	up	up	ADP
ajlm-2912	26	6	to	to	PART
ajlm-2912	26	7	three	three	NUM
ajlm-2912	26	8	times	time	NOUN
ajlm-2912	26	9	higher	high	ADJ
ajlm-2912	26	10	for	for	ADP
ajlm-2912	26	11	those	those	PRON
ajlm-2912	26	12	with	with	ADP
ajlm-2912	26	13	afflicted	afflict	VERB
ajlm-2912	26	14	first	first	ADJ
ajlm-2912	26	15	-	-	PUNCT
ajlm-2912	26	16	degree	degree	NOUN
ajlm-2912	26	17	family	family	NOUN
ajlm-2912	26	18	members	member	NOUN
ajlm-2912	26	19	than	than	ADP
ajlm-2912	26	20	for	for	ADP
ajlm-2912	26	21	those	those	PRON
ajlm-2912	26	22	who	who	PRON
ajlm-2912	26	23	do	do	AUX
ajlm-2912	26	24	not	not	PART
ajlm-2912	26	25	have	have	VERB
ajlm-2912	26	26	a	a	DET
ajlm-2912	26	27	family	family	NOUN
ajlm-2912	26	28	history.7	history.7	NOUN
ajlm-2912	26	29	despite	despite	SCONJ
ajlm-2912	26	30	studies	study	NOUN
ajlm-2912	26	31	,	,	PUNCT
ajlm-2912	26	32	no	no	DET
ajlm-2912	26	33	single	single	ADJ
ajlm-2912	26	34	primary	primary	ADJ
ajlm-2912	26	35	cause	cause	NOUN
ajlm-2912	26	36	has	have	AUX
ajlm-2912	26	37	been	be	AUX
ajlm-2912	26	38	identified	identify	VERB
ajlm-2912	26	39	and	and	CCONJ
ajlm-2912	26	40	the	the	DET
ajlm-2912	26	41	aetiology	aetiology	NOUN
ajlm-2912	26	42	and	and	CCONJ
ajlm-2912	26	43	pathogenesis	pathogenesis	NOUN
ajlm-2912	26	44	of	of	ADP
ajlm-2912	26	45	acne	acne	NOUN
ajlm-2912	26	46	remain	remain	VERB
ajlm-2912	26	47	unclear.8,9	unclear.8,9	ADJ
ajlm-2912	27	1	it	it	PRON
ajlm-2912	27	2	has	have	AUX
ajlm-2912	27	3	been	be	AUX
ajlm-2912	27	4	suggested	suggest	VERB
ajlm-2912	27	5	that	that	SCONJ
ajlm-2912	27	6	one	one	NUM
ajlm-2912	27	7	of	of	ADP
ajlm-2912	27	8	the	the	DET
ajlm-2912	27	9	pathogenic	pathogenic	ADJ
ajlm-2912	27	10	conditions	condition	NOUN
ajlm-2912	27	11	in	in	ADP
ajlm-2912	27	12	av	av	PROPN
ajlm-2912	27	13	is	be	AUX
ajlm-2912	27	14	the	the	DET
ajlm-2912	27	15	generation	generation	NOUN
ajlm-2912	27	16	of	of	ADP
ajlm-2912	27	17	ros	ros	PROPN
ajlm-2912	27	18	(	(	PUNCT
ajlm-2912	27	19	reactive	reactive	ADJ
ajlm-2912	27	20	oxygen	oxygen	NOUN
ajlm-2912	27	21	species	specie	NOUN
ajlm-2912	27	22	)	)	PUNCT
ajlm-2912	27	23	by	by	ADP
ajlm-2912	27	24	neutrophils	neutrophil	NOUN
ajlm-2912	27	25	,	,	PUNCT
ajlm-2912	27	26	resulting	result	VERB
ajlm-2912	27	27	in	in	ADP
ajlm-2912	27	28	tissue	tissue	NOUN
ajlm-2912	27	29	injury	injury	NOUN
ajlm-2912	27	30	and	and	CCONJ
ajlm-2912	27	31	inhibition	inhibition	NOUN
ajlm-2912	27	32	of	of	ADP
ajlm-2912	27	33	ros	ros	PROPN
ajlm-2912	27	34	production	production	NOUN
ajlm-2912	27	35	can	can	AUX
ajlm-2912	27	36	be	be	AUX
ajlm-2912	27	37	beneficial	beneficial	ADJ
ajlm-2912	27	38	from	from	ADP
ajlm-2912	27	39	a	a	DET
ajlm-2912	27	40	therapeutic	therapeutic	ADJ
ajlm-2912	27	41	standpoint.10,11	standpoint.10,11	NOUN
ajlm-2912	27	42	the	the	DET
ajlm-2912	27	43	ros	ros	PROPN
ajlm-2912	27	44	system	system	NOUN
ajlm-2912	27	45	includes	include	VERB
ajlm-2912	27	46	free	free	ADJ
ajlm-2912	27	47	radicals	radical	NOUN
ajlm-2912	27	48	such	such	ADJ
ajlm-2912	27	49	as	as	ADP
ajlm-2912	27	50	the	the	DET
ajlm-2912	27	51	superoxide	superoxide	NOUN
ajlm-2912	27	52	ion	ion	NOUN
ajlm-2912	27	53	radical	radical	NOUN
ajlm-2912	27	54	,	,	PUNCT
ajlm-2912	27	55	the	the	DET
ajlm-2912	27	56	hydroxyl	hydroxyl	NOUN
ajlm-2912	27	57	radical	radical	NOUN
ajlm-2912	27	58	,	,	PUNCT
ajlm-2912	27	59	and	and	CCONJ
ajlm-2912	27	60	the	the	DET
ajlm-2912	27	61	nitric	nitric	ADJ
ajlm-2912	27	62	oxide	oxide	NOUN
ajlm-2912	27	63	radical	radical	ADJ
ajlm-2912	27	64	,	,	PUNCT
ajlm-2912	27	65	as	as	ADV
ajlm-2912	27	66	well	well	ADV
ajlm-2912	27	67	as	as	ADP
ajlm-2912	27	68	non	non	NOUN
ajlm-2912	27	69	-	-	NOUN
ajlm-2912	27	70	radicals	radical	NOUN
ajlm-2912	27	71	such	such	ADJ
ajlm-2912	27	72	as	as	ADP
ajlm-2912	27	73	hydrogen	hydrogen	NOUN
ajlm-2912	27	74	peroxide	peroxide	NOUN
ajlm-2912	27	75	and	and	CCONJ
ajlm-2912	27	76	ozone	ozone	NOUN
ajlm-2912	27	77	.	.	PUNCT
ajlm-2912	28	1	these	these	PRON
ajlm-2912	28	2	have	have	AUX
ajlm-2912	28	3	been	be	AUX
ajlm-2912	28	4	linked	link	VERB
ajlm-2912	28	5	to	to	ADP
ajlm-2912	28	6	processes	process	NOUN
ajlm-2912	28	7	of	of	ADP
ajlm-2912	28	8	mutagenesis	mutagenesis	NOUN
ajlm-2912	28	9	,	,	PUNCT
ajlm-2912	28	10	tumorigenesis	tumorigenesis	NOUN
ajlm-2912	28	11	,	,	PUNCT
ajlm-2912	28	12	inflammatory	inflammatory	ADJ
ajlm-2912	28	13	responses	response	NOUN
ajlm-2912	28	14	,	,	PUNCT
ajlm-2912	28	15	and	and	CCONJ
ajlm-2912	28	16	senescence.12,13	senescence.12,13	VERB
ajlm-2912	28	17	acne	acne	NOUN
ajlm-2912	28	18	is	be	AUX
ajlm-2912	28	19	characterised	characterise	VERB
ajlm-2912	28	20	by	by	ADP
ajlm-2912	28	21	changes	change	NOUN
ajlm-2912	28	22	in	in	ADP
ajlm-2912	28	23	sebum	sebum	NOUN
ajlm-2912	28	24	composition	composition	NOUN
ajlm-2912	28	25	,	,	PUNCT
ajlm-2912	28	26	and	and	CCONJ
ajlm-2912	28	27	neutrophil	neutrophil	ADV
ajlm-2912	28	28	-	-	PUNCT
ajlm-2912	28	29	produced	produce	VERB
ajlm-2912	28	30	ros	ros	PROPN
ajlm-2912	28	31	contribute	contribute	VERB
ajlm-2912	28	32	to	to	ADP
ajlm-2912	28	33	follicular	follicular	ADJ
ajlm-2912	28	34	wall	wall	NOUN
ajlm-2912	28	35	irritation	irritation	NOUN
ajlm-2912	28	36	and	and	CCONJ
ajlm-2912	28	37	destruction	destruction	NOUN
ajlm-2912	28	38	,	,	PUNCT
ajlm-2912	28	39	which	which	PRON
ajlm-2912	28	40	in	in	ADP
ajlm-2912	28	41	turn	turn	NOUN
ajlm-2912	28	42	fuels	fuel	VERB
ajlm-2912	28	43	the	the	DET
ajlm-2912	28	44	inflammatory	inflammatory	ADJ
ajlm-2912	28	45	course	course	NOUN
ajlm-2912	28	46	of	of	ADP
ajlm-2912	28	47	acne.14	acne.14	PROPN
ajlm-2912	28	48	moreover	moreover	ADV
ajlm-2912	28	49	,	,	PUNCT
ajlm-2912	28	50	the	the	DET
ajlm-2912	28	51	reactions	reaction	NOUN
ajlm-2912	28	52	between	between	ADP
ajlm-2912	28	53	lipidic	lipidic	ADJ
ajlm-2912	28	54	structures	structure	NOUN
ajlm-2912	28	55	and	and	CCONJ
ajlm-2912	28	56	ros	ros	PROPN
ajlm-2912	28	57	can	can	AUX
ajlm-2912	28	58	result	result	VERB
ajlm-2912	28	59	in	in	ADP
ajlm-2912	28	60	the	the	DET
ajlm-2912	28	61	peroxidation	peroxidation	NOUN
ajlm-2912	28	62	of	of	ADP
ajlm-2912	28	63	polyunsaturated	polyunsaturate	VERB
ajlm-2912	28	64	fatty	fatty	NOUN
ajlm-2912	28	65	acid	acid	NOUN
ajlm-2912	28	66	and	and	CCONJ
ajlm-2912	28	67	the	the	DET
ajlm-2912	28	68	production	production	NOUN
ajlm-2912	28	69	of	of	ADP
ajlm-2912	28	70	toxic	toxic	ADJ
ajlm-2912	28	71	compounds	compound	NOUN
ajlm-2912	28	72	such	such	ADJ
ajlm-2912	28	73	as	as	ADP
ajlm-2912	28	74	malondialdehyde	malondialdehyde	PROPN
ajlm-2912	28	75	(	(	PUNCT
ajlm-2912	28	76	mda	mda	PROPN
ajlm-2912	28	77	)	)	PUNCT
ajlm-2912	28	78	,	,	PUNCT
ajlm-2912	28	79	which	which	PRON
ajlm-2912	28	80	can	can	AUX
ajlm-2912	28	81	be	be	AUX
ajlm-2912	28	82	used	use	VERB
ajlm-2912	28	83	as	as	ADP
ajlm-2912	28	84	markers	marker	NOUN
ajlm-2912	28	85	to	to	PART
ajlm-2912	28	86	assess	assess	VERB
ajlm-2912	28	87	oxidative	oxidative	ADJ
ajlm-2912	28	88	damage	damage	NOUN
ajlm-2912	28	89	in	in	ADP
ajlm-2912	28	90	cells.15	cells.15	NOUN
ajlm-2912	28	91	enzymatic	enzymatic	ADJ
ajlm-2912	28	92	and	and	CCONJ
ajlm-2912	28	93	non	non	ADJ
ajlm-2912	28	94	-	-	ADJ
ajlm-2912	28	95	enzymatic	enzymatic	ADJ
ajlm-2912	28	96	antioxidant	antioxidant	ADJ
ajlm-2912	28	97	defence	defence	NOUN
ajlm-2912	28	98	mechanisms	mechanism	NOUN
ajlm-2912	28	99	are	be	AUX
ajlm-2912	28	100	both	both	PRON
ajlm-2912	28	101	present	present	ADJ
ajlm-2912	28	102	in	in	ADP
ajlm-2912	28	103	human	human	ADJ
ajlm-2912	28	104	cells	cell	NOUN
ajlm-2912	28	105	.	.	PUNCT
ajlm-2912	29	1	as	as	ADP
ajlm-2912	29	2	the	the	DET
ajlm-2912	29	3	first	first	ADJ
ajlm-2912	29	4	line	line	NOUN
ajlm-2912	29	5	of	of	ADP
ajlm-2912	29	6	defence	defence	NOUN
ajlm-2912	29	7	against	against	ADP
ajlm-2912	29	8	oxygen	oxygen	NOUN
ajlm-2912	29	9	-	-	PUNCT
ajlm-2912	29	10	derived	derive	VERB
ajlm-2912	29	11	free	free	ADJ
ajlm-2912	29	12	radicals	radical	NOUN
ajlm-2912	29	13	,	,	PUNCT
ajlm-2912	29	14	the	the	DET
ajlm-2912	29	15	sod	sod	NOUN
ajlm-2912	29	16	–	–	PUNCT
ajlm-2912	29	17	cat	cat	NOUN
ajlm-2912	29	18	(	(	PUNCT
ajlm-2912	29	19	superoxide	superoxide	NOUN
ajlm-2912	29	20	dismutase	dismutase	NOUN
ajlm-2912	29	21	–	–	PUNCT
ajlm-2912	29	22	catalase	catalase	NOUN
ajlm-2912	29	23	)	)	PUNCT
ajlm-2912	29	24	system	system	NOUN
ajlm-2912	29	25	is	be	AUX
ajlm-2912	29	26	a	a	DET
ajlm-2912	29	27	key	key	ADJ
ajlm-2912	29	28	enzymatic	enzymatic	ADJ
ajlm-2912	29	29	system	system	NOUN
ajlm-2912	29	30	that	that	PRON
ajlm-2912	29	31	catalyses	catalyse	VERB
ajlm-2912	29	32	the	the	DET
ajlm-2912	29	33	dismutation	dismutation	NOUN
ajlm-2912	29	34	of	of	ADP
ajlm-2912	29	35	superoxide	superoxide	NOUN
ajlm-2912	29	36	into	into	ADP
ajlm-2912	29	37	hydrogen	hydrogen	NOUN
ajlm-2912	29	38	peroxide	peroxide	NOUN
ajlm-2912	29	39	,	,	PUNCT
ajlm-2912	29	40	which	which	PRON
ajlm-2912	29	41	subsequently	subsequently	ADV
ajlm-2912	29	42	converts	convert	VERB
ajlm-2912	29	43	into	into	ADP
ajlm-2912	29	44	water	water	NOUN
ajlm-2912	29	45	by	by	ADP
ajlm-2912	29	46	catalase	catalase	NOUN
ajlm-2912	29	47	.	.	PUNCT
ajlm-2912	30	1	this	this	DET
ajlm-2912	30	2	process	process	NOUN
ajlm-2912	30	3	regulates	regulate	VERB
ajlm-2912	30	4	the	the	DET
ajlm-2912	30	5	production	production	NOUN
ajlm-2912	30	6	of	of	ADP
ajlm-2912	30	7	ros	ros	PROPN
ajlm-2912	30	8	and	and	CCONJ
ajlm-2912	30	9	is	be	AUX
ajlm-2912	30	10	therefore	therefore	ADV
ajlm-2912	30	11	essential	essential	ADJ
ajlm-2912	30	12	for	for	ADP
ajlm-2912	30	13	preserving	preserve	VERB
ajlm-2912	30	14	a	a	DET
ajlm-2912	30	15	proper	proper	ADJ
ajlm-2912	30	16	cellular	cellular	ADJ
ajlm-2912	30	17	redox	redox	NOUN
ajlm-2912	30	18	balance.16	balance.16	PROPN
ajlm-2912	30	19	oxidative	oxidative	ADJ
ajlm-2912	30	20	stress	stress	NOUN
ajlm-2912	30	21	can	can	AUX
ajlm-2912	30	22	result	result	VERB
ajlm-2912	30	23	from	from	ADP
ajlm-2912	30	24	changes	change	NOUN
ajlm-2912	30	25	in	in	ADP
ajlm-2912	30	26	this	this	DET
ajlm-2912	30	27	natural	natural	ADJ
ajlm-2912	30	28	balance	balance	NOUN
ajlm-2912	30	29	,	,	PUNCT
ajlm-2912	30	30	which	which	PRON
ajlm-2912	30	31	can	can	AUX
ajlm-2912	30	32	be	be	AUX
ajlm-2912	30	33	brought	bring	VERB
ajlm-2912	30	34	on	on	ADP
ajlm-2912	30	35	by	by	ADP
ajlm-2912	30	36	increased	increase	VERB
ajlm-2912	30	37	ros	ros	PROPN
ajlm-2912	30	38	generation	generation	NOUN
ajlm-2912	30	39	and/or	and/or	CCONJ
ajlm-2912	30	40	decreased	decrease	VERB
ajlm-2912	30	41	antioxidant	antioxidant	ADJ
ajlm-2912	30	42	levels.17,18	levels.17,18	NOUN
ajlm-2912	30	43	a	a	DET
ajlm-2912	30	44	few	few	ADJ
ajlm-2912	30	45	studies	study	NOUN
ajlm-2912	30	46	have	have	AUX
ajlm-2912	30	47	reported	report	VERB
ajlm-2912	30	48	the	the	DET
ajlm-2912	30	49	increased	increase	VERB
ajlm-2912	30	50	oxidative	oxidative	ADJ
ajlm-2912	30	51	stress	stress	NOUN
ajlm-2912	30	52	in	in	ADP
ajlm-2912	30	53	av.19,20	av.19,20	NOUN
ajlm-2912	30	54	however	however	ADV
ajlm-2912	30	55	,	,	PUNCT
ajlm-2912	30	56	the	the	DET
ajlm-2912	30	57	disturbance	disturbance	NOUN
ajlm-2912	30	58	in	in	ADP
ajlm-2912	30	59	oxidants	oxidant	NOUN
ajlm-2912	30	60	–	–	PUNCT
ajlm-2912	30	61	antioxidant	antioxidant	NOUN
ajlm-2912	30	62	systems	system	NOUN
ajlm-2912	30	63	in	in	ADP
ajlm-2912	30	64	the	the	DET
ajlm-2912	30	65	disease	disease	NOUN
ajlm-2912	30	66	progression	progression	NOUN
ajlm-2912	30	67	has	have	AUX
ajlm-2912	30	68	not	not	PART
ajlm-2912	30	69	been	be	AUX
ajlm-2912	30	70	studied	study	VERB
ajlm-2912	30	71	extensively	extensively	ADV
ajlm-2912	30	72	in	in	ADP
ajlm-2912	30	73	the	the	DET
ajlm-2912	30	74	indian	indian	ADJ
ajlm-2912	30	75	regional	regional	ADJ
ajlm-2912	30	76	setting	setting	NOUN
ajlm-2912	30	77	.	.	PUNCT
ajlm-2912	31	1	therefore	therefore	ADV
ajlm-2912	31	2	,	,	PUNCT
ajlm-2912	31	3	we	we	PRON
ajlm-2912	31	4	measured	measure	VERB
ajlm-2912	31	5	the	the	DET
ajlm-2912	31	6	levels	level	NOUN
ajlm-2912	31	7	of	of	ADP
ajlm-2912	31	8	biochemical	biochemical	ADJ
ajlm-2912	31	9	indicators	indicator	NOUN
ajlm-2912	31	10	of	of	ADP
ajlm-2912	31	11	oxidative	oxidative	ADJ
ajlm-2912	31	12	stress	stress	NOUN
ajlm-2912	31	13	in	in	ADP
ajlm-2912	31	14	patients	patient	NOUN
ajlm-2912	31	15	of	of	ADP
ajlm-2912	31	16	av	av	PROPN
ajlm-2912	31	17	,	,	PUNCT
ajlm-2912	31	18	and	and	CCONJ
ajlm-2912	31	19	compared	compare	VERB
ajlm-2912	31	20	their	their	PRON
ajlm-2912	31	21	relationship	relationship	NOUN
ajlm-2912	31	22	to	to	ADP
ajlm-2912	31	23	the	the	DET
ajlm-2912	31	24	severity	severity	NOUN
ajlm-2912	31	25	of	of	ADP
ajlm-2912	31	26	disease	disease	NOUN
ajlm-2912	31	27	activity	activity	NOUN
ajlm-2912	31	28	(	(	PUNCT
ajlm-2912	31	29	grades	grade	NOUN
ajlm-2912	31	30	1	1	NUM
ajlm-2912	31	31	,	,	PUNCT
ajlm-2912	31	32	2	2	NUM
ajlm-2912	31	33	,	,	PUNCT
ajlm-2912	31	34	3	3	NUM
ajlm-2912	31	35	,	,	PUNCT
ajlm-2912	31	36	and	and	CCONJ
ajlm-2912	31	37	4	4	X
ajlm-2912	31	38	)	)	PUNCT
ajlm-2912	31	39	in	in	ADP
ajlm-2912	31	40	the	the	DET
ajlm-2912	31	41	indian	indian	ADJ
ajlm-2912	31	42	population	population	NOUN
ajlm-2912	31	43	.	.	PUNCT
ajlm-2912	32	1	our	our	PRON
ajlm-2912	32	2	results	result	NOUN
ajlm-2912	32	3	not	not	PART
ajlm-2912	32	4	only	only	ADV
ajlm-2912	32	5	support	support	VERB
ajlm-2912	32	6	an	an	DET
ajlm-2912	32	7	association	association	NOUN
ajlm-2912	32	8	between	between	ADP
ajlm-2912	32	9	oxidative	oxidative	ADJ
ajlm-2912	32	10	stress	stress	NOUN
ajlm-2912	32	11	and	and	CCONJ
ajlm-2912	32	12	acne	acne	NOUN
ajlm-2912	32	13	;	;	PUNCT
ajlm-2912	32	14	they	they	PRON
ajlm-2912	32	15	show	show	VERB
ajlm-2912	32	16	that	that	SCONJ
ajlm-2912	32	17	it	it	PRON
ajlm-2912	32	18	may	may	AUX
ajlm-2912	32	19	be	be	AUX
ajlm-2912	32	20	used	use	VERB
ajlm-2912	32	21	as	as	ADP
ajlm-2912	32	22	a	a	DET
ajlm-2912	32	23	biomarker	biomarker	NOUN
ajlm-2912	32	24	index	index	NOUN
ajlm-2912	32	25	for	for	ADP
ajlm-2912	32	26	evaluating	evaluate	VERB
ajlm-2912	32	27	the	the	DET
ajlm-2912	32	28	activity	activity	NOUN
ajlm-2912	32	29	of	of	ADP
ajlm-2912	32	30	the	the	DET
ajlm-2912	32	31	disease	disease	NOUN
ajlm-2912	32	32	and	and	CCONJ
ajlm-2912	32	33	to	to	PART
ajlm-2912	32	34	monitor	monitor	VERB
ajlm-2912	32	35	the	the	DET
ajlm-2912	32	36	course	course	NOUN
ajlm-2912	32	37	of	of	ADP
ajlm-2912	32	38	treatment	treatment	NOUN
ajlm-2912	32	39	.	.	PUNCT
ajlm-2912	33	1	methods	method	NOUN
ajlm-2912	33	2	ethical	ethical	ADJ
ajlm-2912	33	3	considerations	consideration	NOUN
ajlm-2912	33	4	the	the	DET
ajlm-2912	33	5	study	study	NOUN
ajlm-2912	33	6	was	be	AUX
ajlm-2912	33	7	carried	carry	VERB
ajlm-2912	33	8	out	out	ADP
ajlm-2912	33	9	in	in	ADP
ajlm-2912	33	10	compliance	compliance	NOUN
ajlm-2912	33	11	with	with	ADP
ajlm-2912	33	12	the	the	DET
ajlm-2912	33	13	declaration	declaration	NOUN
ajlm-2912	33	14	of	of	ADP
ajlm-2912	33	15	helsinki	helsinki	PROPN
ajlm-2912	33	16	and	and	CCONJ
ajlm-2912	33	17	approved	approve	VERB
ajlm-2912	33	18	by	by	ADP
ajlm-2912	33	19	the	the	DET
ajlm-2912	33	20	institution	institution	NOUN
ajlm-2912	33	21	ethics	ethic	NOUN
ajlm-2912	33	22	committee	committee	PROPN
ajlm-2912	33	23	of	of	ADP
ajlm-2912	33	24	sgt	sgt	PROPN
ajlm-2912	33	25	university	university	PROPN
ajlm-2912	33	26	,	,	PUNCT
ajlm-2912	33	27	faculty	faculty	NOUN
ajlm-2912	33	28	of	of	ADP
ajlm-2912	33	29	medicine	medicine	NOUN
ajlm-2912	33	30	and	and	CCONJ
ajlm-2912	33	31	health	health	NOUN
ajlm-2912	33	32	sciences	science	NOUN
ajlm-2912	33	33	,	,	PUNCT
ajlm-2912	33	34	with	with	ADP
ajlm-2912	33	35	vide	vide	NOUN
ajlm-2912	33	36	letter	letter	NOUN
ajlm-2912	33	37	number	number	NOUN
ajlm-2912	33	38	iec	iec	PROPN
ajlm-2912	33	39	/	/	SYM
ajlm-2912	33	40	fmhs	fmhs	NOUN
ajlm-2912	33	41	/	/	SYM
ajlm-2912	33	42	md	md	PROPN
ajlm-2912	33	43	/	/	SYM
ajlm-2912	33	44	ms/2023	ms/2023	PROPN
ajlm-2912	33	45	-	-	PUNCT
ajlm-2912	33	46	29	29	NUM
ajlm-2912	33	47	dated	date	VERB
ajlm-2912	33	48	03/06/2023	03/06/2023	NUM
ajlm-2912	33	49	.	.	PUNCT
ajlm-2912	34	1	written	write	VERB
ajlm-2912	34	2	and	and	CCONJ
ajlm-2912	34	3	informed	informed	ADJ
ajlm-2912	34	4	consent	consent	NOUN
ajlm-2912	34	5	was	be	AUX
ajlm-2912	34	6	obtained	obtain	VERB
ajlm-2912	34	7	after	after	ADP
ajlm-2912	34	8	explaining	explain	VERB
ajlm-2912	34	9	the	the	DET
ajlm-2912	34	10	purpose	purpose	NOUN
ajlm-2912	34	11	and	and	CCONJ
ajlm-2912	34	12	details	detail	NOUN
ajlm-2912	34	13	of	of	ADP
ajlm-2912	34	14	the	the	DET
ajlm-2912	34	15	study	study	NOUN
ajlm-2912	34	16	to	to	ADP
ajlm-2912	34	17	all	all	PRON
ajlm-2912	34	18	of	of	ADP
ajlm-2912	34	19	the	the	DET
ajlm-2912	34	20	subjects	subject	NOUN
ajlm-2912	34	21	.	.	PUNCT
ajlm-2912	35	1	protocol	protocol	NOUN
ajlm-2912	35	2	numbers	number	NOUN
ajlm-2912	35	3	were	be	AUX
ajlm-2912	35	4	assigned	assign	VERB
ajlm-2912	35	5	for	for	ADP
ajlm-2912	35	6	reference	reference	NOUN
ajlm-2912	35	7	,	,	PUNCT
ajlm-2912	35	8	and	and	CCONJ
ajlm-2912	35	9	participant	participant	ADJ
ajlm-2912	35	10	personal	personal	ADJ
ajlm-2912	35	11	information	information	NOUN
ajlm-2912	35	12	was	be	AUX
ajlm-2912	35	13	kept	keep	VERB
ajlm-2912	35	14	private	private	ADJ
ajlm-2912	35	15	and	and	CCONJ
ajlm-2912	35	16	used	use	VERB
ajlm-2912	35	17	only	only	ADV
ajlm-2912	35	18	for	for	ADP
ajlm-2912	35	19	research	research	NOUN
ajlm-2912	35	20	.	.	PUNCT
ajlm-2912	36	1	data	datum	NOUN
ajlm-2912	36	2	security	security	NOUN
ajlm-2912	36	3	measures	measure	NOUN
ajlm-2912	36	4	included	include	VERB
ajlm-2912	36	5	password	password	NOUN
ajlm-2912	36	6	protection	protection	NOUN
ajlm-2912	36	7	of	of	ADP
ajlm-2912	36	8	the	the	DET
ajlm-2912	36	9	computer	computer	NOUN
ajlm-2912	36	10	and	and	CCONJ
ajlm-2912	36	11	data	datum	NOUN
ajlm-2912	36	12	storage	storage	NOUN
ajlm-2912	36	13	in	in	ADP
ajlm-2912	36	14	a	a	DET
ajlm-2912	36	15	safe	safe	ADJ
ajlm-2912	36	16	physical	physical	ADJ
ajlm-2912	36	17	location	location	NOUN
ajlm-2912	36	18	.	.	PUNCT
ajlm-2912	37	1	study	study	NOUN
ajlm-2912	37	2	design	design	NOUN
ajlm-2912	37	3	and	and	CCONJ
ajlm-2912	37	4	settings	setting	NOUN
ajlm-2912	37	5	this	this	DET
ajlm-2912	37	6	observational	observational	ADJ
ajlm-2912	37	7	cross	cross	ADJ
ajlm-2912	37	8	-	-	ADJ
ajlm-2912	37	9	sectional	sectional	ADJ
ajlm-2912	37	10	study	study	NOUN
ajlm-2912	37	11	was	be	AUX
ajlm-2912	37	12	carried	carry	VERB
ajlm-2912	37	13	out	out	ADP
ajlm-2912	37	14	in	in	ADP
ajlm-2912	37	15	the	the	DET
ajlm-2912	37	16	department	department	NOUN
ajlm-2912	37	17	of	of	ADP
ajlm-2912	37	18	biochemistry	biochemistry	NOUN
ajlm-2912	37	19	of	of	ADP
ajlm-2912	37	20	the	the	DET
ajlm-2912	37	21	faculty	faculty	NOUN
ajlm-2912	37	22	of	of	ADP
ajlm-2912	37	23	medicine	medicine	NOUN
ajlm-2912	37	24	and	and	CCONJ
ajlm-2912	37	25	health	health	NOUN
ajlm-2912	37	26	sciences	science	NOUN
ajlm-2912	37	27	at	at	ADP
ajlm-2912	37	28	sgt	sgt	PROPN
ajlm-2912	37	29	university	university	PROPN
ajlm-2912	37	30	,	,	PUNCT
ajlm-2912	37	31	gurugram	gurugram	PROPN
ajlm-2912	37	32	,	,	PUNCT
ajlm-2912	37	33	india	india	PROPN
ajlm-2912	37	34	,	,	PUNCT
ajlm-2912	37	35	from	from	ADP
ajlm-2912	37	36	01	01	NUM
ajlm-2912	37	37	july	july	PROPN
ajlm-2912	37	38	2023	2023	NUM
ajlm-2912	37	39	to	to	ADP
ajlm-2912	37	40	30	30	NUM
ajlm-2912	37	41	june	june	PROPN
ajlm-2912	37	42	2024	2024	NUM
ajlm-2912	37	43	.	.	PUNCT
ajlm-2912	38	1	sample	sample	NOUN
ajlm-2912	38	2	size	size	NOUN
ajlm-2912	38	3	acne	acne	NOUN
ajlm-2912	38	4	severity	severity	NOUN
ajlm-2912	38	5	was	be	AUX
ajlm-2912	38	6	assessed	assess	VERB
ajlm-2912	38	7	by	by	ADP
ajlm-2912	38	8	a	a	DET
ajlm-2912	38	9	single	single	ADJ
ajlm-2912	38	10	experienced	experienced	ADJ
ajlm-2912	38	11	dermatologist	dermatologist	NOUN
ajlm-2912	38	12	using	use	VERB
ajlm-2912	38	13	a	a	DET
ajlm-2912	38	14	simple	simple	ADJ
ajlm-2912	38	15	grading	grade	VERB
ajlm-2912	38	16	system	system	NOUN
ajlm-2912	38	17	by	by	ADP
ajlm-2912	38	18	tutakne	tutakne	NOUN
ajlm-2912	38	19	and	and	CCONJ
ajlm-2912	38	20	chari,21	chari,21	NOUN
ajlm-2912	38	21	to	to	PART
ajlm-2912	38	22	ensure	ensure	VERB
ajlm-2912	38	23	consistency	consistency	NOUN
ajlm-2912	38	24	and	and	CCONJ
ajlm-2912	38	25	avoid	avoid	VERB
ajlm-2912	38	26	interrater	interrater	ADJ
ajlm-2912	38	27	variability	variability	NOUN
ajlm-2912	38	28	:	:	PUNCT
ajlm-2912	38	29	grade	grade	NOUN
ajlm-2912	38	30	1	1	NUM
ajlm-2912	38	31	:	:	PUNCT
ajlm-2912	38	32	comedones	comedo	NOUN
ajlm-2912	38	33	,	,	PUNCT
ajlm-2912	38	34	occasional	occasional	ADJ
ajlm-2912	38	35	papules	papule	NOUN
ajlm-2912	38	36	grade	grade	NOUN
ajlm-2912	38	37	2	2	NUM
ajlm-2912	38	38	:	:	PUNCT
ajlm-2912	38	39	papules	papule	NOUN
ajlm-2912	38	40	,	,	PUNCT
ajlm-2912	38	41	comedones	comedo	NOUN
ajlm-2912	38	42	,	,	PUNCT
ajlm-2912	38	43	few	few	ADJ
ajlm-2912	38	44	pustules	pustule	NOUN
ajlm-2912	38	45	grade	grade	NOUN
ajlm-2912	38	46	3	3	NUM
ajlm-2912	38	47	:	:	PUNCT
ajlm-2912	38	48	prominent	prominent	ADJ
ajlm-2912	38	49	pustules	pustule	NOUN
ajlm-2912	38	50	,	,	PUNCT
ajlm-2912	38	51	nodules	nodule	NOUN
ajlm-2912	38	52	and	and	CCONJ
ajlm-2912	38	53	abscesses	abscess	NOUN
ajlm-2912	38	54	grade	grade	NOUN
ajlm-2912	38	55	4	4	NUM
ajlm-2912	38	56	:	:	PUNCT
ajlm-2912	38	57	mainly	mainly	ADV
ajlm-2912	38	58	cysts	cyst	NOUN
ajlm-2912	38	59	,	,	PUNCT
ajlm-2912	38	60	abscesses	abscess	NOUN
ajlm-2912	38	61	,	,	PUNCT
ajlm-2912	38	62	widespread	widespread	ADJ
ajlm-2912	38	63	scarring	scarring	NOUN
ajlm-2912	38	64	by	by	ADP
ajlm-2912	38	65	keeping	keep	VERB
ajlm-2912	38	66	the	the	DET
ajlm-2912	38	67	confidence	confidence	NOUN
ajlm-2912	38	68	level	level	NOUN
ajlm-2912	38	69	at	at	ADP
ajlm-2912	38	70	95	95	NUM
ajlm-2912	38	71	%	%	NOUN
ajlm-2912	38	72	(	(	PUNCT
ajlm-2912	38	73	1.96	1.96	NUM
ajlm-2912	38	74	)	)	PUNCT
ajlm-2912	38	75	,	,	PUNCT
ajlm-2912	38	76	prevalence	prevalence	NOUN
ajlm-2912	38	77	(	(	PUNCT
ajlm-2912	38	78	85%),22	85%),22	NUM
ajlm-2912	38	79	and	and	CCONJ
ajlm-2912	38	80	maximum	maximum	ADJ
ajlm-2912	38	81	allowance	allowance	NOUN
ajlm-2912	38	82	of	of	ADP
ajlm-2912	38	83	error	error	NOUN
ajlm-2912	38	84	(	(	PUNCT
ajlm-2912	38	85	5	5	NUM
ajlm-2912	38	86	%	%	NOUN
ajlm-2912	38	87	)	)	PUNCT
ajlm-2912	38	88	in	in	ADP
ajlm-2912	38	89	the	the	DET
ajlm-2912	38	90	cochran	cochran	NOUN
ajlm-2912	38	91	’s	’s	PART
ajlm-2912	38	92	formula	formula	NOUN
ajlm-2912	38	93	(	(	PUNCT
ajlm-2912	38	94	n	n	NOUN
ajlm-2912	38	95	=	=	SYM
ajlm-2912	38	96	z2pq	z2pq	NOUN
ajlm-2912	38	97	/	/	SYM
ajlm-2912	38	98	e2	e2	PROPN
ajlm-2912	38	99	)	)	PUNCT
ajlm-2912	38	100	,	,	PUNCT
ajlm-2912	38	101	a	a	DET
ajlm-2912	38	102	sample	sample	NOUN
ajlm-2912	38	103	size	size	NOUN
ajlm-2912	38	104	of	of	ADP
ajlm-2912	38	105	196	196	NUM
ajlm-2912	38	106	subjects	subject	NOUN
ajlm-2912	38	107	was	be	AUX
ajlm-2912	38	108	established	establish	VERB
ajlm-2912	38	109	.	.	PUNCT
ajlm-2912	39	1	we	we	PRON
ajlm-2912	39	2	rounded	round	VERB
ajlm-2912	39	3	up	up	ADP
ajlm-2912	39	4	to	to	ADP
ajlm-2912	39	5	200	200	NUM
ajlm-2912	39	6	to	to	PART
ajlm-2912	39	7	account	account	VERB
ajlm-2912	39	8	for	for	ADP
ajlm-2912	39	9	potential	potential	ADJ
ajlm-2912	39	10	exclusions	exclusion	NOUN
ajlm-2912	39	11	.	.	PUNCT
ajlm-2912	40	1	therefore	therefore	ADV
ajlm-2912	40	2	,	,	PUNCT
ajlm-2912	40	3	200	200	NUM
ajlm-2912	40	4	subjects	subject	NOUN
ajlm-2912	40	5	(	(	PUNCT
ajlm-2912	40	6	50	50	NUM
ajlm-2912	40	7	in	in	ADP
ajlm-2912	40	8	each	each	DET
ajlm-2912	40	9	grade	grade	NOUN
ajlm-2912	40	10	of	of	ADP
ajlm-2912	40	11	av	av	NOUN
ajlm-2912	40	12	:	:	PUNCT
ajlm-2912	40	13	grades	grade	NOUN
ajlm-2912	40	14	1	1	NUM
ajlm-2912	40	15	,	,	PUNCT
ajlm-2912	40	16	2	2	NUM
ajlm-2912	40	17	,	,	PUNCT
ajlm-2912	40	18	3	3	NUM
ajlm-2912	40	19	,	,	PUNCT
ajlm-2912	40	20	and	and	CCONJ
ajlm-2912	40	21	4	4	NUM
ajlm-2912	40	22	)	)	PUNCT
ajlm-2912	40	23	and	and	CCONJ
ajlm-2912	40	24	50	50	NUM
ajlm-2912	40	25	healthy	healthy	ADJ
ajlm-2912	40	26	controls	control	NOUN
ajlm-2912	40	27	were	be	AUX
ajlm-2912	40	28	selected	select	VERB
ajlm-2912	40	29	.	.	PUNCT
ajlm-2912	41	1	for	for	ADP
ajlm-2912	41	2	sub	sub	ADJ
ajlm-2912	41	3	-	-	NOUN
ajlm-2912	41	4	group	group	ADJ
ajlm-2912	41	5	comparison	comparison	NOUN
ajlm-2912	41	6	,	,	PUNCT
ajlm-2912	41	7	a	a	DET
ajlm-2912	41	8	post	post	ADJ
ajlm-2912	41	9	-	-	ADJ
ajlm-2912	41	10	hoc	hoc	ADJ
ajlm-2912	41	11	power	power	NOUN
ajlm-2912	41	12	calculation	calculation	NOUN
ajlm-2912	41	13	was	be	AUX
ajlm-2912	41	14	performed	perform	VERB
ajlm-2912	41	15	in	in	ADP
ajlm-2912	41	16	acne	acne	NOUN
ajlm-2912	41	17	grades	grade	NOUN
ajlm-2912	41	18	.	.	PUNCT
ajlm-2912	42	1	by	by	ADP
ajlm-2912	42	2	keeping	keep	VERB
ajlm-2912	42	3	alpha	alpha	NOUN
ajlm-2912	42	4	=	=	NOUN
ajlm-2912	42	5	0.05	0.05	NUM
ajlm-2912	42	6	,	,	PUNCT
ajlm-2912	42	7	power	power	NOUN
ajlm-2912	42	8	(	(	PUNCT
ajlm-2912	42	9	1	1	NUM
ajlm-2912	42	10	-	-	SYM
ajlm-2912	42	11	β	β	NOUN
ajlm-2912	42	12	)	)	PUNCT
ajlm-2912	42	13	comes	come	VERB
ajlm-2912	42	14	as	as	ADP
ajlm-2912	42	15	:	:	PUNCT
ajlm-2912	42	16	for	for	ADP
ajlm-2912	42	17	sod	sod	NOUN
ajlm-2912	42	18	,	,	PUNCT
ajlm-2912	42	19	large	large	ADJ
ajlm-2912	42	20	effect	effect	NOUN
ajlm-2912	42	21	size	size	NOUN
ajlm-2912	42	22	(	(	PUNCT
ajlm-2912	42	23	cohen	cohen	PROPN
ajlm-2912	42	24	’s	’s	PART
ajlm-2912	42	25	d	d	X
ajlm-2912	42	26	=	=	SYM
ajlm-2912	42	27	1.14	1.14	NUM
ajlm-2912	42	28	)	)	PUNCT
ajlm-2912	42	29	and	and	CCONJ
ajlm-2912	42	30	power	power	NOUN
ajlm-2912	42	31	=	=	SYM
ajlm-2912	42	32	1.0	1.0	NUM
ajlm-2912	42	33	.	.	PUNCT
ajlm-2912	42	34	malondialdehyde	malondialdehyde	PROPN
ajlm-2912	42	35	and	and	CCONJ
ajlm-2912	42	36	gsh	gsh	PROPN
ajlm-2912	42	37	(	(	PUNCT
ajlm-2912	42	38	glutathione	glutathione	NOUN
ajlm-2912	42	39	)	)	PUNCT
ajlm-2912	42	40	comparisons	comparison	NOUN
ajlm-2912	42	41	demonstrated	demonstrate	VERB
ajlm-2912	42	42	high	high	ADJ
ajlm-2912	42	43	power	power	NOUN
ajlm-2912	42	44	,	,	PUNCT
ajlm-2912	42	45	whereas	whereas	SCONJ
ajlm-2912	42	46	cat	cat	NOUN
ajlm-2912	42	47	comparisons	comparison	NOUN
ajlm-2912	42	48	had	have	VERB
ajlm-2912	42	49	smaller	small	ADJ
ajlm-2912	42	50	effect	effect	NOUN
ajlm-2912	42	51	sizes	size	NOUN
ajlm-2912	42	52	and	and	CCONJ
ajlm-2912	42	53	slightly	slightly	ADV
ajlm-2912	42	54	lower	low	ADJ
ajlm-2912	42	55	power	power	NOUN
ajlm-2912	42	56	(	(	PUNCT
ajlm-2912	42	57	0.85	0.85	NUM
ajlm-2912	42	58	)	)	PUNCT
ajlm-2912	42	59	.	.	PUNCT
ajlm-2912	43	1	eligibility	eligibility	NOUN
ajlm-2912	43	2	criteria	criteria	VERB
ajlm-2912	43	3	the	the	DET
ajlm-2912	43	4	cross	cross	ADJ
ajlm-2912	43	5	-	-	ADJ
ajlm-2912	43	6	sectional	sectional	ADJ
ajlm-2912	43	7	study	study	NOUN
ajlm-2912	43	8	included	include	VERB
ajlm-2912	43	9	patients	patient	NOUN
ajlm-2912	43	10	with	with	ADP
ajlm-2912	43	11	av	av	PROPN
ajlm-2912	43	12	,	,	PUNCT
ajlm-2912	43	13	who	who	PRON
ajlm-2912	43	14	did	do	AUX
ajlm-2912	43	15	not	not	PART
ajlm-2912	43	16	receive	receive	VERB
ajlm-2912	43	17	any	any	DET
ajlm-2912	43	18	topical	topical	ADJ
ajlm-2912	43	19	or	or	CCONJ
ajlm-2912	43	20	systemic	systemic	ADJ
ajlm-2912	43	21	treatment	treatment	NOUN
ajlm-2912	43	22	in	in	ADP
ajlm-2912	43	23	the	the	DET
ajlm-2912	43	24	previous	previous	ADJ
ajlm-2912	43	25	four	four	NUM
ajlm-2912	43	26	weeks	week	NOUN
ajlm-2912	43	27	,	,	PUNCT
ajlm-2912	43	28	were	be	AUX
ajlm-2912	43	29	aged	age	VERB
ajlm-2912	43	30	between	between	ADP
ajlm-2912	43	31	18	18	NUM
ajlm-2912	43	32	and	and	CCONJ
ajlm-2912	43	33	45	45	NUM
ajlm-2912	43	34	years	year	NOUN
ajlm-2912	43	35	,	,	PUNCT
ajlm-2912	43	36	were	be	AUX
ajlm-2912	43	37	from	from	ADP
ajlm-2912	43	38	both	both	DET
ajlm-2912	43	39	genders	gender	NOUN
ajlm-2912	43	40	,	,	PUNCT
ajlm-2912	43	41	and	and	CCONJ
ajlm-2912	43	42	were	be	AUX
ajlm-2912	43	43	willing	willing	ADJ
ajlm-2912	43	44	to	to	PART
ajlm-2912	43	45	participate	participate	VERB
ajlm-2912	43	46	.	.	PUNCT
ajlm-2912	44	1	however	however	ADV
ajlm-2912	44	2	,	,	PUNCT
ajlm-2912	44	3	the	the	DET
ajlm-2912	44	4	study	study	NOUN
ajlm-2912	44	5	excluded	exclude	VERB
ajlm-2912	44	6	patients	patient	NOUN
ajlm-2912	44	7	on	on	ADP
ajlm-2912	44	8	immune	immune	ADJ
ajlm-2912	44	9	-	-	PUNCT
ajlm-2912	44	10	suppressive	suppressive	NOUN
ajlm-2912	44	11	therapy	therapy	NOUN
ajlm-2912	44	12	such	such	ADJ
ajlm-2912	44	13	as	as	ADP
ajlm-2912	44	14	corticosteroids	corticosteroid	NOUN
ajlm-2912	44	15	,	,	PUNCT
ajlm-2912	44	16	regular	regular	ADJ
ajlm-2912	44	17	analgaesic	analgaesic	ADJ
ajlm-2912	44	18	intake	intake	NOUN
ajlm-2912	44	19	,	,	PUNCT
ajlm-2912	44	20	and	and	CCONJ
ajlm-2912	44	21	hormonal	hormonal	ADJ
ajlm-2912	44	22	therapy	therapy	NOUN
ajlm-2912	44	23	;	;	PUNCT
ajlm-2912	44	24	patients	patient	NOUN
ajlm-2912	44	25	with	with	ADP
ajlm-2912	44	26	any	any	DET
ajlm-2912	44	27	systemic	systemic	ADJ
ajlm-2912	44	28	disease	disease	NOUN
ajlm-2912	44	29	(	(	PUNCT
ajlm-2912	44	30	diabetes	diabetes	NOUN
ajlm-2912	44	31	mellitus	mellitus	NOUN
ajlm-2912	44	32	,	,	PUNCT
ajlm-2912	44	33	liver	liver	NOUN
ajlm-2912	44	34	disease	disease	NOUN
ajlm-2912	44	35	,	,	PUNCT
ajlm-2912	44	36	thyroid	thyroid	NOUN
ajlm-2912	44	37	disorders	disorder	NOUN
ajlm-2912	44	38	,	,	PUNCT
ajlm-2912	44	39	cardiovascular	cardiovascular	ADJ
ajlm-2912	44	40	events	event	NOUN
ajlm-2912	44	41	,	,	PUNCT
ajlm-2912	44	42	known	know	VERB
ajlm-2912	44	43	cases	case	NOUN
ajlm-2912	44	44	of	of	ADP
ajlm-2912	44	45	malignancy	malignancy	NOUN
ajlm-2912	44	46	)	)	PUNCT
ajlm-2912	44	47	;	;	PUNCT
ajlm-2912	44	48	patients	patient	NOUN
ajlm-2912	44	49	with	with	ADP
ajlm-2912	44	50	any	any	DET
ajlm-2912	44	51	dermatological	dermatological	ADJ
ajlm-2912	44	52	disorder	disorder	NOUN
ajlm-2912	44	53	other	other	ADJ
ajlm-2912	44	54	than	than	ADP
ajlm-2912	44	55	av	av	PRON
ajlm-2912	44	56	;	;	PUNCT
ajlm-2912	44	57	patients	patient	NOUN
ajlm-2912	44	58	taking	take	VERB
ajlm-2912	44	59	any	any	DET
ajlm-2912	44	60	vitamin	vitamin	NOUN
ajlm-2912	44	61	supplementation	supplementation	NOUN
ajlm-2912	44	62	;	;	PUNCT
ajlm-2912	44	63	pregnant	pregnant	ADJ
ajlm-2912	44	64	and	and	CCONJ
ajlm-2912	44	65	lactating	lactate	VERB
ajlm-2912	44	66	women	woman	NOUN
ajlm-2912	44	67	;	;	PUNCT
ajlm-2912	44	68	and	and	CCONJ
ajlm-2912	44	69	smoking	smoking	NOUN
ajlm-2912	44	70	and/or	and/or	CCONJ
ajlm-2912	44	71	alcohol	alcohol	NOUN
ajlm-2912	44	72	abusers	abuser	NOUN
ajlm-2912	44	73	.	.	PUNCT
ajlm-2912	45	1	the	the	DET
ajlm-2912	45	2	information	information	NOUN
ajlm-2912	45	3	on	on	ADP
ajlm-2912	45	4	social	social	ADJ
ajlm-2912	45	5	demographics	demographic	NOUN
ajlm-2912	45	6	and	and	CCONJ
ajlm-2912	45	7	disease	disease	NOUN
ajlm-2912	45	8	duration	duration	NOUN
ajlm-2912	45	9	was	be	AUX
ajlm-2912	45	10	collected	collect	VERB
ajlm-2912	45	11	by	by	ADP
ajlm-2912	45	12	directly	directly	ADV
ajlm-2912	45	13	interviewing	interview	VERB
ajlm-2912	45	14	study	study	NOUN
ajlm-2912	45	15	participants	participant	NOUN
ajlm-2912	45	16	in	in	ADP
ajlm-2912	45	17	the	the	DET
ajlm-2912	45	18	local	local	ADJ
ajlm-2912	45	19	language	language	NOUN
ajlm-2912	45	20	using	use	VERB
ajlm-2912	45	21	a	a	DET
ajlm-2912	45	22	semi	semi	ADJ
ajlm-2912	45	23	-	-	ADJ
ajlm-2912	45	24	structured	structured	ADJ
ajlm-2912	45	25	questionnaire	questionnaire	NOUN
ajlm-2912	45	26	.	.	PUNCT
ajlm-2912	46	1	sample	sample	NOUN
ajlm-2912	46	2	collection	collection	NOUN
ajlm-2912	46	3	and	and	CCONJ
ajlm-2912	46	4	equipment	equipment	NOUN
ajlm-2912	46	5	using	use	VERB
ajlm-2912	46	6	aseptic	aseptic	ADJ
ajlm-2912	46	7	technique	technique	NOUN
ajlm-2912	46	8	,	,	PUNCT
ajlm-2912	46	9	5	5	NUM
ajlm-2912	46	10	ml	ml	NOUN
ajlm-2912	46	11	of	of	ADP
ajlm-2912	46	12	venous	venous	ADJ
ajlm-2912	46	13	blood	blood	NOUN
ajlm-2912	46	14	was	be	AUX
ajlm-2912	46	15	taken	take	VERB
ajlm-2912	46	16	in	in	ADP
ajlm-2912	46	17	dry	dry	ADJ
ajlm-2912	46	18	sterile	sterile	ADJ
ajlm-2912	46	19	red	red	ADJ
ajlm-2912	46	20	top	top	NOUN
ajlm-2912	46	21	(	(	PUNCT
ajlm-2912	46	22	serum	serum	NOUN
ajlm-2912	46	23	)	)	PUNCT
ajlm-2912	46	24	vacutainers	vacutainer	NOUN
ajlm-2912	46	25	from	from	ADP
ajlm-2912	46	26	each	each	DET
ajlm-2912	46	27	participant	participant	NOUN
ajlm-2912	46	28	after	after	ADP
ajlm-2912	46	29	gaining	gain	VERB
ajlm-2912	46	30	written	write	VERB
ajlm-2912	46	31	consent	consent	NOUN
ajlm-2912	46	32	.	.	PUNCT
ajlm-2912	47	1	serum	serum	NOUN
ajlm-2912	47	2	was	be	AUX
ajlm-2912	47	3	separated	separate	VERB
ajlm-2912	47	4	by	by	ADP
ajlm-2912	47	5	centrifugation	centrifugation	NOUN
ajlm-2912	47	6	at	at	ADP
ajlm-2912	47	7	3500	3500	NUM
ajlm-2912	47	8	revolutions	revolution	NOUN
ajlm-2912	47	9	per	per	ADP
ajlm-2912	47	10	minute	minute	NOUN
ajlm-2912	47	11	(	(	PUNCT
ajlm-2912	47	12	rpm	rpm	NOUN
ajlm-2912	47	13	)	)	PUNCT
ajlm-2912	47	14	for	for	ADP
ajlm-2912	47	15	10	10	NUM
ajlm-2912	47	16	min	min	NOUN
ajlm-2912	47	17	.	.	PROPN
ajlm-2912	47	18	serum	serum	PROPN
ajlm-2912	47	19	sod	sod	PROPN
ajlm-2912	47	20	,	,	PUNCT
ajlm-2912	47	21	cat	cat	NOUN
ajlm-2912	47	22	,	,	PUNCT
ajlm-2912	47	23	gsh	gsh	PROPN
ajlm-2912	47	24	and	and	CCONJ
ajlm-2912	47	25	mda	mda	PROPN
ajlm-2912	47	26	were	be	AUX
ajlm-2912	47	27	measured	measure	VERB
ajlm-2912	47	28	using	use	VERB
ajlm-2912	47	29	the	the	DET
ajlm-2912	47	30	erba	erba	PROPN
ajlm-2912	47	31	lisa	lisa	PROPN
ajlm-2912	47	32	scan	scan	VERB
ajlm-2912	47	33	em	em	PRON
ajlm-2912	47	34	analyser	analyser	NOUN
ajlm-2912	47	35	(	(	PUNCT
ajlm-2912	47	36	erba	erba	NOUN
ajlm-2912	47	37	diagnostics	diagnostic	NOUN
ajlm-2912	47	38	mannheim	mannheim	PROPN
ajlm-2912	47	39	gmbh	gmbh	PROPN
ajlm-2912	47	40	,	,	PUNCT
ajlm-2912	47	41	mannheim	mannheim	PROPN
ajlm-2912	47	42	,	,	PUNCT
ajlm-2912	47	43	germany	germany	PROPN
ajlm-2912	47	44	)	)	PUNCT
ajlm-2912	47	45	via	via	ADP
ajlm-2912	47	46	an	an	DET
ajlm-2912	47	47	enzyme	enzyme	NOUN
ajlm-2912	47	48	-	-	PUNCT
ajlm-2912	47	49	linked	link	VERB
ajlm-2912	47	50	immunosorbent	immunosorbent	NOUN
ajlm-2912	47	51	assay	assay	PROPN
ajlm-2912	47	52	kit	kit	PROPN
ajlm-2912	47	53	.	.	PUNCT
ajlm-2912	48	1	calibration	calibration	NOUN
ajlm-2912	48	2	and	and	CCONJ
ajlm-2912	48	3	quality	quality	NOUN
ajlm-2912	48	4	control	control	NOUN
ajlm-2912	48	5	of	of	ADP
ajlm-2912	48	6	this	this	DET
ajlm-2912	48	7	analyser	analyser	NOUN
ajlm-2912	48	8	were	be	AUX
ajlm-2912	48	9	performed	perform	VERB
ajlm-2912	48	10	before	before	SCONJ
ajlm-2912	48	11	the	the	DET
ajlm-2912	48	12	samples	sample	NOUN
ajlm-2912	48	13	were	be	AUX
ajlm-2912	48	14	run	run	VERB
ajlm-2912	48	15	.	.	PUNCT
ajlm-2912	49	1	the	the	DET
ajlm-2912	49	2	manufacturer	manufacturer	NOUN
ajlm-2912	49	3	’s	’s	PART
ajlm-2912	49	4	instructions	instruction	NOUN
ajlm-2912	49	5	for	for	ADP
ajlm-2912	49	6	the	the	DET
ajlm-2912	49	7	machine	machine	NOUN
ajlm-2912	49	8	and	and	CCONJ
ajlm-2912	49	9	the	the	DET
ajlm-2912	49	10	reagents	reagent	NOUN
ajlm-2912	49	11	were	be	AUX
ajlm-2912	49	12	strictly	strictly	ADV
ajlm-2912	49	13	followed	follow	VERB
ajlm-2912	49	14	.	.	PUNCT
ajlm-2912	50	1	standard	standard	ADJ
ajlm-2912	50	2	curves	curve	NOUN
ajlm-2912	50	3	were	be	AUX
ajlm-2912	50	4	generated	generate	VERB
ajlm-2912	50	5	for	for	ADP
ajlm-2912	50	6	each	each	DET
ajlm-2912	50	7	biomarker	biomarker	NOUN
ajlm-2912	50	8	(	(	PUNCT
ajlm-2912	50	9	sod	sod	NOUN
ajlm-2912	50	10	,	,	PUNCT
ajlm-2912	50	11	cat	cat	NOUN
ajlm-2912	50	12	,	,	PUNCT
ajlm-2912	50	13	gsh	gsh	PROPN
ajlm-2912	50	14	,	,	PUNCT
ajlm-2912	50	15	mda	mda	PROPN
ajlm-2912	50	16	)	)	PUNCT
ajlm-2912	50	17	using	use	VERB
ajlm-2912	50	18	the	the	DET
ajlm-2912	50	19	calibrators	calibrator	NOUN
ajlm-2912	50	20	provided	provide	VERB
ajlm-2912	50	21	in	in	ADP
ajlm-2912	50	22	the	the	DET
ajlm-2912	50	23	enzyme	enzyme	NOUN
ajlm-2912	50	24	-	-	PUNCT
ajlm-2912	50	25	linked	link	VERB
ajlm-2912	50	26	immunosorbent	immunosorbent	NOUN
ajlm-2912	50	27	assay	assay	NOUN
ajlm-2912	50	28	kits	kit	NOUN
ajlm-2912	50	29	,	,	PUNCT
ajlm-2912	50	30	and	and	CCONJ
ajlm-2912	50	31	sample	sample	NOUN
ajlm-2912	50	32	concentrations	concentration	NOUN
ajlm-2912	50	33	were	be	AUX
ajlm-2912	50	34	calculated	calculate	VERB
ajlm-2912	50	35	from	from	ADP
ajlm-2912	50	36	these	these	DET
ajlm-2912	50	37	curves	curve	NOUN
ajlm-2912	50	38	.	.	PUNCT
ajlm-2912	51	1	to	to	PART
ajlm-2912	51	2	reduce	reduce	VERB
ajlm-2912	51	3	the	the	DET
ajlm-2912	51	4	analytical	analytical	ADJ
ajlm-2912	51	5	variation	variation	NOUN
ajlm-2912	51	6	,	,	PUNCT
ajlm-2912	51	7	all	all	DET
ajlm-2912	51	8	samples	sample	NOUN
ajlm-2912	51	9	were	be	AUX
ajlm-2912	51	10	analysed	analyse	VERB
ajlm-2912	51	11	using	use	VERB
ajlm-2912	51	12	the	the	DET
ajlm-2912	51	13	same	same	ADJ
ajlm-2912	51	14	lots	lot	NOUN
ajlm-2912	51	15	of	of	ADP
ajlm-2912	51	16	reagent	reagent	ADJ
ajlm-2912	51	17	kits	kit	NOUN
ajlm-2912	51	18	,	,	PUNCT
ajlm-2912	51	19	and	and	CCONJ
ajlm-2912	51	20	intra	intra	ADJ
ajlm-2912	51	21	-	-	ADJ
ajlm-2912	51	22	assay	assay	ADJ
ajlm-2912	51	23	coefficient	coefficient	NOUN
ajlm-2912	51	24	of	of	ADP
ajlm-2912	51	25	variation	variation	NOUN
ajlm-2912	51	26	values	value	NOUN
ajlm-2912	51	27	remained	remain	VERB
ajlm-2912	51	28	within	within	ADP
ajlm-2912	51	29	acceptable	acceptable	ADJ
ajlm-2912	51	30	limits	limit	NOUN
ajlm-2912	51	31	.	.	PUNCT
ajlm-2912	52	1	(	(	PUNCT
ajlm-2912	52	2	table	table	NOUN
ajlm-2912	52	3	1	1	NUM
ajlm-2912	52	4	)	)	PUNCT
ajlm-2912	52	5	.	.	PUNCT
ajlm-2912	53	1	table	table	NOUN
ajlm-2912	53	2	1	1	NUM
ajlm-2912	53	3	:	:	PUNCT
ajlm-2912	53	4	 	 	SPACE
ajlm-2912	53	5	different	different	ADJ
ajlm-2912	53	6	parameters	parameter	NOUN
ajlm-2912	53	7	with	with	ADP
ajlm-2912	53	8	method	method	NOUN
ajlm-2912	53	9	,	,	PUNCT
ajlm-2912	53	10	cut	cut	NOUN
ajlm-2912	53	11	-	-	PUNCT
ajlm-2912	53	12	off	off	ADP
ajlm-2912	53	13	range	range	NOUN
ajlm-2912	53	14	and	and	CCONJ
ajlm-2912	53	15	coefficient	coefficient	NOUN
ajlm-2912	53	16	of	of	ADP
ajlm-2912	53	17	variation	variation	NOUN
ajlm-2912	53	18	,	,	PUNCT
ajlm-2912	53	19	gurugram	gurugram	PROPN
ajlm-2912	53	20	,	,	PUNCT
ajlm-2912	53	21	india	india	PROPN
ajlm-2912	53	22	,	,	PUNCT
ajlm-2912	53	23	from	from	ADP
ajlm-2912	53	24	01	01	NUM
ajlm-2912	53	25	july	july	PROPN
ajlm-2912	53	26	2023	2023	NUM
ajlm-2912	53	27	to	to	ADP
ajlm-2912	53	28	30	30	NUM
ajlm-2912	53	29	june	june	PROPN
ajlm-2912	53	30	2024	2024	NUM
ajlm-2912	53	31	.	.	PUNCT
ajlm-2912	54	1	statistical	statistical	ADJ
ajlm-2912	54	2	analysis	analysis	NOUN
ajlm-2912	54	3	data	datum	NOUN
ajlm-2912	54	4	and	and	CCONJ
ajlm-2912	54	5	various	various	ADJ
ajlm-2912	54	6	parameters	parameter	NOUN
ajlm-2912	54	7	were	be	AUX
ajlm-2912	54	8	analysed	analyse	VERB
ajlm-2912	54	9	on	on	ADP
ajlm-2912	54	10	ibm	ibm	PROPN
ajlm-2912	54	11	®	®	NOUN
ajlm-2912	54	12	spss	spss	PROPN
ajlm-2912	54	13	®	®	PROPN
ajlm-2912	54	14	statistics	statistic	NOUN
ajlm-2912	54	15	(	(	PUNCT
ajlm-2912	54	16	spss	spss	PROPN
ajlm-2912	54	17	®	®	NOUN
ajlm-2912	54	18	)	)	PUNCT
ajlm-2912	54	19	version	version	NOUN
ajlm-2912	54	20	24	24	NUM
ajlm-2912	54	21	(	(	PUNCT
ajlm-2912	54	22	ibm	ibm	PROPN
ajlm-2912	54	23	corporation	corporation	PROPN
ajlm-2912	54	24	,	,	PUNCT
ajlm-2912	54	25	armonk	armonk	PROPN
ajlm-2912	54	26	,	,	PUNCT
ajlm-2912	54	27	new	new	PROPN
ajlm-2912	54	28	york	york	PROPN
ajlm-2912	54	29	,	,	PUNCT
ajlm-2912	54	30	united	united	PROPN
ajlm-2912	54	31	states	states	PROPN
ajlm-2912	54	32	)	)	PUNCT
ajlm-2912	54	33	.	.	PUNCT
ajlm-2912	55	1	the	the	DET
ajlm-2912	55	2	shapiro	shapiro	PROPN
ajlm-2912	55	3	-	-	PUNCT
ajlm-2912	55	4	wilk	wilk	NOUN
ajlm-2912	55	5	test	test	NOUN
ajlm-2912	55	6	was	be	AUX
ajlm-2912	55	7	applied	apply	VERB
ajlm-2912	55	8	for	for	ADP
ajlm-2912	55	9	assessing	assess	VERB
ajlm-2912	55	10	the	the	DET
ajlm-2912	55	11	normal	normal	ADJ
ajlm-2912	55	12	distribution	distribution	NOUN
ajlm-2912	55	13	of	of	ADP
ajlm-2912	55	14	the	the	DET
ajlm-2912	55	15	dataset	dataset	NOUN
ajlm-2912	55	16	and	and	CCONJ
ajlm-2912	55	17	was	be	AUX
ajlm-2912	55	18	found	find	VERB
ajlm-2912	55	19	to	to	PART
ajlm-2912	55	20	be	be	AUX
ajlm-2912	55	21	normally	normally	ADV
ajlm-2912	55	22	distributed	distribute	VERB
ajlm-2912	55	23	.	.	PUNCT
ajlm-2912	56	1	mean	mean	VERB
ajlm-2912	56	2	and	and	CCONJ
ajlm-2912	56	3	standard	standard	ADJ
ajlm-2912	56	4	deviation	deviation	NOUN
ajlm-2912	56	5	of	of	ADP
ajlm-2912	56	6	all	all	DET
ajlm-2912	56	7	parameters	parameter	NOUN
ajlm-2912	56	8	were	be	AUX
ajlm-2912	56	9	calculated	calculate	VERB
ajlm-2912	56	10	.	.	PUNCT
ajlm-2912	57	1	a	a	DET
ajlm-2912	57	2	student	student	NOUN
ajlm-2912	57	3	’s	’s	PART
ajlm-2912	57	4	t	t	PROPN
ajlm-2912	57	5	-	-	PUNCT
ajlm-2912	57	6	test	test	NOUN
ajlm-2912	57	7	(	(	PUNCT
ajlm-2912	57	8	unpaired	unpaired	ADJ
ajlm-2912	57	9	)	)	PUNCT
ajlm-2912	57	10	was	be	AUX
ajlm-2912	57	11	used	use	VERB
ajlm-2912	57	12	to	to	PART
ajlm-2912	57	13	compare	compare	VERB
ajlm-2912	57	14	two	two	NUM
ajlm-2912	57	15	groups	group	NOUN
ajlm-2912	57	16	while	while	SCONJ
ajlm-2912	57	17	a	a	DET
ajlm-2912	57	18	one	one	NUM
ajlm-2912	57	19	-	-	PUNCT
ajlm-2912	57	20	way	way	NOUN
ajlm-2912	57	21	analysis	analysis	NOUN
ajlm-2912	57	22	of	of	ADP
ajlm-2912	57	23	variance	variance	NOUN
ajlm-2912	57	24	test	test	NOUN
ajlm-2912	57	25	was	be	AUX
ajlm-2912	57	26	applied	apply	VERB
ajlm-2912	57	27	to	to	PART
ajlm-2912	57	28	compare	compare	VERB
ajlm-2912	57	29	the	the	DET
ajlm-2912	57	30	various	various	ADJ
ajlm-2912	57	31	parameters	parameter	NOUN
ajlm-2912	57	32	in	in	ADP
ajlm-2912	57	33	three	three	NUM
ajlm-2912	57	34	or	or	CCONJ
ajlm-2912	57	35	more	more	ADJ
ajlm-2912	57	36	groups	group	NOUN
ajlm-2912	57	37	.	.	PUNCT
ajlm-2912	58	1	a	a	DET
ajlm-2912	58	2	post	post	ADJ
ajlm-2912	58	3	-	-	ADJ
ajlm-2912	58	4	hoc	hoc	ADJ
ajlm-2912	58	5	test	test	NOUN
ajlm-2912	58	6	was	be	AUX
ajlm-2912	58	7	conducted	conduct	VERB
ajlm-2912	58	8	to	to	PART
ajlm-2912	58	9	determine	determine	VERB
ajlm-2912	58	10	pair	pair	NOUN
ajlm-2912	58	11	-	-	PUNCT
ajlm-2912	58	12	wise	wise	ADJ
ajlm-2912	58	13	differences	difference	NOUN
ajlm-2912	58	14	between	between	ADP
ajlm-2912	58	15	groups	group	NOUN
ajlm-2912	58	16	.	.	PUNCT
ajlm-2912	59	1	pearson	pearson	PROPN
ajlm-2912	59	2	’s	’s	PART
ajlm-2912	59	3	correlation	correlation	NOUN
ajlm-2912	59	4	coefficient	coefficient	NOUN
ajlm-2912	59	5	(	(	PUNCT
ajlm-2912	59	6	r	r	NOUN
ajlm-2912	59	7	-	-	PUNCT
ajlm-2912	59	8	value	value	NOUN
ajlm-2912	59	9	)	)	PUNCT
ajlm-2912	59	10	was	be	AUX
ajlm-2912	59	11	applied	apply	VERB
ajlm-2912	59	12	to	to	PART
ajlm-2912	59	13	find	find	VERB
ajlm-2912	59	14	the	the	DET
ajlm-2912	59	15	correlation	correlation	NOUN
ajlm-2912	59	16	.	.	PUNCT
ajlm-2912	60	1	the	the	DET
ajlm-2912	60	2	p	p	X
ajlm-2912	60	3	<	<	X
ajlm-2912	60	4	0.05	0.05	NUM
ajlm-2912	60	5	was	be	AUX
ajlm-2912	60	6	considered	consider	VERB
ajlm-2912	60	7	as	as	ADP
ajlm-2912	60	8	statistically	statistically	ADV
ajlm-2912	60	9	significant	significant	ADJ
ajlm-2912	60	10	,	,	PUNCT
ajlm-2912	60	11	and	and	CCONJ
ajlm-2912	60	12	p	p	X
ajlm-2912	60	13	<	<	X
ajlm-2912	60	14	0.001	0.001	NUM
ajlm-2912	60	15	,	,	PUNCT
ajlm-2912	60	16	highly	highly	ADV
ajlm-2912	60	17	significant	significant	ADJ
ajlm-2912	60	18	.	.	PUNCT
ajlm-2912	61	1	results	result	VERB
ajlm-2912	61	2	general	general	ADJ
ajlm-2912	61	3	characteristics	characteristic	NOUN
ajlm-2912	61	4	of	of	ADP
ajlm-2912	61	5	study	study	NOUN
ajlm-2912	61	6	population	population	NOUN
ajlm-2912	61	7	the	the	DET
ajlm-2912	61	8	present	present	ADJ
ajlm-2912	61	9	study	study	NOUN
ajlm-2912	61	10	included	include	VERB
ajlm-2912	61	11	50	50	NUM
ajlm-2912	61	12	healthy	healthy	ADJ
ajlm-2912	61	13	controls	control	NOUN
ajlm-2912	61	14	:	:	PUNCT
ajlm-2912	61	15	29	29	NUM
ajlm-2912	61	16	women	woman	NOUN
ajlm-2912	61	17	and	and	CCONJ
ajlm-2912	61	18	21	21	NUM
ajlm-2912	61	19	men	man	NOUN
ajlm-2912	61	20	with	with	ADP
ajlm-2912	61	21	a	a	DET
ajlm-2912	61	22	mean	mean	ADJ
ajlm-2912	61	23	age	age	NOUN
ajlm-2912	61	24	of	of	ADP
ajlm-2912	61	25	25.80	25.80	NUM
ajlm-2912	61	26	±	±	NUM
ajlm-2912	61	27	5.45	5.45	NUM
ajlm-2912	61	28	years	year	NOUN
ajlm-2912	61	29	.	.	PUNCT
ajlm-2912	62	1	two	two	NUM
ajlm-2912	62	2	hundred	hundred	NUM
ajlm-2912	62	3	patients	patient	NOUN
ajlm-2912	62	4	with	with	ADP
ajlm-2912	62	5	av—121	av—121	ADJ
ajlm-2912	62	6	females	female	NOUN
ajlm-2912	62	7	and	and	CCONJ
ajlm-2912	62	8	79	79	NUM
ajlm-2912	62	9	males	male	NOUN
ajlm-2912	62	10	—	—	PUNCT
ajlm-2912	62	11	were	be	AUX
ajlm-2912	62	12	also	also	ADV
ajlm-2912	62	13	enrolled	enrol	VERB
ajlm-2912	62	14	(	(	PUNCT
ajlm-2912	62	15	figure	figure	NOUN
ajlm-2912	62	16	1	1	NUM
ajlm-2912	62	17	)	)	PUNCT
ajlm-2912	62	18	.	.	PUNCT
ajlm-2912	63	1	the	the	DET
ajlm-2912	63	2	mean	mean	ADJ
ajlm-2912	63	3	age	age	NOUN
ajlm-2912	63	4	and	and	CCONJ
ajlm-2912	63	5	gender	gender	NOUN
ajlm-2912	63	6	distribution	distribution	NOUN
ajlm-2912	63	7	of	of	ADP
ajlm-2912	63	8	each	each	DET
ajlm-2912	63	9	grade	grade	NOUN
ajlm-2912	63	10	of	of	ADP
ajlm-2912	63	11	av	av	PROPN
ajlm-2912	63	12	is	be	AUX
ajlm-2912	63	13	expressed	express	VERB
ajlm-2912	63	14	in	in	ADP
ajlm-2912	63	15	table	table	NOUN
ajlm-2912	63	16	2	2	NUM
ajlm-2912	63	17	,	,	PUNCT
ajlm-2912	63	18	with	with	ADP
ajlm-2912	63	19	p	p	PROPN
ajlm-2912	63	20	=	=	PROPN
ajlm-2912	63	21	0.0007	0.0007	NUM
ajlm-2912	63	22	.	.	PUNCT
ajlm-2912	64	1	the	the	DET
ajlm-2912	64	2	distribution	distribution	NOUN
ajlm-2912	64	3	of	of	ADP
ajlm-2912	64	4	patients	patient	NOUN
ajlm-2912	64	5	according	accord	VERB
ajlm-2912	64	6	to	to	ADP
ajlm-2912	64	7	duration	duration	NOUN
ajlm-2912	64	8	of	of	ADP
ajlm-2912	64	9	acne	acne	NOUN
ajlm-2912	64	10	is	be	AUX
ajlm-2912	64	11	shown	show	VERB
ajlm-2912	64	12	in	in	ADP
ajlm-2912	64	13	table	table	NOUN
ajlm-2912	64	14	3	3	NUM
ajlm-2912	64	15	.	.	PUNCT
ajlm-2912	65	1	over	over	ADP
ajlm-2912	65	2	31.4	31.4	NUM
ajlm-2912	65	3	%	%	NOUN
ajlm-2912	65	4	of	of	ADP
ajlm-2912	65	5	the	the	DET
ajlm-2912	65	6	women	woman	NOUN
ajlm-2912	65	7	had	have	AUX
ajlm-2912	65	8	struggled	struggle	VERB
ajlm-2912	65	9	with	with	ADP
ajlm-2912	65	10	av	av	PRON
ajlm-2912	65	11	for	for	ADP
ajlm-2912	65	12	2–5	2–5	PROPN
ajlm-2912	65	13	years	year	NOUN
ajlm-2912	65	14	,	,	PUNCT
ajlm-2912	65	15	while	while	SCONJ
ajlm-2912	65	16	a	a	DET
ajlm-2912	65	17	higher	high	ADJ
ajlm-2912	65	18	number	number	NOUN
ajlm-2912	65	19	of	of	ADP
ajlm-2912	65	20	men	man	NOUN
ajlm-2912	65	21	(	(	PUNCT
ajlm-2912	65	22	50.6	50.6	NUM
ajlm-2912	65	23	%	%	NOUN
ajlm-2912	65	24	)	)	PUNCT
ajlm-2912	65	25	had	have	VERB
ajlm-2912	65	26	acne	acne	NOUN
ajlm-2912	65	27	for	for	ADP
ajlm-2912	65	28	a	a	DET
ajlm-2912	65	29	similar	similar	ADJ
ajlm-2912	65	30	time	time	NOUN
ajlm-2912	65	31	period	period	NOUN
ajlm-2912	65	32	,	,	PUNCT
ajlm-2912	65	33	followed	follow	VERB
ajlm-2912	65	34	by	by	ADP
ajlm-2912	65	35	34.2	34.2	NUM
ajlm-2912	65	36	%	%	NOUN
ajlm-2912	65	37	who	who	PRON
ajlm-2912	65	38	had	have	VERB
ajlm-2912	65	39	acne	acne	NOUN
ajlm-2912	65	40	for	for	ADP
ajlm-2912	65	41	more	more	ADJ
ajlm-2912	65	42	than	than	ADP
ajlm-2912	65	43	five	five	NUM
ajlm-2912	65	44	years	year	NOUN
ajlm-2912	65	45	(	(	PUNCT
ajlm-2912	65	46	p	p	X
ajlm-2912	65	47	<	<	X
ajlm-2912	65	48	0.0001	0.0001	NUM
ajlm-2912	65	49	)	)	PUNCT
ajlm-2912	65	50	.	.	PUNCT
ajlm-2912	66	1	figure	figure	VERB
ajlm-2912	66	2	1	1	NUM
ajlm-2912	66	3	:	:	PUNCT
ajlm-2912	66	4	a	a	DET
ajlm-2912	66	5	bar	bar	NOUN
ajlm-2912	66	6	graph	graph	NOUN
ajlm-2912	66	7	showing	show	VERB
ajlm-2912	66	8	number	number	NOUN
ajlm-2912	66	9	of	of	ADP
ajlm-2912	66	10	male	male	ADJ
ajlm-2912	66	11	and	and	CCONJ
ajlm-2912	66	12	female	female	ADJ
ajlm-2912	66	13	participants	participant	NOUN
ajlm-2912	66	14	in	in	ADP
ajlm-2912	66	15	control	control	NOUN
ajlm-2912	66	16	and	and	CCONJ
ajlm-2912	66	17	acne	acne	NOUN
ajlm-2912	66	18	patients	patient	NOUN
ajlm-2912	66	19	,	,	PUNCT
ajlm-2912	66	20	gurugram	gurugram	PROPN
ajlm-2912	66	21	,	,	PUNCT
ajlm-2912	66	22	india	india	PROPN
ajlm-2912	66	23	,	,	PUNCT
ajlm-2912	66	24	from	from	ADP
ajlm-2912	66	25	01	01	NUM
ajlm-2912	66	26	july	july	PROPN
ajlm-2912	66	27	2023	2023	NUM
ajlm-2912	66	28	to	to	ADP
ajlm-2912	66	29	30	30	NUM
ajlm-2912	66	30	june	june	PROPN
ajlm-2912	66	31	2024	2024	NUM
ajlm-2912	66	32	.	.	PUNCT
ajlm-2912	67	1	table	table	NOUN
ajlm-2912	67	2	2	2	NUM
ajlm-2912	67	3	:	:	PUNCT
ajlm-2912	67	4	 	 	SPACE
ajlm-2912	67	5	demographic	demographic	ADJ
ajlm-2912	67	6	data	datum	NOUN
ajlm-2912	67	7	of	of	ADP
ajlm-2912	67	8	controls	control	NOUN
ajlm-2912	67	9	and	and	CCONJ
ajlm-2912	67	10	cases	case	NOUN
ajlm-2912	67	11	,	,	PUNCT
ajlm-2912	67	12	gurugram	gurugram	PROPN
ajlm-2912	67	13	,	,	PUNCT
ajlm-2912	67	14	india	india	PROPN
ajlm-2912	67	15	,	,	PUNCT
ajlm-2912	67	16	from	from	ADP
ajlm-2912	67	17	01	01	NUM
ajlm-2912	67	18	july	july	PROPN
ajlm-2912	67	19	2023	2023	NUM
ajlm-2912	67	20	to	to	ADP
ajlm-2912	67	21	30	30	NUM
ajlm-2912	67	22	june	june	PROPN
ajlm-2912	67	23	2024	2024	NUM
ajlm-2912	67	24	.	.	PUNCT
ajlm-2912	68	1	table	table	NOUN
ajlm-2912	68	2	3	3	NUM
ajlm-2912	68	3	:	:	PUNCT
ajlm-2912	68	4	 	 	SPACE
ajlm-2912	68	5	disease	disease	NOUN
ajlm-2912	68	6	duration	duration	NOUN
ajlm-2912	68	7	of	of	ADP
ajlm-2912	68	8	acne	acne	NOUN
ajlm-2912	68	9	vulgaris	vulgaris	NOUN
ajlm-2912	68	10	patients	patient	NOUN
ajlm-2912	68	11	,	,	PUNCT
ajlm-2912	68	12	gurugram	gurugram	PROPN
ajlm-2912	68	13	,	,	PUNCT
ajlm-2912	68	14	india	india	PROPN
ajlm-2912	68	15	,	,	PUNCT
ajlm-2912	68	16	from	from	ADP
ajlm-2912	68	17	01	01	NUM
ajlm-2912	68	18	july	july	PROPN
ajlm-2912	68	19	2023	2023	NUM
ajlm-2912	68	20	to	to	ADP
ajlm-2912	68	21	30	30	NUM
ajlm-2912	68	22	june	june	PROPN
ajlm-2912	68	23	2024	2024	NUM
ajlm-2912	68	24	.	.	PUNCT
ajlm-2912	69	1	table	table	NOUN
ajlm-2912	69	2	4	4	NUM
ajlm-2912	69	3	shows	show	VERB
ajlm-2912	69	4	a	a	DET
ajlm-2912	69	5	comparison	comparison	NOUN
ajlm-2912	69	6	of	of	ADP
ajlm-2912	69	7	sod	sod	NOUN
ajlm-2912	69	8	,	,	PUNCT
ajlm-2912	69	9	cat	cat	NOUN
ajlm-2912	69	10	,	,	PUNCT
ajlm-2912	69	11	gsh	gsh	PROPN
ajlm-2912	69	12	and	and	CCONJ
ajlm-2912	69	13	mda	mda	PROPN
ajlm-2912	69	14	levels	level	NOUN
ajlm-2912	69	15	between	between	ADP
ajlm-2912	69	16	controls	control	NOUN
ajlm-2912	69	17	and	and	CCONJ
ajlm-2912	69	18	severity	severity	NOUN
ajlm-2912	69	19	grades	grade	NOUN
ajlm-2912	69	20	of	of	ADP
ajlm-2912	69	21	acne	acne	NOUN
ajlm-2912	69	22	.	.	PUNCT
ajlm-2912	70	1	the	the	DET
ajlm-2912	70	2	serum	serum	NOUN
ajlm-2912	70	3	levels	level	NOUN
ajlm-2912	70	4	of	of	ADP
ajlm-2912	70	5	sod	sod	NOUN
ajlm-2912	70	6	were	be	AUX
ajlm-2912	70	7	lowest	low	ADJ
ajlm-2912	70	8	in	in	ADP
ajlm-2912	70	9	severe	severe	ADJ
ajlm-2912	70	10	cases	case	NOUN
ajlm-2912	70	11	(	(	PUNCT
ajlm-2912	70	12	grade	grade	NOUN
ajlm-2912	70	13	4	4	NUM
ajlm-2912	70	14	)	)	PUNCT
ajlm-2912	70	15	and	and	CCONJ
ajlm-2912	70	16	highest	high	ADJ
ajlm-2912	70	17	in	in	ADP
ajlm-2912	70	18	mild	mild	ADJ
ajlm-2912	70	19	cases	case	NOUN
ajlm-2912	70	20	(	(	PUNCT
ajlm-2912	70	21	grade	grade	NOUN
ajlm-2912	70	22	1	1	NUM
ajlm-2912	70	23	)	)	PUNCT
ajlm-2912	70	24	,	,	PUNCT
ajlm-2912	70	25	when	when	SCONJ
ajlm-2912	70	26	compared	compare	VERB
ajlm-2912	70	27	with	with	ADP
ajlm-2912	70	28	controls	control	NOUN
ajlm-2912	70	29	with	with	ADP
ajlm-2912	70	30	a	a	DET
ajlm-2912	70	31	mean	mean	ADJ
ajlm-2912	70	32	±	±	NOUN
ajlm-2912	70	33	standard	standard	ADJ
ajlm-2912	70	34	deviation	deviation	NOUN
ajlm-2912	70	35	of	of	ADP
ajlm-2912	70	36	5.68	5.68	NUM
ajlm-2912	70	37	u	u	NOUN
ajlm-2912	70	38	/	/	SYM
ajlm-2912	70	39	ml	ml	NOUN
ajlm-2912	70	40	±	±	NUM
ajlm-2912	70	41	1.95	1.95	NUM
ajlm-2912	70	42	u	u	NOUN
ajlm-2912	70	43	/	/	SYM
ajlm-2912	70	44	ml	ml	ADP
ajlm-2912	70	45	,	,	PUNCT
ajlm-2912	70	46	11.71	11.71	NUM
ajlm-2912	70	47	u	u	NOUN
ajlm-2912	70	48	/	/	SYM
ajlm-2912	70	49	ml	ml	NOUN
ajlm-2912	70	50	±	±	NUM
ajlm-2912	70	51	2.12	2.12	NUM
ajlm-2912	70	52	u	u	NOUN
ajlm-2912	70	53	/	/	SYM
ajlm-2912	70	54	ml	ml	ADP
ajlm-2912	70	55	,	,	PUNCT
ajlm-2912	70	56	and	and	CCONJ
ajlm-2912	70	57	89.39	89.39	NUM
ajlm-2912	70	58	u	u	NOUN
ajlm-2912	70	59	/	/	SYM
ajlm-2912	70	60	ml	ml	PROPN
ajlm-2912	70	61	±	±	PROPN
ajlm-2912	70	62	9.91	9.91	NUM
ajlm-2912	70	63	u	u	NOUN
ajlm-2912	70	64	/	/	SYM
ajlm-2912	70	65	ml	ml	PROPN
ajlm-2912	70	66	(	(	PUNCT
ajlm-2912	70	67	p	p	X
ajlm-2912	70	68	<	<	X
ajlm-2912	70	69	0.0001	0.0001	NUM
ajlm-2912	70	70	)	)	PUNCT
ajlm-2912	70	71	.	.	PUNCT
ajlm-2912	71	1	similarly	similarly	ADV
ajlm-2912	71	2	,	,	PUNCT
ajlm-2912	71	3	the	the	DET
ajlm-2912	71	4	serum	serum	NOUN
ajlm-2912	71	5	levels	level	NOUN
ajlm-2912	71	6	of	of	ADP
ajlm-2912	71	7	cat	cat	NOUN
ajlm-2912	71	8	and	and	CCONJ
ajlm-2912	71	9	gsh	gsh	PROPN
ajlm-2912	71	10	were	be	AUX
ajlm-2912	71	11	markedly	markedly	ADV
ajlm-2912	71	12	decreased	decrease	VERB
ajlm-2912	71	13	in	in	ADP
ajlm-2912	71	14	grade	grade	NOUN
ajlm-2912	71	15	4	4	NUM
ajlm-2912	71	16	acne	acne	NOUN
ajlm-2912	71	17	patients	patient	NOUN
ajlm-2912	71	18	versus	versus	ADP
ajlm-2912	71	19	individuals	individual	NOUN
ajlm-2912	71	20	in	in	ADP
ajlm-2912	71	21	any	any	DET
ajlm-2912	71	22	other	other	ADJ
ajlm-2912	71	23	grades	grade	NOUN
ajlm-2912	71	24	.	.	PUNCT
ajlm-2912	72	1	meanwhile	meanwhile	ADV
ajlm-2912	72	2	,	,	PUNCT
ajlm-2912	72	3	a	a	DET
ajlm-2912	72	4	comparison	comparison	NOUN
ajlm-2912	72	5	of	of	ADP
ajlm-2912	72	6	mda	mda	PROPN
ajlm-2912	72	7	levels	level	NOUN
ajlm-2912	72	8	across	across	ADP
ajlm-2912	72	9	the	the	DET
ajlm-2912	72	10	four	four	NUM
ajlm-2912	72	11	grades	grade	NOUN
ajlm-2912	72	12	revealed	reveal	VERB
ajlm-2912	72	13	a	a	DET
ajlm-2912	72	14	substantial	substantial	ADJ
ajlm-2912	72	15	difference	difference	NOUN
ajlm-2912	72	16	.	.	PUNCT
ajlm-2912	73	1	malondialdehyde	malondialdehyde	NOUN
ajlm-2912	73	2	levels	level	NOUN
ajlm-2912	73	3	were	be	AUX
ajlm-2912	73	4	significantly	significantly	ADV
ajlm-2912	73	5	lower	low	ADJ
ajlm-2912	73	6	in	in	ADP
ajlm-2912	73	7	grade	grade	NOUN
ajlm-2912	73	8	1	1	NUM
ajlm-2912	73	9	,	,	PUNCT
ajlm-2912	73	10	and	and	CCONJ
ajlm-2912	73	11	higher	high	ADJ
ajlm-2912	73	12	in	in	ADP
ajlm-2912	73	13	grades	grade	NOUN
ajlm-2912	73	14	3	3	NUM
ajlm-2912	73	15	and	and	CCONJ
ajlm-2912	73	16	4	4	NUM
ajlm-2912	73	17	(	(	PUNCT
ajlm-2912	73	18	p	p	X
ajlm-2912	73	19	<	<	X
ajlm-2912	73	20	0.0001	0.0001	NUM
ajlm-2912	73	21	)	)	PUNCT
ajlm-2912	73	22	.	.	PUNCT
ajlm-2912	74	1	post	post	ADJ
ajlm-2912	74	2	-	-	ADJ
ajlm-2912	74	3	hoc	hoc	ADJ
ajlm-2912	74	4	pair	pair	NOUN
ajlm-2912	74	5	-	-	PUNCT
ajlm-2912	74	6	wise	wise	ADJ
ajlm-2912	74	7	comparisons	comparison	NOUN
ajlm-2912	74	8	between	between	ADP
ajlm-2912	74	9	acne	acne	NOUN
ajlm-2912	74	10	severity	severity	NOUN
ajlm-2912	74	11	grades	grade	NOUN
ajlm-2912	74	12	revealed	reveal	VERB
ajlm-2912	74	13	significant	significant	ADJ
ajlm-2912	74	14	differences	difference	NOUN
ajlm-2912	74	15	for	for	ADP
ajlm-2912	74	16	most	most	ADJ
ajlm-2912	74	17	oxidative	oxidative	ADJ
ajlm-2912	74	18	stress	stress	NOUN
ajlm-2912	74	19	markers	marker	NOUN
ajlm-2912	74	20	.	.	PUNCT
ajlm-2912	75	1	superoxide	superoxide	NOUN
ajlm-2912	75	2	dismutase	dismutase	NOUN
ajlm-2912	75	3	levels	level	NOUN
ajlm-2912	75	4	showed	show	VERB
ajlm-2912	75	5	highly	highly	ADV
ajlm-2912	75	6	significant	significant	ADJ
ajlm-2912	75	7	reductions	reduction	NOUN
ajlm-2912	75	8	across	across	ADP
ajlm-2912	75	9	all	all	DET
ajlm-2912	75	10	grade	grade	NOUN
ajlm-2912	75	11	comparisons	comparison	NOUN
ajlm-2912	75	12	(	(	PUNCT
ajlm-2912	75	13	p	p	NOUN
ajlm-2912	75	14	≤	≤	NUM
ajlm-2912	75	15	0.0001	0.0001	NUM
ajlm-2912	75	16	)	)	PUNCT
ajlm-2912	75	17	.	.	PUNCT
ajlm-2912	76	1	catalase	catalase	NOUN
ajlm-2912	76	2	levels	level	NOUN
ajlm-2912	76	3	were	be	AUX
ajlm-2912	76	4	comparable	comparable	ADJ
ajlm-2912	76	5	between	between	ADP
ajlm-2912	76	6	grades	grade	NOUN
ajlm-2912	76	7	1	1	NUM
ajlm-2912	76	8	and	and	CCONJ
ajlm-2912	76	9	2	2	NUM
ajlm-2912	76	10	(	(	PUNCT
ajlm-2912	76	11	p	p	NOUN
ajlm-2912	76	12	=	=	NOUN
ajlm-2912	76	13	0.0703	0.0703	NUM
ajlm-2912	76	14	)	)	PUNCT
ajlm-2912	76	15	,	,	PUNCT
ajlm-2912	76	16	but	but	CCONJ
ajlm-2912	76	17	significantly	significantly	ADV
ajlm-2912	76	18	lower	low	ADJ
ajlm-2912	76	19	from	from	ADP
ajlm-2912	76	20	grade	grade	NOUN
ajlm-2912	76	21	2	2	NUM
ajlm-2912	76	22	onwards	onward	NOUN
ajlm-2912	76	23	(	(	PUNCT
ajlm-2912	76	24	p	p	NOUN
ajlm-2912	76	25	≤	≤	NUM
ajlm-2912	76	26	0.0001	0.0001	NUM
ajlm-2912	76	27	)	)	PUNCT
ajlm-2912	76	28	.	.	PUNCT
ajlm-2912	77	1	glutathione	glutathione	NOUN
ajlm-2912	77	2	levels	level	NOUN
ajlm-2912	77	3	demonstrated	demonstrate	VERB
ajlm-2912	77	4	an	an	DET
ajlm-2912	77	5	early	early	ADJ
ajlm-2912	77	6	decline	decline	NOUN
ajlm-2912	77	7	,	,	PUNCT
ajlm-2912	77	8	with	with	ADP
ajlm-2912	77	9	a	a	DET
ajlm-2912	77	10	significant	significant	ADJ
ajlm-2912	77	11	difference	difference	NOUN
ajlm-2912	77	12	observed	observe	VERB
ajlm-2912	77	13	between	between	ADP
ajlm-2912	77	14	grades	grade	NOUN
ajlm-2912	77	15	1	1	NUM
ajlm-2912	77	16	and	and	CCONJ
ajlm-2912	77	17	2	2	NUM
ajlm-2912	77	18	(	(	PUNCT
ajlm-2912	77	19	p	p	X
ajlm-2912	77	20	=	=	NOUN
ajlm-2912	77	21	0.0161	0.0161	NUM
ajlm-2912	77	22	)	)	PUNCT
ajlm-2912	77	23	,	,	PUNCT
ajlm-2912	77	24	and	and	CCONJ
ajlm-2912	77	25	highly	highly	ADV
ajlm-2912	77	26	significant	significant	ADJ
ajlm-2912	77	27	differences	difference	NOUN
ajlm-2912	77	28	in	in	ADP
ajlm-2912	77	29	subsequent	subsequent	ADJ
ajlm-2912	77	30	grade	grade	NOUN
ajlm-2912	77	31	comparisons	comparison	NOUN
ajlm-2912	77	32	(	(	PUNCT
ajlm-2912	77	33	p	p	X
ajlm-2912	77	34	<	<	X
ajlm-2912	77	35	0.0001	0.0001	NUM
ajlm-2912	77	36	)	)	PUNCT
ajlm-2912	77	37	.	.	PUNCT
ajlm-2912	78	1	malondialdehyde	malondialdehyde	NOUN
ajlm-2912	78	2	levels	level	NOUN
ajlm-2912	78	3	were	be	AUX
ajlm-2912	78	4	significantly	significantly	ADV
ajlm-2912	78	5	elevated	elevate	VERB
ajlm-2912	78	6	across	across	ADP
ajlm-2912	78	7	all	all	DET
ajlm-2912	78	8	inter	inter	ADJ
ajlm-2912	78	9	-	-	ADJ
ajlm-2912	78	10	grade	grade	ADJ
ajlm-2912	78	11	comparisons	comparison	NOUN
ajlm-2912	78	12	(	(	PUNCT
ajlm-2912	78	13	p	p	X
ajlm-2912	78	14	<	<	X
ajlm-2912	78	15	0.0001	0.0001	NUM
ajlm-2912	78	16	)	)	PUNCT
ajlm-2912	78	17	,	,	PUNCT
ajlm-2912	78	18	confirming	confirm	VERB
ajlm-2912	78	19	progressive	progressive	ADJ
ajlm-2912	78	20	oxidative	oxidative	ADJ
ajlm-2912	78	21	damage	damage	NOUN
ajlm-2912	78	22	with	with	ADP
ajlm-2912	78	23	increasing	increase	VERB
ajlm-2912	78	24	acne	acne	NOUN
ajlm-2912	78	25	severity	severity	NOUN
ajlm-2912	78	26	(	(	PUNCT
ajlm-2912	78	27	table	table	NOUN
ajlm-2912	78	28	5	5	NUM
ajlm-2912	78	29	)	)	PUNCT
ajlm-2912	78	30	.	.	PUNCT
ajlm-2912	79	1	table	table	NOUN
ajlm-2912	79	2	4	4	NUM
ajlm-2912	79	3	:	:	PUNCT
ajlm-2912	79	4	 	 	SPACE
ajlm-2912	79	5	oxidative	oxidative	ADJ
ajlm-2912	79	6	biomarkers	biomarker	NOUN
ajlm-2912	79	7	levels	level	NOUN
ajlm-2912	79	8	in	in	ADP
ajlm-2912	79	9	controls	control	NOUN
ajlm-2912	79	10	and	and	CCONJ
ajlm-2912	79	11	acne	acne	NOUN
ajlm-2912	79	12	patients	patient	NOUN
ajlm-2912	79	13	of	of	ADP
ajlm-2912	79	14	varying	vary	VERB
ajlm-2912	79	15	severity	severity	NOUN
ajlm-2912	79	16	,	,	PUNCT
ajlm-2912	79	17	gurugram	gurugram	PROPN
ajlm-2912	79	18	,	,	PUNCT
ajlm-2912	79	19	india	india	PROPN
ajlm-2912	79	20	,	,	PUNCT
ajlm-2912	79	21	from	from	ADP
ajlm-2912	79	22	01	01	NUM
ajlm-2912	79	23	july	july	PROPN
ajlm-2912	79	24	2023	2023	NUM
ajlm-2912	79	25	to	to	ADP
ajlm-2912	79	26	30	30	NUM
ajlm-2912	79	27	june	june	PROPN
ajlm-2912	79	28	2024	2024	NUM
ajlm-2912	79	29	.	.	PUNCT
ajlm-2912	80	1	table	table	NOUN
ajlm-2912	80	2	5	5	NUM
ajlm-2912	80	3	:	:	PUNCT
ajlm-2912	80	4	 	 	SPACE
ajlm-2912	80	5	post	post	ADJ
ajlm-2912	80	6	-	-	ADJ
ajlm-2912	80	7	hoc	hoc	ADJ
ajlm-2912	80	8	multiple	multiple	ADJ
ajlm-2912	80	9	comparisons	comparison	NOUN
ajlm-2912	80	10	of	of	ADP
ajlm-2912	80	11	oxidative	oxidative	ADJ
ajlm-2912	80	12	stress	stress	NOUN
ajlm-2912	80	13	markers	marker	NOUN
ajlm-2912	80	14	between	between	ADP
ajlm-2912	80	15	acne	acne	NOUN
ajlm-2912	80	16	severity	severity	NOUN
ajlm-2912	80	17	grades	grade	NOUN
ajlm-2912	80	18	,	,	PUNCT
ajlm-2912	80	19	gurugram	gurugram	PROPN
ajlm-2912	80	20	,	,	PUNCT
ajlm-2912	80	21	india	india	PROPN
ajlm-2912	80	22	,	,	PUNCT
ajlm-2912	80	23	from	from	ADP
ajlm-2912	80	24	01	01	NUM
ajlm-2912	80	25	july	july	PROPN
ajlm-2912	80	26	2023	2023	NUM
ajlm-2912	80	27	to	to	ADP
ajlm-2912	80	28	30	30	NUM
ajlm-2912	80	29	june	june	PROPN
ajlm-2912	80	30	2024	2024	NUM
ajlm-2912	80	31	.	.	PUNCT
ajlm-2912	81	1	to	to	PART
ajlm-2912	81	2	adjust	adjust	VERB
ajlm-2912	81	3	for	for	ADP
ajlm-2912	81	4	potential	potential	ADJ
ajlm-2912	81	5	confounding	confound	VERB
ajlm-2912	81	6	variables	variable	NOUN
ajlm-2912	81	7	and	and	CCONJ
ajlm-2912	81	8	to	to	PART
ajlm-2912	81	9	explore	explore	VERB
ajlm-2912	81	10	the	the	DET
ajlm-2912	81	11	combined	combined	ADJ
ajlm-2912	81	12	effect	effect	NOUN
ajlm-2912	81	13	of	of	ADP
ajlm-2912	81	14	oxidative	oxidative	ADJ
ajlm-2912	81	15	stress	stress	NOUN
ajlm-2912	81	16	markers	marker	NOUN
ajlm-2912	81	17	,	,	PUNCT
ajlm-2912	81	18	a	a	DET
ajlm-2912	81	19	multiple	multiple	ADJ
ajlm-2912	81	20	linear	linear	ADJ
ajlm-2912	81	21	regression	regression	NOUN
ajlm-2912	81	22	analysis	analysis	NOUN
ajlm-2912	81	23	was	be	AUX
ajlm-2912	81	24	performed	perform	VERB
ajlm-2912	81	25	.	.	PUNCT
ajlm-2912	82	1	acne	acne	NOUN
ajlm-2912	82	2	severity	severity	NOUN
ajlm-2912	82	3	was	be	AUX
ajlm-2912	82	4	used	use	VERB
ajlm-2912	82	5	as	as	ADP
ajlm-2912	82	6	the	the	DET
ajlm-2912	82	7	dependent	dependent	ADJ
ajlm-2912	82	8	variable	variable	NOUN
ajlm-2912	82	9	,	,	PUNCT
ajlm-2912	82	10	with	with	ADP
ajlm-2912	82	11	serum	serum	NOUN
ajlm-2912	82	12	levels	level	NOUN
ajlm-2912	82	13	of	of	ADP
ajlm-2912	82	14	sod	sod	NOUN
ajlm-2912	82	15	,	,	PUNCT
ajlm-2912	82	16	cat	cat	NOUN
ajlm-2912	82	17	,	,	PUNCT
ajlm-2912	82	18	gsh	gsh	PROPN
ajlm-2912	82	19	,	,	PUNCT
ajlm-2912	82	20	mda	mda	PROPN
ajlm-2912	82	21	,	,	PUNCT
ajlm-2912	82	22	and	and	CCONJ
ajlm-2912	82	23	patient	patient	ADJ
ajlm-2912	82	24	age	age	NOUN
ajlm-2912	82	25	as	as	ADP
ajlm-2912	82	26	independent	independent	ADJ
ajlm-2912	82	27	predictor	predictor	NOUN
ajlm-2912	82	28	variables	variable	NOUN
ajlm-2912	82	29	.	.	PUNCT
ajlm-2912	83	1	as	as	SCONJ
ajlm-2912	83	2	shown	show	VERB
ajlm-2912	83	3	in	in	ADP
ajlm-2912	83	4	table	table	NOUN
ajlm-2912	83	5	6	6	NUM
ajlm-2912	83	6	,	,	PUNCT
ajlm-2912	83	7	mda	mda	PROPN
ajlm-2912	83	8	was	be	AUX
ajlm-2912	83	9	a	a	DET
ajlm-2912	83	10	significant	significant	ADJ
ajlm-2912	83	11	positive	positive	ADJ
ajlm-2912	83	12	predictor	predictor	NOUN
ajlm-2912	83	13	(	(	PUNCT
ajlm-2912	83	14	b	b	NOUN
ajlm-2912	83	15	=	=	SYM
ajlm-2912	83	16	0.232	0.232	NUM
ajlm-2912	83	17	,	,	PUNCT
ajlm-2912	83	18	p	p	X
ajlm-2912	83	19	<	<	X
ajlm-2912	83	20	0.0001	0.0001	NUM
ajlm-2912	83	21	)	)	PUNCT
ajlm-2912	83	22	,	,	PUNCT
ajlm-2912	83	23	while	while	SCONJ
ajlm-2912	83	24	sod	sod	NOUN
ajlm-2912	83	25	(	(	PUNCT
ajlm-2912	83	26	b	b	NOUN
ajlm-2912	83	27	=	=	SYM
ajlm-2912	83	28	−0.125	−0.125	PROPN
ajlm-2912	83	29	,	,	PUNCT
ajlm-2912	83	30	p	p	X
ajlm-2912	83	31	<	<	X
ajlm-2912	83	32	0.0001	0.0001	NUM
ajlm-2912	83	33	)	)	PUNCT
ajlm-2912	83	34	,	,	PUNCT
ajlm-2912	83	35	cat	cat	NOUN
ajlm-2912	83	36	(	(	PUNCT
ajlm-2912	83	37	b	b	X
ajlm-2912	83	38	=	=	SYM
ajlm-2912	83	39	−1.920	−1.920	NOUN
ajlm-2912	83	40	,	,	PUNCT
ajlm-2912	83	41	p	p	NOUN
ajlm-2912	83	42	=	=	NOUN
ajlm-2912	83	43	0.0004	0.0004	NUM
ajlm-2912	83	44	)	)	PUNCT
ajlm-2912	83	45	,	,	PUNCT
ajlm-2912	83	46	and	and	CCONJ
ajlm-2912	83	47	gsh	gsh	X
ajlm-2912	83	48	(	(	PUNCT
ajlm-2912	83	49	b	b	NOUN
ajlm-2912	83	50	=	=	SYM
ajlm-2912	83	51	−0.839	−0.839	PROPN
ajlm-2912	83	52	,	,	PUNCT
ajlm-2912	83	53	p	p	X
ajlm-2912	83	54	<	<	X
ajlm-2912	83	55	0.0001	0.0001	NUM
ajlm-2912	83	56	)	)	PUNCT
ajlm-2912	83	57	were	be	AUX
ajlm-2912	83	58	significant	significant	ADJ
ajlm-2912	83	59	negative	negative	ADJ
ajlm-2912	83	60	predictors	predictor	NOUN
ajlm-2912	83	61	.	.	PUNCT
ajlm-2912	84	1	age	age	NOUN
ajlm-2912	84	2	was	be	AUX
ajlm-2912	84	3	not	not	PART
ajlm-2912	84	4	a	a	DET
ajlm-2912	84	5	significant	significant	ADJ
ajlm-2912	84	6	predictor	predictor	NOUN
ajlm-2912	84	7	(	(	PUNCT
ajlm-2912	84	8	p	p	NOUN
ajlm-2912	84	9	=	=	NOUN
ajlm-2912	84	10	0.311	0.311	NUM
ajlm-2912	84	11	)	)	PUNCT
ajlm-2912	84	12	.	.	PUNCT
ajlm-2912	85	1	overall	overall	ADV
ajlm-2912	85	2	,	,	PUNCT
ajlm-2912	85	3	these	these	DET
ajlm-2912	85	4	findings	finding	NOUN
ajlm-2912	85	5	indicate	indicate	VERB
ajlm-2912	85	6	that	that	PRON
ajlm-2912	85	7	oxidative	oxidative	ADJ
ajlm-2912	85	8	stress	stress	NOUN
ajlm-2912	85	9	markers	marker	NOUN
ajlm-2912	85	10	independently	independently	ADV
ajlm-2912	85	11	contribute	contribute	VERB
ajlm-2912	85	12	to	to	ADP
ajlm-2912	85	13	acne	acne	NOUN
ajlm-2912	85	14	severity	severity	NOUN
ajlm-2912	85	15	,	,	PUNCT
ajlm-2912	85	16	with	with	ADP
ajlm-2912	85	17	higher	high	ADJ
ajlm-2912	85	18	oxidative	oxidative	ADJ
ajlm-2912	85	19	damage	damage	NOUN
ajlm-2912	85	20	(	(	PUNCT
ajlm-2912	85	21	mda	mda	PROPN
ajlm-2912	85	22	)	)	PUNCT
ajlm-2912	85	23	and	and	CCONJ
ajlm-2912	85	24	lower	low	ADJ
ajlm-2912	85	25	antioxidants	antioxidant	NOUN
ajlm-2912	85	26	(	(	PUNCT
ajlm-2912	85	27	sod	sod	NOUN
ajlm-2912	85	28	,	,	PUNCT
ajlm-2912	85	29	cat	cat	NOUN
ajlm-2912	85	30	,	,	PUNCT
ajlm-2912	85	31	gsh	gsh	PROPN
ajlm-2912	85	32	)	)	PUNCT
ajlm-2912	85	33	predicting	predict	VERB
ajlm-2912	85	34	more	more	ADV
ajlm-2912	85	35	severe	severe	ADJ
ajlm-2912	85	36	disease	disease	NOUN
ajlm-2912	85	37	.	.	PUNCT
ajlm-2912	86	1	table	table	NOUN
ajlm-2912	86	2	6	6	NUM
ajlm-2912	86	3	:	:	PUNCT
ajlm-2912	86	4	 	 	SPACE
ajlm-2912	86	5	multiple	multiple	ADJ
ajlm-2912	86	6	linear	linear	ADJ
ajlm-2912	86	7	regression	regression	NOUN
ajlm-2912	86	8	analysis	analysis	NOUN
ajlm-2912	86	9	of	of	ADP
ajlm-2912	86	10	oxidative	oxidative	ADJ
ajlm-2912	86	11	stress	stress	NOUN
ajlm-2912	86	12	markers	marker	NOUN
ajlm-2912	86	13	and	and	CCONJ
ajlm-2912	86	14	age	age	NOUN
ajlm-2912	86	15	as	as	ADP
ajlm-2912	86	16	predictors	predictor	NOUN
ajlm-2912	86	17	of	of	ADP
ajlm-2912	86	18	acne	acne	NOUN
ajlm-2912	86	19	severity	severity	NOUN
ajlm-2912	86	20	,	,	PUNCT
ajlm-2912	86	21	gurugram	gurugram	PROPN
ajlm-2912	86	22	,	,	PUNCT
ajlm-2912	86	23	india	india	PROPN
ajlm-2912	86	24	,	,	PUNCT
ajlm-2912	86	25	from	from	ADP
ajlm-2912	86	26	01	01	NUM
ajlm-2912	86	27	july	july	PROPN
ajlm-2912	86	28	2023	2023	NUM
ajlm-2912	86	29	to	to	ADP
ajlm-2912	86	30	30	30	NUM
ajlm-2912	86	31	june	june	PROPN
ajlm-2912	86	32	2024	2024	NUM
ajlm-2912	86	33	.	.	PUNCT
ajlm-2912	87	1	table	table	NOUN
ajlm-2912	87	2	7	7	NUM
ajlm-2912	87	3	,	,	PUNCT
ajlm-2912	87	4	table	table	NOUN
ajlm-2912	87	5	8	8	NUM
ajlm-2912	87	6	,	,	PUNCT
ajlm-2912	87	7	table	table	NOUN
ajlm-2912	87	8	9	9	NUM
ajlm-2912	87	9	,	,	PUNCT
ajlm-2912	87	10	table	table	NOUN
ajlm-2912	87	11	10	10	NUM
ajlm-2912	87	12	,	,	PUNCT
ajlm-2912	87	13	figure	figure	NOUN
ajlm-2912	87	14	2	2	NUM
ajlm-2912	87	15	,	,	PUNCT
ajlm-2912	87	16	figure	figure	NOUN
ajlm-2912	87	17	3	3	NUM
ajlm-2912	87	18	,	,	PUNCT
ajlm-2912	87	19	figure	figure	VERB
ajlm-2912	87	20	4	4	NUM
ajlm-2912	87	21	and	and	CCONJ
ajlm-2912	87	22	figure	figure	VERB
ajlm-2912	87	23	5	5	NUM
ajlm-2912	87	24	displays	display	VERB
ajlm-2912	87	25	the	the	DET
ajlm-2912	87	26	correlation	correlation	NOUN
ajlm-2912	87	27	between	between	ADP
ajlm-2912	87	28	acne	acne	NOUN
ajlm-2912	87	29	severity	severity	NOUN
ajlm-2912	87	30	and	and	CCONJ
ajlm-2912	87	31	levels	level	NOUN
ajlm-2912	87	32	of	of	ADP
ajlm-2912	87	33	oxidative	oxidative	ADJ
ajlm-2912	87	34	and	and	CCONJ
ajlm-2912	87	35	antioxidative	antioxidative	ADJ
ajlm-2912	87	36	biomarkers	biomarker	NOUN
ajlm-2912	87	37	.	.	PUNCT
ajlm-2912	88	1	a	a	DET
ajlm-2912	88	2	significant	significant	ADJ
ajlm-2912	88	3	negative	negative	ADJ
ajlm-2912	88	4	correlation	correlation	NOUN
ajlm-2912	88	5	was	be	AUX
ajlm-2912	88	6	observed	observe	VERB
ajlm-2912	88	7	between	between	ADP
ajlm-2912	88	8	mda	mda	PROPN
ajlm-2912	88	9	levels	level	NOUN
ajlm-2912	88	10	and	and	CCONJ
ajlm-2912	88	11	cat	cat	NOUN
ajlm-2912	88	12	activity	activity	NOUN
ajlm-2912	88	13	in	in	ADP
ajlm-2912	88	14	the	the	DET
ajlm-2912	88	15	serum	serum	NOUN
ajlm-2912	88	16	of	of	ADP
ajlm-2912	88	17	grade	grade	NOUN
ajlm-2912	88	18	4	4	NUM
ajlm-2912	88	19	acne	acne	NOUN
ajlm-2912	88	20	patients	patient	NOUN
ajlm-2912	88	21	(	(	PUNCT
ajlm-2912	88	22	r	r	NOUN
ajlm-2912	88	23	=	=	PUNCT
ajlm-2912	88	24	–	–	PUNCT
ajlm-2912	88	25	0.403	0.403	NUM
ajlm-2912	88	26	,	,	PUNCT
ajlm-2912	88	27	p	p	NOUN
ajlm-2912	88	28	=	=	PROPN
ajlm-2912	88	29	0.0037	0.0037	NUM
ajlm-2912	88	30	)	)	PUNCT
ajlm-2912	88	31	.	.	PUNCT
ajlm-2912	89	1	however	however	ADV
ajlm-2912	89	2	,	,	PUNCT
ajlm-2912	89	3	no	no	DET
ajlm-2912	89	4	significant	significant	ADJ
ajlm-2912	89	5	correlation	correlation	NOUN
ajlm-2912	89	6	was	be	AUX
ajlm-2912	89	7	found	find	VERB
ajlm-2912	89	8	in	in	ADP
ajlm-2912	89	9	the	the	DET
ajlm-2912	89	10	other	other	ADJ
ajlm-2912	89	11	acne	acne	NOUN
ajlm-2912	89	12	subgroups	subgroup	NOUN
ajlm-2912	89	13	.	.	PUNCT
ajlm-2912	90	1	figure	figure	VERB
ajlm-2912	90	2	2	2	NUM
ajlm-2912	90	3	:	:	PUNCT
ajlm-2912	90	4	correlation	correlation	NOUN
ajlm-2912	90	5	between	between	ADP
ajlm-2912	90	6	oxidative	oxidative	ADJ
ajlm-2912	90	7	stress	stress	NOUN
ajlm-2912	90	8	biomarker	biomarker	NOUN
ajlm-2912	90	9	and	and	CCONJ
ajlm-2912	90	10	antioxidants	antioxidant	NOUN
ajlm-2912	90	11	in	in	ADP
ajlm-2912	90	12	grade	grade	NOUN
ajlm-2912	90	13	1	1	NUM
ajlm-2912	90	14	acne	acne	NOUN
ajlm-2912	90	15	patients	patient	NOUN
ajlm-2912	90	16	,	,	PUNCT
ajlm-2912	90	17	gurugram	gurugram	PROPN
ajlm-2912	90	18	,	,	PUNCT
ajlm-2912	90	19	india	india	PROPN
ajlm-2912	90	20	,	,	PUNCT
ajlm-2912	90	21	from	from	ADP
ajlm-2912	90	22	01	01	NUM
ajlm-2912	90	23	july	july	PROPN
ajlm-2912	90	24	2023	2023	NUM
ajlm-2912	90	25	to	to	ADP
ajlm-2912	90	26	30	30	NUM
ajlm-2912	90	27	june	june	PROPN
ajlm-2912	90	28	2024	2024	NUM
ajlm-2912	90	29	.	.	PUNCT
ajlm-2912	91	1	correlation	correlation	NOUN
ajlm-2912	91	2	between	between	ADP
ajlm-2912	91	3	(	(	PUNCT
ajlm-2912	91	4	a	a	NOUN
ajlm-2912	91	5	)	)	PUNCT
ajlm-2912	91	6	mda	mda	NOUN
ajlm-2912	91	7	and	and	CCONJ
ajlm-2912	91	8	sod	sod	PROPN
ajlm-2912	91	9	(	(	PUNCT
ajlm-2912	91	10	non	non	ADJ
ajlm-2912	91	11	-	-	ADJ
ajlm-2912	91	12	significant	significant	ADJ
ajlm-2912	91	13	,	,	PUNCT
ajlm-2912	91	14	p	p	NOUN
ajlm-2912	91	15	=	=	NOUN
ajlm-2912	91	16	0.3491	0.3491	NUM
ajlm-2912	91	17	,	,	PUNCT
ajlm-2912	91	18	r	r	NOUN
ajlm-2912	91	19	=	=	SYM
ajlm-2912	91	20	−0.1352	−0.1352	NOUN
ajlm-2912	91	21	)	)	PUNCT
ajlm-2912	91	22	;	;	PUNCT
ajlm-2912	91	23	(	(	PUNCT
ajlm-2912	91	24	b	b	X
ajlm-2912	91	25	)	)	PUNCT
ajlm-2912	91	26	mda	mda	NOUN
ajlm-2912	91	27	and	and	CCONJ
ajlm-2912	91	28	cat	cat	NOUN
ajlm-2912	91	29	(	(	PUNCT
ajlm-2912	91	30	non	non	ADJ
ajlm-2912	91	31	-	-	ADJ
ajlm-2912	91	32	significant	significant	ADJ
ajlm-2912	91	33	,	,	PUNCT
ajlm-2912	91	34	p	p	X
ajlm-2912	91	35	=	=	NOUN
ajlm-2912	91	36	0.9753	0.9753	NUM
ajlm-2912	91	37	,	,	PUNCT
ajlm-2912	91	38	r	r	NOUN
ajlm-2912	91	39	=	=	NOUN
ajlm-2912	91	40	0.0044	0.0044	NUM
ajlm-2912	91	41	)	)	PUNCT
ajlm-2912	91	42	;	;	PUNCT
ajlm-2912	91	43	and	and	CCONJ
ajlm-2912	91	44	(	(	PUNCT
ajlm-2912	91	45	c	c	X
ajlm-2912	91	46	)	)	PUNCT
ajlm-2912	91	47	mda	mda	PROPN
ajlm-2912	91	48	and	and	CCONJ
ajlm-2912	91	49	gsh	gsh	PROPN
ajlm-2912	91	50	(	(	PUNCT
ajlm-2912	91	51	non	non	ADJ
ajlm-2912	91	52	-	-	ADJ
ajlm-2912	91	53	significant	significant	ADJ
ajlm-2912	91	54	,	,	PUNCT
ajlm-2912	91	55	p	p	X
ajlm-2912	91	56	=	=	NOUN
ajlm-2912	91	57	0.6738	0.6738	NOUN
ajlm-2912	91	58	,	,	PUNCT
ajlm-2912	91	59	r	r	NOUN
ajlm-2912	91	60	=	=	SYM
ajlm-2912	91	61	−0.0610	−0.0610	NUM
ajlm-2912	91	62	)	)	PUNCT
ajlm-2912	91	63	.	.	PUNCT
ajlm-2912	92	1	figure	figure	VERB
ajlm-2912	92	2	3	3	NUM
ajlm-2912	92	3	:	:	PUNCT
ajlm-2912	92	4	correlation	correlation	NOUN
ajlm-2912	92	5	between	between	ADP
ajlm-2912	92	6	oxidative	oxidative	ADJ
ajlm-2912	92	7	stress	stress	NOUN
ajlm-2912	92	8	biomarker	biomarker	NOUN
ajlm-2912	92	9	and	and	CCONJ
ajlm-2912	92	10	antioxidants	antioxidant	NOUN
ajlm-2912	92	11	in	in	ADP
ajlm-2912	92	12	grade	grade	NOUN
ajlm-2912	92	13	2	2	NUM
ajlm-2912	92	14	acne	acne	NOUN
ajlm-2912	92	15	patients	patient	NOUN
ajlm-2912	92	16	,	,	PUNCT
ajlm-2912	92	17	gurugram	gurugram	PROPN
ajlm-2912	92	18	,	,	PUNCT
ajlm-2912	92	19	india	india	PROPN
ajlm-2912	92	20	,	,	PUNCT
ajlm-2912	92	21	from	from	ADP
ajlm-2912	92	22	01	01	NUM
ajlm-2912	92	23	july	july	PROPN
ajlm-2912	92	24	2023	2023	NUM
ajlm-2912	92	25	to	to	ADP
ajlm-2912	92	26	30	30	NUM
ajlm-2912	92	27	june	june	PROPN
ajlm-2912	92	28	2024	2024	NUM
ajlm-2912	92	29	.	.	PUNCT
ajlm-2912	93	1	correlation	correlation	NOUN
ajlm-2912	93	2	between	between	ADP
ajlm-2912	93	3	(	(	PUNCT
ajlm-2912	93	4	a	a	NOUN
ajlm-2912	93	5	)	)	PUNCT
ajlm-2912	93	6	mda	mda	NOUN
ajlm-2912	93	7	and	and	CCONJ
ajlm-2912	93	8	sod	sod	PROPN
ajlm-2912	93	9	(	(	PUNCT
ajlm-2912	93	10	non	non	ADJ
ajlm-2912	93	11	-	-	ADJ
ajlm-2912	93	12	significant	significant	ADJ
ajlm-2912	93	13	,	,	PUNCT
ajlm-2912	93	14	p	p	X
ajlm-2912	93	15	=	=	NOUN
ajlm-2912	93	16	0.9943	0.9943	NUM
ajlm-2912	93	17	,	,	PUNCT
ajlm-2912	93	18	r	r	NOUN
ajlm-2912	93	19	=	=	SYM
ajlm-2912	93	20	0.0010	0.0010	NUM
ajlm-2912	93	21	)	)	PUNCT
ajlm-2912	93	22	;	;	PUNCT
ajlm-2912	93	23	(	(	PUNCT
ajlm-2912	93	24	b	b	X
ajlm-2912	93	25	)	)	PUNCT
ajlm-2912	93	26	mda	mda	NOUN
ajlm-2912	93	27	and	and	CCONJ
ajlm-2912	93	28	cat	cat	NOUN
ajlm-2912	93	29	(	(	PUNCT
ajlm-2912	93	30	non	non	ADJ
ajlm-2912	93	31	-	-	ADJ
ajlm-2912	93	32	significant	significant	ADJ
ajlm-2912	93	33	,	,	PUNCT
ajlm-2912	93	34	p	p	NOUN
ajlm-2912	93	35	=	=	NOUN
ajlm-2912	93	36	0.4299	0.4299	NUM
ajlm-2912	93	37	,	,	PUNCT
ajlm-2912	93	38	r	r	NOUN
ajlm-2912	93	39	=	=	SYM
ajlm-2912	93	40	0.1141	0.1141	NUM
ajlm-2912	93	41	)	)	PUNCT
ajlm-2912	93	42	;	;	PUNCT
ajlm-2912	93	43	and	and	CCONJ
ajlm-2912	93	44	(	(	PUNCT
ajlm-2912	93	45	c	c	X
ajlm-2912	93	46	)	)	PUNCT
ajlm-2912	93	47	mda	mda	PROPN
ajlm-2912	93	48	and	and	CCONJ
ajlm-2912	93	49	gsh	gsh	PROPN
ajlm-2912	93	50	(	(	PUNCT
ajlm-2912	93	51	non	non	ADJ
ajlm-2912	93	52	-	-	ADJ
ajlm-2912	93	53	significant	significant	ADJ
ajlm-2912	93	54	,	,	PUNCT
ajlm-2912	93	55	p	p	NOUN
ajlm-2912	93	56	=	=	PROPN
ajlm-2912	93	57	0.7104	0.7104	NUM
ajlm-2912	93	58	,	,	PUNCT
ajlm-2912	93	59	r	r	NOUN
ajlm-2912	93	60	=	=	SYM
ajlm-2912	93	61	0.0538	0.0538	NUM
ajlm-2912	93	62	)	)	PUNCT
ajlm-2912	93	63	.	.	PUNCT
ajlm-2912	94	1	figure	figure	VERB
ajlm-2912	94	2	4	4	NUM
ajlm-2912	94	3	:	:	PUNCT
ajlm-2912	94	4	correlation	correlation	NOUN
ajlm-2912	94	5	between	between	ADP
ajlm-2912	94	6	oxidative	oxidative	ADJ
ajlm-2912	94	7	stress	stress	NOUN
ajlm-2912	94	8	biomarker	biomarker	NOUN
ajlm-2912	94	9	and	and	CCONJ
ajlm-2912	94	10	antioxidants	antioxidant	NOUN
ajlm-2912	94	11	in	in	ADP
ajlm-2912	94	12	grade	grade	NOUN
ajlm-2912	94	13	3	3	NUM
ajlm-2912	94	14	acne	acne	NOUN
ajlm-2912	94	15	patients	patient	NOUN
ajlm-2912	94	16	,	,	PUNCT
ajlm-2912	94	17	gurugram	gurugram	PROPN
ajlm-2912	94	18	,	,	PUNCT
ajlm-2912	94	19	india	india	PROPN
ajlm-2912	94	20	,	,	PUNCT
ajlm-2912	94	21	from	from	ADP
ajlm-2912	94	22	01	01	NUM
ajlm-2912	94	23	july	july	PROPN
ajlm-2912	94	24	2023	2023	NUM
ajlm-2912	94	25	to	to	ADP
ajlm-2912	94	26	30	30	NUM
ajlm-2912	94	27	june	june	PROPN
ajlm-2912	94	28	2024	2024	NUM
ajlm-2912	94	29	.	.	PUNCT
ajlm-2912	95	1	correlation	correlation	NOUN
ajlm-2912	95	2	between	between	ADP
ajlm-2912	95	3	(	(	PUNCT
ajlm-2912	95	4	a	a	NOUN
ajlm-2912	95	5	)	)	PUNCT
ajlm-2912	95	6	mda	mda	NOUN
ajlm-2912	95	7	and	and	CCONJ
ajlm-2912	95	8	sod	sod	PROPN
ajlm-2912	95	9	(	(	PUNCT
ajlm-2912	95	10	non	non	ADJ
ajlm-2912	95	11	-	-	ADJ
ajlm-2912	95	12	significant	significant	ADJ
ajlm-2912	95	13	,	,	PUNCT
ajlm-2912	95	14	p	p	X
ajlm-2912	95	15	=	=	NOUN
ajlm-2912	95	16	0.4306	0.4306	NUM
ajlm-2912	95	17	,	,	PUNCT
ajlm-2912	95	18	r	r	NOUN
ajlm-2912	95	19	=	=	SYM
ajlm-2912	95	20	0.1140	0.1140	NUM
ajlm-2912	95	21	)	)	PUNCT
ajlm-2912	95	22	;	;	PUNCT
ajlm-2912	95	23	(	(	PUNCT
ajlm-2912	95	24	b	b	X
ajlm-2912	95	25	)	)	PUNCT
ajlm-2912	95	26	mda	mda	NOUN
ajlm-2912	95	27	and	and	CCONJ
ajlm-2912	95	28	cat	cat	NOUN
ajlm-2912	95	29	(	(	PUNCT
ajlm-2912	95	30	non	non	ADJ
ajlm-2912	95	31	-	-	ADJ
ajlm-2912	95	32	significant	significant	ADJ
ajlm-2912	95	33	,	,	PUNCT
ajlm-2912	95	34	p	p	X
ajlm-2912	95	35	=	=	NOUN
ajlm-2912	95	36	0.2106	0.2106	NUM
ajlm-2912	95	37	,	,	PUNCT
ajlm-2912	95	38	r	r	NOUN
ajlm-2912	95	39	=	=	SYM
ajlm-2912	95	40	0.1802	0.1802	NUM
ajlm-2912	95	41	)	)	PUNCT
ajlm-2912	95	42	;	;	PUNCT
ajlm-2912	95	43	and	and	CCONJ
ajlm-2912	95	44	(	(	PUNCT
ajlm-2912	95	45	c	c	X
ajlm-2912	95	46	)	)	PUNCT
ajlm-2912	95	47	mda	mda	PROPN
ajlm-2912	95	48	and	and	CCONJ
ajlm-2912	95	49	gsh	gsh	PROPN
ajlm-2912	95	50	(	(	PUNCT
ajlm-2912	95	51	non	non	ADJ
ajlm-2912	95	52	-	-	ADJ
ajlm-2912	95	53	significant	significant	ADJ
ajlm-2912	95	54	,	,	PUNCT
ajlm-2912	95	55	p	p	X
ajlm-2912	95	56	=	=	SYM
ajlm-2912	95	57	0.6938	0.6938	NUM
ajlm-2912	95	58	,	,	PUNCT
ajlm-2912	95	59	r	r	NOUN
ajlm-2912	95	60	=	=	SYM
ajlm-2912	95	61	−0.0570	−0.0570	NOUN
ajlm-2912	95	62	)	)	PUNCT
ajlm-2912	95	63	.	.	PUNCT
ajlm-2912	96	1	figure	figure	VERB
ajlm-2912	96	2	5	5	NUM
ajlm-2912	96	3	:	:	PUNCT
ajlm-2912	96	4	correlation	correlation	NOUN
ajlm-2912	96	5	between	between	ADP
ajlm-2912	96	6	oxidative	oxidative	ADJ
ajlm-2912	96	7	stress	stress	NOUN
ajlm-2912	96	8	biomarker	biomarker	NOUN
ajlm-2912	96	9	and	and	CCONJ
ajlm-2912	96	10	antioxidants	antioxidant	NOUN
ajlm-2912	96	11	in	in	ADP
ajlm-2912	96	12	grade	grade	NOUN
ajlm-2912	96	13	4	4	NUM
ajlm-2912	96	14	acne	acne	NOUN
ajlm-2912	96	15	patients	patient	NOUN
ajlm-2912	96	16	,	,	PUNCT
ajlm-2912	96	17	gurugram	gurugram	PROPN
ajlm-2912	96	18	,	,	PUNCT
ajlm-2912	96	19	india	india	PROPN
ajlm-2912	96	20	,	,	PUNCT
ajlm-2912	96	21	from	from	ADP
ajlm-2912	96	22	01	01	NUM
ajlm-2912	96	23	july	july	PROPN
ajlm-2912	96	24	2023	2023	NUM
ajlm-2912	96	25	to	to	ADP
ajlm-2912	96	26	30	30	NUM
ajlm-2912	96	27	june	june	PROPN
ajlm-2912	96	28	2024	2024	NUM
ajlm-2912	96	29	.	.	PUNCT
ajlm-2912	97	1	correlation	correlation	NOUN
ajlm-2912	97	2	between	between	ADP
ajlm-2912	97	3	(	(	PUNCT
ajlm-2912	97	4	a	a	NOUN
ajlm-2912	97	5	)	)	PUNCT
ajlm-2912	97	6	mda	mda	NOUN
ajlm-2912	97	7	and	and	CCONJ
ajlm-2912	97	8	sod	sod	PROPN
ajlm-2912	97	9	(	(	PUNCT
ajlm-2912	97	10	non	non	ADJ
ajlm-2912	97	11	-	-	ADJ
ajlm-2912	97	12	significant	significant	ADJ
ajlm-2912	97	13	,	,	PUNCT
ajlm-2912	97	14	p	p	X
ajlm-2912	97	15	=	=	NOUN
ajlm-2912	97	16	0.8880	0.8880	NUM
ajlm-2912	97	17	,	,	PUNCT
ajlm-2912	97	18	r	r	NOUN
ajlm-2912	97	19	=	=	SYM
ajlm-2912	97	20	0.0204	0.0204	NUM
ajlm-2912	97	21	)	)	PUNCT
ajlm-2912	97	22	;	;	PUNCT
ajlm-2912	97	23	(	(	PUNCT
ajlm-2912	97	24	b	b	X
ajlm-2912	97	25	)	)	PUNCT
ajlm-2912	97	26	mda	mda	NOUN
ajlm-2912	97	27	and	and	CCONJ
ajlm-2912	97	28	cat	cat	NOUN
ajlm-2912	97	29	(	(	PUNCT
ajlm-2912	97	30	significant	significant	ADJ
ajlm-2912	97	31	,	,	PUNCT
ajlm-2912	97	32	p	p	NOUN
ajlm-2912	97	33	=	=	NOUN
ajlm-2912	97	34	0.0037	0.0037	NUM
ajlm-2912	97	35	,	,	PUNCT
ajlm-2912	97	36	r	r	NOUN
ajlm-2912	97	37	=	=	SYM
ajlm-2912	97	38	−0.4035	−0.4035	PROPN
ajlm-2912	97	39	)	)	PUNCT
ajlm-2912	97	40	;	;	PUNCT
ajlm-2912	97	41	and	and	CCONJ
ajlm-2912	97	42	(	(	PUNCT
ajlm-2912	97	43	c	c	X
ajlm-2912	97	44	)	)	PUNCT
ajlm-2912	97	45	mda	mda	PROPN
ajlm-2912	97	46	and	and	CCONJ
ajlm-2912	97	47	gsh	gsh	PROPN
ajlm-2912	97	48	(	(	PUNCT
ajlm-2912	97	49	non	non	ADJ
ajlm-2912	97	50	-	-	ADJ
ajlm-2912	97	51	significant	significant	ADJ
ajlm-2912	97	52	,	,	PUNCT
ajlm-2912	97	53	p	p	NOUN
ajlm-2912	97	54	=	=	PROPN
ajlm-2912	97	55	0.4202	0.4202	NUM
ajlm-2912	97	56	,	,	PUNCT
ajlm-2912	97	57	r	r	NOUN
ajlm-2912	97	58	=	=	SYM
ajlm-2912	97	59	0.1166	0.1166	NUM
ajlm-2912	97	60	)	)	PUNCT
ajlm-2912	97	61	.	.	PUNCT
ajlm-2912	98	1	table	table	NOUN
ajlm-2912	98	2	7	7	NUM
ajlm-2912	98	3	:	:	PUNCT
ajlm-2912	98	4	 	 	SPACE
ajlm-2912	98	5	correlation	correlation	NOUN
ajlm-2912	98	6	analysis	analysis	NOUN
ajlm-2912	98	7	of	of	ADP
ajlm-2912	98	8	oxidative	oxidative	ADJ
ajlm-2912	98	9	markers	marker	NOUN
ajlm-2912	98	10	in	in	ADP
ajlm-2912	98	11	grade	grade	NOUN
ajlm-2912	98	12	1	1	NUM
ajlm-2912	98	13	acne	acne	NOUN
ajlm-2912	98	14	patients	patient	NOUN
ajlm-2912	98	15	,	,	PUNCT
ajlm-2912	98	16	gurugram	gurugram	PROPN
ajlm-2912	98	17	,	,	PUNCT
ajlm-2912	98	18	india	india	PROPN
ajlm-2912	98	19	,	,	PUNCT
ajlm-2912	98	20	from	from	ADP
ajlm-2912	98	21	01	01	NUM
ajlm-2912	98	22	july	july	PROPN
ajlm-2912	98	23	2023	2023	NUM
ajlm-2912	98	24	to	to	ADP
ajlm-2912	98	25	30	30	NUM
ajlm-2912	98	26	june	june	PROPN
ajlm-2912	98	27	2024	2024	NUM
ajlm-2912	98	28	.	.	PUNCT
ajlm-2912	99	1	table	table	NOUN
ajlm-2912	99	2	8	8	NUM
ajlm-2912	99	3	:	:	PUNCT
ajlm-2912	99	4	 	 	SPACE
ajlm-2912	99	5	correlation	correlation	NOUN
ajlm-2912	99	6	analysis	analysis	NOUN
ajlm-2912	99	7	of	of	ADP
ajlm-2912	99	8	oxidative	oxidative	ADJ
ajlm-2912	99	9	markers	marker	NOUN
ajlm-2912	99	10	in	in	ADP
ajlm-2912	99	11	grade	grade	NOUN
ajlm-2912	99	12	2	2	NUM
ajlm-2912	99	13	acne	acne	NOUN
ajlm-2912	99	14	patients	patient	NOUN
ajlm-2912	99	15	,	,	PUNCT
ajlm-2912	99	16	gurugram	gurugram	PROPN
ajlm-2912	99	17	,	,	PUNCT
ajlm-2912	99	18	india	india	PROPN
ajlm-2912	99	19	,	,	PUNCT
ajlm-2912	99	20	from	from	ADP
ajlm-2912	99	21	01	01	NUM
ajlm-2912	99	22	july	july	PROPN
ajlm-2912	99	23	2023	2023	NUM
ajlm-2912	99	24	to	to	ADP
ajlm-2912	99	25	30	30	NUM
ajlm-2912	99	26	june	june	PROPN
ajlm-2912	99	27	2024	2024	NUM
ajlm-2912	99	28	.	.	PUNCT
ajlm-2912	100	1	table	table	NOUN
ajlm-2912	100	2	9	9	NUM
ajlm-2912	100	3	:	:	PUNCT
ajlm-2912	100	4	 	 	SPACE
ajlm-2912	100	5	correlation	correlation	NOUN
ajlm-2912	100	6	analysis	analysis	NOUN
ajlm-2912	100	7	of	of	ADP
ajlm-2912	100	8	oxidative	oxidative	ADJ
ajlm-2912	100	9	markers	marker	NOUN
ajlm-2912	100	10	in	in	ADP
ajlm-2912	100	11	grade	grade	NOUN
ajlm-2912	100	12	3	3	NUM
ajlm-2912	100	13	acne	acne	NOUN
ajlm-2912	100	14	patients	patient	NOUN
ajlm-2912	100	15	,	,	PUNCT
ajlm-2912	100	16	gurugram	gurugram	PROPN
ajlm-2912	100	17	,	,	PUNCT
ajlm-2912	100	18	india	india	PROPN
ajlm-2912	100	19	,	,	PUNCT
ajlm-2912	100	20	from	from	ADP
ajlm-2912	100	21	01	01	NUM
ajlm-2912	100	22	july	july	PROPN
ajlm-2912	100	23	2023	2023	NUM
ajlm-2912	100	24	to	to	ADP
ajlm-2912	100	25	30	30	NUM
ajlm-2912	100	26	june	june	PROPN
ajlm-2912	100	27	2024	2024	NUM
ajlm-2912	100	28	.	.	PUNCT
ajlm-2912	101	1	table	table	NOUN
ajlm-2912	101	2	10	10	NUM
ajlm-2912	101	3	:	:	PUNCT
ajlm-2912	101	4	 	 	SPACE
ajlm-2912	101	5	correlation	correlation	NOUN
ajlm-2912	101	6	analysis	analysis	NOUN
ajlm-2912	101	7	of	of	ADP
ajlm-2912	101	8	oxidative	oxidative	ADJ
ajlm-2912	101	9	markers	marker	NOUN
ajlm-2912	101	10	in	in	ADP
ajlm-2912	101	11	grade	grade	NOUN
ajlm-2912	101	12	4	4	NUM
ajlm-2912	101	13	acne	acne	NOUN
ajlm-2912	101	14	patients	patient	NOUN
ajlm-2912	101	15	,	,	PUNCT
ajlm-2912	101	16	gurugram	gurugram	PROPN
ajlm-2912	101	17	,	,	PUNCT
ajlm-2912	101	18	india	india	PROPN
ajlm-2912	101	19	,	,	PUNCT
ajlm-2912	101	20	from	from	ADP
ajlm-2912	101	21	01	01	NUM
ajlm-2912	101	22	july	july	PROPN
ajlm-2912	101	23	2023	2023	NUM
ajlm-2912	101	24	to	to	ADP
ajlm-2912	101	25	30	30	NUM
ajlm-2912	101	26	june	june	PROPN
ajlm-2912	101	27	2024	2024	NUM
ajlm-2912	101	28	.	.	PUNCT
ajlm-2912	102	1	discussion	discussion	NOUN
ajlm-2912	102	2	the	the	DET
ajlm-2912	102	3	current	current	ADJ
ajlm-2912	102	4	study	study	NOUN
ajlm-2912	102	5	’s	’s	PART
ajlm-2912	102	6	findings	finding	NOUN
ajlm-2912	102	7	showed	show	VERB
ajlm-2912	102	8	that	that	SCONJ
ajlm-2912	102	9	lipid	lipid	ADJ
ajlm-2912	102	10	peroxide	peroxide	NOUN
ajlm-2912	102	11	levels	level	NOUN
ajlm-2912	102	12	in	in	ADP
ajlm-2912	102	13	patients	patient	NOUN
ajlm-2912	102	14	of	of	ADP
ajlm-2912	102	15	av	av	PRON
ajlm-2912	102	16	were	be	AUX
ajlm-2912	102	17	much	much	ADV
ajlm-2912	102	18	higher	high	ADJ
ajlm-2912	102	19	than	than	ADP
ajlm-2912	102	20	those	those	PRON
ajlm-2912	102	21	of	of	ADP
ajlm-2912	102	22	healthy	healthy	ADJ
ajlm-2912	102	23	controls	control	NOUN
ajlm-2912	102	24	.	.	PUNCT
ajlm-2912	103	1	on	on	ADP
ajlm-2912	103	2	the	the	DET
ajlm-2912	103	3	other	other	ADJ
ajlm-2912	103	4	hand	hand	NOUN
ajlm-2912	103	5	,	,	PUNCT
ajlm-2912	103	6	the	the	DET
ajlm-2912	103	7	activities	activity	NOUN
ajlm-2912	103	8	of	of	ADP
ajlm-2912	103	9	serum	serum	NOUN
ajlm-2912	103	10	sod	sod	NOUN
ajlm-2912	103	11	and	and	CCONJ
ajlm-2912	103	12	cat	cat	NOUN
ajlm-2912	103	13	as	as	ADV
ajlm-2912	103	14	well	well	ADV
ajlm-2912	103	15	as	as	ADP
ajlm-2912	103	16	the	the	DET
ajlm-2912	103	17	levels	level	NOUN
ajlm-2912	103	18	of	of	ADP
ajlm-2912	103	19	gsh	gsh	PROPN
ajlm-2912	103	20	were	be	AUX
ajlm-2912	103	21	statistically	statistically	ADV
ajlm-2912	103	22	reduced	reduce	VERB
ajlm-2912	103	23	in	in	ADP
ajlm-2912	103	24	acne	acne	NOUN
ajlm-2912	103	25	patients	patient	NOUN
ajlm-2912	103	26	.	.	PUNCT
ajlm-2912	104	1	prior	prior	ADJ
ajlm-2912	104	2	research	research	NOUN
ajlm-2912	104	3	has	have	AUX
ajlm-2912	104	4	demonstrated	demonstrate	VERB
ajlm-2912	104	5	that	that	SCONJ
ajlm-2912	104	6	in	in	ADP
ajlm-2912	104	7	inflammatory	inflammatory	ADJ
ajlm-2912	104	8	diseases	disease	NOUN
ajlm-2912	104	9	,	,	PUNCT
ajlm-2912	104	10	the	the	DET
ajlm-2912	104	11	level	level	NOUN
ajlm-2912	104	12	of	of	ADP
ajlm-2912	104	13	lipid	lipid	NOUN
ajlm-2912	104	14	peroxidation	peroxidation	NOUN
ajlm-2912	104	15	increases	increase	NOUN
ajlm-2912	104	16	.	.	PUNCT
ajlm-2912	105	1	furthermore	furthermore	ADV
ajlm-2912	105	2	,	,	PUNCT
ajlm-2912	105	3	mda	mda	PROPN
ajlm-2912	105	4	is	be	AUX
ajlm-2912	105	5	thought	think	VERB
ajlm-2912	105	6	to	to	PART
ajlm-2912	105	7	be	be	AUX
ajlm-2912	105	8	a	a	DET
ajlm-2912	105	9	sign	sign	NOUN
ajlm-2912	105	10	of	of	ADP
ajlm-2912	105	11	oxidative	oxidative	ADJ
ajlm-2912	105	12	stress	stress	NOUN
ajlm-2912	105	13	within	within	ADP
ajlm-2912	105	14	cells.27	cells.27	PROPN
ajlm-2912	105	15	therefore	therefore	ADV
ajlm-2912	105	16	,	,	PUNCT
ajlm-2912	105	17	the	the	DET
ajlm-2912	105	18	elevated	elevated	ADJ
ajlm-2912	105	19	serum	serum	NOUN
ajlm-2912	105	20	mda	mda	PROPN
ajlm-2912	105	21	levels	level	NOUN
ajlm-2912	105	22	in	in	ADP
ajlm-2912	105	23	this	this	DET
ajlm-2912	105	24	study	study	NOUN
ajlm-2912	105	25	could	could	AUX
ajlm-2912	105	26	be	be	AUX
ajlm-2912	105	27	the	the	DET
ajlm-2912	105	28	consequence	consequence	NOUN
ajlm-2912	105	29	of	of	ADP
ajlm-2912	105	30	cellular	cellular	ADJ
ajlm-2912	105	31	damage	damage	NOUN
ajlm-2912	105	32	caused	cause	VERB
ajlm-2912	105	33	by	by	ADP
ajlm-2912	105	34	ros	ros	PROPN
ajlm-2912	105	35	.	.	PUNCT
ajlm-2912	106	1	these	these	DET
ajlm-2912	106	2	findings	finding	NOUN
ajlm-2912	106	3	imply	imply	VERB
ajlm-2912	106	4	that	that	SCONJ
ajlm-2912	106	5	acne	acne	NOUN
ajlm-2912	106	6	is	be	AUX
ajlm-2912	106	7	mediated	mediate	VERB
ajlm-2912	106	8	by	by	ADP
ajlm-2912	106	9	the	the	DET
ajlm-2912	106	10	increased	increase	VERB
ajlm-2912	106	11	ros	ros	PROPN
ajlm-2912	106	12	production	production	NOUN
ajlm-2912	106	13	,	,	PUNCT
ajlm-2912	106	14	which	which	PRON
ajlm-2912	106	15	can	can	AUX
ajlm-2912	106	16	be	be	AUX
ajlm-2912	106	17	linked	link	VERB
ajlm-2912	106	18	to	to	ADP
ajlm-2912	106	19	a	a	DET
ajlm-2912	106	20	decrease	decrease	NOUN
ajlm-2912	106	21	in	in	ADP
ajlm-2912	106	22	antioxidant	antioxidant	ADJ
ajlm-2912	106	23	enzyme	enzyme	NOUN
ajlm-2912	106	24	levels	level	NOUN
ajlm-2912	106	25	,	,	PUNCT
ajlm-2912	106	26	such	such	ADJ
ajlm-2912	106	27	as	as	ADP
ajlm-2912	106	28	sod	sod	NOUN
ajlm-2912	106	29	or	or	CCONJ
ajlm-2912	106	30	cat	cat	NOUN
ajlm-2912	106	31	.	.	PUNCT
ajlm-2912	107	1	it	it	PRON
ajlm-2912	107	2	has	have	AUX
ajlm-2912	107	3	been	be	AUX
ajlm-2912	107	4	noted	note	VERB
ajlm-2912	107	5	that	that	SCONJ
ajlm-2912	107	6	the	the	DET
ajlm-2912	107	7	sod	sod	NOUN
ajlm-2912	107	8	-	-	PUNCT
ajlm-2912	107	9	cat	cat	NOUN
ajlm-2912	107	10	system	system	NOUN
ajlm-2912	107	11	increases	increase	VERB
ajlm-2912	107	12	or	or	CCONJ
ajlm-2912	107	13	decreases	decrease	NOUN
ajlm-2912	107	14	or	or	CCONJ
ajlm-2912	107	15	goes	go	VERB
ajlm-2912	107	16	in	in	ADP
ajlm-2912	107	17	two	two	NUM
ajlm-2912	107	18	different	different	ADJ
ajlm-2912	107	19	directions	direction	NOUN
ajlm-2912	107	20	in	in	ADP
ajlm-2912	107	21	a	a	DET
ajlm-2912	107	22	variety	variety	NOUN
ajlm-2912	107	23	of	of	ADP
ajlm-2912	107	24	disorders.15	disorders.15	PROPN
ajlm-2912	107	25	on	on	ADP
ajlm-2912	107	26	the	the	DET
ajlm-2912	107	27	other	other	ADJ
ajlm-2912	107	28	hand	hand	NOUN
ajlm-2912	107	29	,	,	PUNCT
ajlm-2912	107	30	there	there	PRON
ajlm-2912	107	31	are	be	VERB
ajlm-2912	107	32	some	some	DET
ajlm-2912	107	33	studies	study	NOUN
ajlm-2912	107	34	that	that	PRON
ajlm-2912	107	35	do	do	AUX
ajlm-2912	107	36	not	not	PART
ajlm-2912	107	37	agree	agree	VERB
ajlm-2912	107	38	with	with	ADP
ajlm-2912	107	39	the	the	DET
ajlm-2912	107	40	current	current	ADJ
ajlm-2912	107	41	study	study	NOUN
ajlm-2912	107	42	.	.	PUNCT
ajlm-2912	108	1	according	accord	VERB
ajlm-2912	108	2	to	to	ADP
ajlm-2912	108	3	a	a	DET
ajlm-2912	108	4	study	study	NOUN
ajlm-2912	108	5	by	by	ADP
ajlm-2912	108	6	mahmoud	mahmoud	PROPN
ajlm-2912	108	7	et	et	PROPN
ajlm-2912	108	8	al	al	PROPN
ajlm-2912	108	9	.	.	PROPN
ajlm-2912	108	10	,28	,28	PUNCT
ajlm-2912	108	11	higher	high	ADJ
ajlm-2912	108	12	levels	level	NOUN
ajlm-2912	108	13	of	of	ADP
ajlm-2912	108	14	sod	sod	NOUN
ajlm-2912	108	15	and	and	CCONJ
ajlm-2912	108	16	mda	mda	PROPN
ajlm-2912	108	17	were	be	AUX
ajlm-2912	108	18	found	find	VERB
ajlm-2912	108	19	in	in	ADP
ajlm-2912	108	20	acne	acne	NOUN
ajlm-2912	108	21	patients	patient	NOUN
ajlm-2912	108	22	than	than	ADP
ajlm-2912	108	23	in	in	ADP
ajlm-2912	108	24	controls	control	NOUN
ajlm-2912	108	25	(	(	PUNCT
ajlm-2912	108	26	p	p	X
ajlm-2912	108	27	<	<	X
ajlm-2912	108	28	0.001).28	0.001).28	NUM
ajlm-2912	108	29	in	in	ADP
ajlm-2912	108	30	their	their	PRON
ajlm-2912	108	31	study	study	NOUN
ajlm-2912	108	32	,	,	PUNCT
ajlm-2912	108	33	37	37	NUM
ajlm-2912	108	34	patients	patient	NOUN
ajlm-2912	108	35	were	be	AUX
ajlm-2912	108	36	divided	divide	VERB
ajlm-2912	108	37	into	into	ADP
ajlm-2912	108	38	two	two	NUM
ajlm-2912	108	39	groups	group	NOUN
ajlm-2912	108	40	.	.	PUNCT
ajlm-2912	109	1	group	group	NOUN
ajlm-2912	109	2	i	i	PRON
ajlm-2912	109	3	(	(	PUNCT
ajlm-2912	109	4	the	the	DET
ajlm-2912	109	5	patient	patient	NOUN
ajlm-2912	109	6	group	group	NOUN
ajlm-2912	109	7	)	)	PUNCT
ajlm-2912	109	8	included	include	VERB
ajlm-2912	109	9	27	27	NUM
ajlm-2912	109	10	patients	patient	NOUN
ajlm-2912	109	11	(	(	PUNCT
ajlm-2912	109	12	21	21	NUM
ajlm-2912	109	13	women	woman	NOUN
ajlm-2912	109	14	and	and	CCONJ
ajlm-2912	109	15	six	six	NUM
ajlm-2912	109	16	men	man	NOUN
ajlm-2912	109	17	)	)	PUNCT
ajlm-2912	109	18	with	with	ADP
ajlm-2912	109	19	acne	acne	NOUN
ajlm-2912	109	20	;	;	PUNCT
ajlm-2912	109	21	and	and	CCONJ
ajlm-2912	109	22	group	group	PROPN
ajlm-2912	109	23	ii	ii	PROPN
ajlm-2912	109	24	(	(	PUNCT
ajlm-2912	109	25	the	the	DET
ajlm-2912	109	26	control	control	PROPN
ajlm-2912	109	27	group	group	PROPN
ajlm-2912	109	28	)	)	PUNCT
ajlm-2912	109	29	included	include	VERB
ajlm-2912	109	30	10	10	NUM
ajlm-2912	109	31	age	age	NOUN
ajlm-2912	109	32	-	-	PUNCT
ajlm-2912	109	33	matched	match	VERB
ajlm-2912	109	34	and	and	CCONJ
ajlm-2912	109	35	sex	sex	NOUN
ajlm-2912	109	36	-	-	PUNCT
ajlm-2912	109	37	matched	match	VERB
ajlm-2912	109	38	healthy	healthy	ADJ
ajlm-2912	109	39	individuals	individual	NOUN
ajlm-2912	109	40	as	as	ADP
ajlm-2912	109	41	controls	control	NOUN
ajlm-2912	109	42	;	;	PUNCT
ajlm-2912	109	43	there	there	PRON
ajlm-2912	109	44	were	be	VERB
ajlm-2912	109	45	eight	eight	NUM
ajlm-2912	109	46	women	woman	NOUN
ajlm-2912	109	47	and	and	CCONJ
ajlm-2912	109	48	two	two	NUM
ajlm-2912	109	49	men	man	NOUN
ajlm-2912	109	50	.	.	PUNCT
ajlm-2912	110	1	similarly	similarly	ADV
ajlm-2912	110	2	,	,	PUNCT
ajlm-2912	110	3	in	in	ADP
ajlm-2912	110	4	another	another	DET
ajlm-2912	110	5	study	study	NOUN
ajlm-2912	110	6	conducted	conduct	VERB
ajlm-2912	110	7	by	by	ADP
ajlm-2912	110	8	el	el	PROPN
ajlm-2912	110	9	garem	garem	PROPN
ajlm-2912	110	10	et	et	PROPN
ajlm-2912	110	11	al	al	PROPN
ajlm-2912	110	12	.	.	PROPN
ajlm-2912	110	13	,	,	PUNCT
ajlm-2912	110	14	50	50	NUM
ajlm-2912	110	15	acne	acne	NOUN
ajlm-2912	110	16	patients	patient	NOUN
ajlm-2912	110	17	and	and	CCONJ
ajlm-2912	110	18	20	20	NUM
ajlm-2912	110	19	healthy	healthy	ADJ
ajlm-2912	110	20	controls	control	NOUN
ajlm-2912	110	21	were	be	AUX
ajlm-2912	110	22	compared	compare	VERB
ajlm-2912	110	23	,	,	PUNCT
ajlm-2912	110	24	and	and	CCONJ
ajlm-2912	110	25	results	result	NOUN
ajlm-2912	110	26	showed	show	VERB
ajlm-2912	110	27	higher	high	ADJ
ajlm-2912	110	28	sod	sod	NOUN
ajlm-2912	110	29	in	in	ADP
ajlm-2912	110	30	acne	acne	NOUN
ajlm-2912	110	31	patients	patient	NOUN
ajlm-2912	110	32	,	,	PUNCT
ajlm-2912	110	33	which	which	PRON
ajlm-2912	110	34	was	be	AUX
ajlm-2912	110	35	statistically	statistically	ADV
ajlm-2912	110	36	non	non	ADJ
ajlm-2912	110	37	-	-	NOUN
ajlm-2912	110	38	significant.14	significant.14	NOUN
ajlm-2912	110	39	a	a	DET
ajlm-2912	110	40	study	study	NOUN
ajlm-2912	110	41	conducted	conduct	VERB
ajlm-2912	110	42	by	by	ADP
ajlm-2912	110	43	arican	arican	PROPN
ajlm-2912	110	44	,	,	PUNCT
ajlm-2912	110	45	kurutas	kuruta	NOUN
ajlm-2912	110	46	,	,	PUNCT
ajlm-2912	110	47	and	and	CCONJ
ajlm-2912	110	48	sasmaz	sasmaz	NOUN
ajlm-2912	110	49	,	,	PUNCT
ajlm-2912	110	50	who	who	PRON
ajlm-2912	110	51	investigated	investigate	VERB
ajlm-2912	110	52	43	43	NUM
ajlm-2912	110	53	acne	acne	NOUN
ajlm-2912	110	54	patients	patient	NOUN
ajlm-2912	110	55	,	,	PUNCT
ajlm-2912	110	56	including	include	VERB
ajlm-2912	110	57	30	30	NUM
ajlm-2912	110	58	women	woman	NOUN
ajlm-2912	110	59	and	and	CCONJ
ajlm-2912	110	60	13	13	NUM
ajlm-2912	110	61	men	man	NOUN
ajlm-2912	110	62	,	,	PUNCT
ajlm-2912	110	63	and	and	CCONJ
ajlm-2912	110	64	46	46	NUM
ajlm-2912	110	65	healthy	healthy	ADJ
ajlm-2912	110	66	controls	control	NOUN
ajlm-2912	110	67	,	,	PUNCT
ajlm-2912	110	68	including	include	VERB
ajlm-2912	110	69	28	28	NUM
ajlm-2912	110	70	women	woman	NOUN
ajlm-2912	110	71	and	and	CCONJ
ajlm-2912	110	72	18	18	NUM
ajlm-2912	110	73	men	man	NOUN
ajlm-2912	110	74	,	,	PUNCT
ajlm-2912	110	75	came	come	VERB
ajlm-2912	110	76	up	up	ADP
ajlm-2912	110	77	with	with	ADP
ajlm-2912	110	78	the	the	DET
ajlm-2912	110	79	result	result	NOUN
ajlm-2912	110	80	of	of	ADP
ajlm-2912	110	81	elevated	elevated	ADJ
ajlm-2912	110	82	sod	sod	NOUN
ajlm-2912	110	83	and	and	CCONJ
ajlm-2912	110	84	mda	mda	NOUN
ajlm-2912	110	85	in	in	ADP
ajlm-2912	110	86	patients	patient	NOUN
ajlm-2912	110	87	compared	compare	VERB
ajlm-2912	110	88	to	to	ADP
ajlm-2912	110	89	the	the	DET
ajlm-2912	110	90	control	control	NOUN
ajlm-2912	110	91	(	(	PUNCT
ajlm-2912	110	92	p	p	X
ajlm-2912	110	93	<	<	X
ajlm-2912	110	94	0.001).20	0.001).20	X
ajlm-2912	110	95	they	they	PRON
ajlm-2912	110	96	proposed	propose	VERB
ajlm-2912	110	97	that	that	SCONJ
ajlm-2912	110	98	the	the	DET
ajlm-2912	110	99	imbalance	imbalance	NOUN
ajlm-2912	110	100	between	between	ADP
ajlm-2912	110	101	oxidants	oxidant	NOUN
ajlm-2912	110	102	and	and	CCONJ
ajlm-2912	110	103	antioxidants	antioxidant	NOUN
ajlm-2912	110	104	in	in	ADP
ajlm-2912	110	105	the	the	DET
ajlm-2912	110	106	cells	cell	NOUN
ajlm-2912	110	107	caused	cause	VERB
ajlm-2912	110	108	oxidative	oxidative	ADJ
ajlm-2912	110	109	stress	stress	NOUN
ajlm-2912	110	110	,	,	PUNCT
ajlm-2912	110	111	which	which	PRON
ajlm-2912	110	112	in	in	ADP
ajlm-2912	110	113	turn	turn	NOUN
ajlm-2912	110	114	led	lead	VERB
ajlm-2912	110	115	to	to	ADP
ajlm-2912	110	116	an	an	DET
ajlm-2912	110	117	increase	increase	NOUN
ajlm-2912	110	118	in	in	ADP
ajlm-2912	110	119	sod	sod	NOUN
ajlm-2912	110	120	levels	level	NOUN
ajlm-2912	110	121	.	.	PUNCT
ajlm-2912	111	1	additionally	additionally	ADV
ajlm-2912	111	2	,	,	PUNCT
ajlm-2912	111	3	our	our	PRON
ajlm-2912	111	4	results	result	NOUN
ajlm-2912	111	5	showed	show	VERB
ajlm-2912	111	6	a	a	DET
ajlm-2912	111	7	correlation	correlation	NOUN
ajlm-2912	111	8	between	between	ADP
ajlm-2912	111	9	the	the	DET
ajlm-2912	111	10	higher	high	ADJ
ajlm-2912	111	11	levels	level	NOUN
ajlm-2912	111	12	of	of	ADP
ajlm-2912	111	13	oxidative	oxidative	ADJ
ajlm-2912	111	14	stress	stress	NOUN
ajlm-2912	111	15	biomarkers	biomarker	NOUN
ajlm-2912	111	16	and	and	CCONJ
ajlm-2912	111	17	the	the	DET
ajlm-2912	111	18	severity	severity	NOUN
ajlm-2912	111	19	of	of	ADP
ajlm-2912	111	20	acne	acne	NOUN
ajlm-2912	111	21	patients	patient	NOUN
ajlm-2912	111	22	.	.	PUNCT
ajlm-2912	112	1	patients	patient	NOUN
ajlm-2912	112	2	with	with	ADP
ajlm-2912	112	3	grade	grade	NOUN
ajlm-2912	112	4	4	4	NUM
ajlm-2912	112	5	acne	acne	NOUN
ajlm-2912	112	6	had	have	VERB
ajlm-2912	112	7	noticeably	noticeably	ADV
ajlm-2912	112	8	higher	high	ADJ
ajlm-2912	112	9	serum	serum	PROPN
ajlm-2912	112	10	mda	mda	PROPN
ajlm-2912	112	11	levels	level	NOUN
ajlm-2912	112	12	than	than	ADP
ajlm-2912	112	13	those	those	PRON
ajlm-2912	112	14	in	in	ADP
ajlm-2912	112	15	patients	patient	NOUN
ajlm-2912	112	16	with	with	ADP
ajlm-2912	112	17	grade	grade	NOUN
ajlm-2912	112	18	1	1	NUM
ajlm-2912	112	19	,	,	PUNCT
ajlm-2912	112	20	grade	grade	NOUN
ajlm-2912	112	21	2	2	NUM
ajlm-2912	112	22	,	,	PUNCT
ajlm-2912	112	23	or	or	CCONJ
ajlm-2912	112	24	grade	grade	NOUN
ajlm-2912	112	25	3	3	NUM
ajlm-2912	112	26	acne	acne	NOUN
ajlm-2912	112	27	.	.	PUNCT
ajlm-2912	113	1	moreover	moreover	ADV
ajlm-2912	113	2	,	,	PUNCT
ajlm-2912	113	3	sod	sod	NOUN
ajlm-2912	113	4	–	–	PUNCT
ajlm-2912	113	5	cat	cat	NOUN
ajlm-2912	113	6	activity	activity	NOUN
ajlm-2912	113	7	and	and	CCONJ
ajlm-2912	113	8	gsh	gsh	PROPN
ajlm-2912	113	9	levels	level	NOUN
ajlm-2912	113	10	were	be	AUX
ajlm-2912	113	11	significantly	significantly	ADV
ajlm-2912	113	12	decreased	decrease	VERB
ajlm-2912	113	13	in	in	ADP
ajlm-2912	113	14	grade	grade	NOUN
ajlm-2912	113	15	4	4	NUM
ajlm-2912	113	16	patients	patient	NOUN
ajlm-2912	113	17	compared	compare	VERB
ajlm-2912	113	18	to	to	ADP
ajlm-2912	113	19	the	the	DET
ajlm-2912	113	20	levels	level	NOUN
ajlm-2912	113	21	of	of	ADP
ajlm-2912	113	22	patients	patient	NOUN
ajlm-2912	113	23	with	with	ADP
ajlm-2912	113	24	other	other	ADJ
ajlm-2912	113	25	grades	grade	NOUN
ajlm-2912	113	26	of	of	ADP
ajlm-2912	113	27	acne	acne	NOUN
ajlm-2912	113	28	.	.	PUNCT
ajlm-2912	114	1	the	the	DET
ajlm-2912	114	2	increase	increase	NOUN
ajlm-2912	114	3	in	in	ADP
ajlm-2912	114	4	sod	sod	NOUN
ajlm-2912	114	5	activities	activity	NOUN
ajlm-2912	114	6	in	in	ADP
ajlm-2912	114	7	grade	grade	NOUN
ajlm-2912	114	8	1	1	NUM
ajlm-2912	114	9	acne	acne	NOUN
ajlm-2912	114	10	patients	patient	NOUN
ajlm-2912	114	11	indicates	indicate	VERB
ajlm-2912	114	12	that	that	SCONJ
ajlm-2912	114	13	the	the	DET
ajlm-2912	114	14	antioxidant	antioxidant	ADJ
ajlm-2912	114	15	defence	defence	NOUN
ajlm-2912	114	16	system	system	NOUN
ajlm-2912	114	17	is	be	AUX
ajlm-2912	114	18	responding	respond	VERB
ajlm-2912	114	19	appropriately	appropriately	ADV
ajlm-2912	114	20	to	to	PART
ajlm-2912	114	21	oxidative	oxidative	ADJ
ajlm-2912	114	22	stress	stress	NOUN
ajlm-2912	114	23	,	,	PUNCT
ajlm-2912	114	24	which	which	PRON
ajlm-2912	114	25	keeps	keep	VERB
ajlm-2912	114	26	mda	mda	PROPN
ajlm-2912	114	27	levels	level	NOUN
ajlm-2912	114	28	within	within	ADP
ajlm-2912	114	29	the	the	DET
ajlm-2912	114	30	normal	normal	ADJ
ajlm-2912	114	31	range	range	NOUN
ajlm-2912	114	32	.	.	PUNCT
ajlm-2912	115	1	this	this	DET
ajlm-2912	115	2	adaptive	adaptive	ADJ
ajlm-2912	115	3	response	response	NOUN
ajlm-2912	115	4	protects	protect	VERB
ajlm-2912	115	5	the	the	DET
ajlm-2912	115	6	cells	cell	NOUN
ajlm-2912	115	7	from	from	ADP
ajlm-2912	115	8	the	the	DET
ajlm-2912	115	9	harmful	harmful	ADJ
ajlm-2912	115	10	products	product	NOUN
ajlm-2912	115	11	of	of	ADP
ajlm-2912	115	12	free	free	ADJ
ajlm-2912	115	13	radical	radical	ADJ
ajlm-2912	115	14	reactions	reaction	NOUN
ajlm-2912	115	15	.	.	PUNCT
ajlm-2912	116	1	membrane	membrane	NOUN
ajlm-2912	116	2	lipids	lipid	NOUN
ajlm-2912	116	3	and	and	CCONJ
ajlm-2912	116	4	other	other	ADJ
ajlm-2912	116	5	tissue	tissue	NOUN
ajlm-2912	116	6	lipids	lipid	NOUN
ajlm-2912	116	7	may	may	AUX
ajlm-2912	116	8	peroxide	peroxide	VERB
ajlm-2912	116	9	as	as	ADP
ajlm-2912	116	10	a	a	DET
ajlm-2912	116	11	result	result	NOUN
ajlm-2912	116	12	of	of	ADP
ajlm-2912	116	13	the	the	DET
ajlm-2912	116	14	increased	increase	VERB
ajlm-2912	116	15	production	production	NOUN
ajlm-2912	116	16	of	of	ADP
ajlm-2912	116	17	ros	ros	PROPN
ajlm-2912	116	18	,	,	PUNCT
ajlm-2912	116	19	which	which	PRON
ajlm-2912	116	20	can	can	AUX
ajlm-2912	116	21	start	start	VERB
ajlm-2912	116	22	the	the	DET
ajlm-2912	116	23	lipid	lipid	NOUN
ajlm-2912	116	24	peroxidation	peroxidation	NOUN
ajlm-2912	116	25	chain	chain	NOUN
ajlm-2912	116	26	reaction	reaction	NOUN
ajlm-2912	116	27	,	,	PUNCT
ajlm-2912	116	28	when	when	SCONJ
ajlm-2912	116	29	the	the	DET
ajlm-2912	116	30	disease	disease	NOUN
ajlm-2912	116	31	process	process	NOUN
ajlm-2912	116	32	becomes	become	VERB
ajlm-2912	116	33	more	more	ADV
ajlm-2912	116	34	severe	severe	ADJ
ajlm-2912	116	35	and	and	CCONJ
ajlm-2912	116	36	the	the	DET
ajlm-2912	116	37	protective	protective	ADJ
ajlm-2912	116	38	mechanism	mechanism	NOUN
ajlm-2912	116	39	is	be	AUX
ajlm-2912	116	40	no	no	ADV
ajlm-2912	116	41	longer	long	ADV
ajlm-2912	116	42	sufficient	sufficient	ADJ
ajlm-2912	116	43	.	.	PUNCT
ajlm-2912	117	1	this	this	PRON
ajlm-2912	117	2	is	be	AUX
ajlm-2912	117	3	shown	show	VERB
ajlm-2912	117	4	with	with	ADP
ajlm-2912	117	5	the	the	DET
ajlm-2912	117	6	decreased	decrease	VERB
ajlm-2912	117	7	sod	sod	NOUN
ajlm-2912	117	8	activities	activity	NOUN
ajlm-2912	117	9	and	and	CCONJ
ajlm-2912	117	10	increased	increase	VERB
ajlm-2912	117	11	mda	mda	PROPN
ajlm-2912	117	12	levels	level	NOUN
ajlm-2912	117	13	observed	observe	VERB
ajlm-2912	117	14	in	in	ADP
ajlm-2912	117	15	patients	patient	NOUN
ajlm-2912	117	16	with	with	ADP
ajlm-2912	117	17	grade	grade	NOUN
ajlm-2912	117	18	2	2	NUM
ajlm-2912	117	19	and	and	CCONJ
ajlm-2912	117	20	grade	grade	NOUN
ajlm-2912	117	21	3	3	NUM
ajlm-2912	117	22	acne	acne	NOUN
ajlm-2912	117	23	.	.	PUNCT
ajlm-2912	118	1	in	in	ADP
ajlm-2912	118	2	patients	patient	NOUN
ajlm-2912	118	3	with	with	ADP
ajlm-2912	118	4	grade	grade	NOUN
ajlm-2912	118	5	4	4	NUM
ajlm-2912	118	6	acne	acne	NOUN
ajlm-2912	118	7	,	,	PUNCT
ajlm-2912	118	8	sod	sod	NOUN
ajlm-2912	118	9	activities	activity	NOUN
ajlm-2912	118	10	were	be	AUX
ajlm-2912	118	11	significantly	significantly	ADV
ajlm-2912	118	12	decreased	decrease	VERB
ajlm-2912	118	13	,	,	PUNCT
ajlm-2912	118	14	and	and	CCONJ
ajlm-2912	118	15	the	the	DET
ajlm-2912	118	16	substantial	substantial	ADJ
ajlm-2912	118	17	increase	increase	NOUN
ajlm-2912	118	18	in	in	ADP
ajlm-2912	118	19	mda	mda	PROPN
ajlm-2912	118	20	levels	level	NOUN
ajlm-2912	118	21	suggests	suggest	VERB
ajlm-2912	118	22	that	that	SCONJ
ajlm-2912	118	23	an	an	DET
ajlm-2912	118	24	increase	increase	NOUN
ajlm-2912	118	25	in	in	ADP
ajlm-2912	118	26	ros	ros	PROPN
ajlm-2912	118	27	production	production	NOUN
ajlm-2912	118	28	has	have	AUX
ajlm-2912	118	29	outpaced	outpace	VERB
ajlm-2912	118	30	the	the	DET
ajlm-2912	118	31	antioxidant	antioxidant	ADJ
ajlm-2912	118	32	capability	capability	NOUN
ajlm-2912	118	33	.	.	PUNCT
ajlm-2912	119	1	contrary	contrary	ADJ
ajlm-2912	119	2	to	to	ADP
ajlm-2912	119	3	the	the	DET
ajlm-2912	119	4	current	current	ADJ
ajlm-2912	119	5	findings	finding	NOUN
ajlm-2912	119	6	,	,	PUNCT
ajlm-2912	119	7	basak	basak	PROPN
ajlm-2912	119	8	et	et	PROPN
ajlm-2912	119	9	al	al	PROPN
ajlm-2912	119	10	.	.	PROPN
ajlm-2912	119	11	did	do	AUX
ajlm-2912	119	12	not	not	PART
ajlm-2912	119	13	find	find	VERB
ajlm-2912	119	14	any	any	DET
ajlm-2912	119	15	correlation	correlation	NOUN
ajlm-2912	119	16	between	between	ADP
ajlm-2912	119	17	acne	acne	NOUN
ajlm-2912	119	18	severity	severity	NOUN
ajlm-2912	119	19	and	and	CCONJ
ajlm-2912	119	20	antioxidant	antioxidant	ADJ
ajlm-2912	119	21	enzymes	enzyme	NOUN
ajlm-2912	119	22	levels	level	NOUN
ajlm-2912	119	23	or	or	CCONJ
ajlm-2912	119	24	mda	mda	NOUN
ajlm-2912	119	25	in	in	ADP
ajlm-2912	119	26	the	the	DET
ajlm-2912	119	27	leukocytes.11	leukocytes.11	NOUN
ajlm-2912	119	28	according	accord	VERB
ajlm-2912	119	29	to	to	ADP
ajlm-2912	119	30	them	they	PRON
ajlm-2912	119	31	,	,	PUNCT
ajlm-2912	119	32	this	this	PRON
ajlm-2912	119	33	proved	prove	VERB
ajlm-2912	119	34	that	that	SCONJ
ajlm-2912	119	35	while	while	SCONJ
ajlm-2912	119	36	each	each	DET
ajlm-2912	119	37	patient	patient	NOUN
ajlm-2912	119	38	’s	’s	PART
ajlm-2912	119	39	oxidant	oxidant	ADJ
ajlm-2912	119	40	and/or	and/or	CCONJ
ajlm-2912	119	41	antioxidant	antioxidant	ADJ
ajlm-2912	119	42	balance	balance	NOUN
ajlm-2912	119	43	may	may	AUX
ajlm-2912	119	44	be	be	AUX
ajlm-2912	119	45	impacted	impact	VERB
ajlm-2912	119	46	to	to	ADP
ajlm-2912	119	47	a	a	DET
ajlm-2912	119	48	certain	certain	ADJ
ajlm-2912	119	49	degree	degree	NOUN
ajlm-2912	119	50	,	,	PUNCT
ajlm-2912	119	51	the	the	DET
ajlm-2912	119	52	total	total	ADJ
ajlm-2912	119	53	number	number	NOUN
ajlm-2912	119	54	of	of	ADP
ajlm-2912	119	55	factors	factor	NOUN
ajlm-2912	119	56	or	or	CCONJ
ajlm-2912	119	57	agents	agent	NOUN
ajlm-2912	119	58	involved	involve	VERB
ajlm-2912	119	59	in	in	ADP
ajlm-2912	119	60	each	each	DET
ajlm-2912	119	61	case	case	NOUN
ajlm-2912	119	62	could	could	AUX
ajlm-2912	119	63	not	not	PART
ajlm-2912	119	64	affect	affect	VERB
ajlm-2912	119	65	the	the	DET
ajlm-2912	119	66	enzyme	enzyme	NOUN
ajlm-2912	119	67	levels	level	NOUN
ajlm-2912	119	68	.	.	PUNCT
ajlm-2912	120	1	we	we	PRON
ajlm-2912	120	2	reasoned	reason	VERB
ajlm-2912	120	3	that	that	SCONJ
ajlm-2912	120	4	this	this	DET
ajlm-2912	120	5	disagreement	disagreement	NOUN
ajlm-2912	120	6	was	be	AUX
ajlm-2912	120	7	most	most	ADV
ajlm-2912	120	8	likely	likely	ADV
ajlm-2912	120	9	caused	cause	VERB
ajlm-2912	120	10	by	by	ADP
ajlm-2912	120	11	the	the	DET
ajlm-2912	120	12	samples	sample	NOUN
ajlm-2912	120	13	used	use	VERB
ajlm-2912	120	14	for	for	ADP
ajlm-2912	120	15	measuring	measure	VERB
ajlm-2912	120	16	oxidative	oxidative	ADJ
ajlm-2912	120	17	biomarkers	biomarker	NOUN
ajlm-2912	120	18	coming	come	VERB
ajlm-2912	120	19	from	from	ADP
ajlm-2912	120	20	different	different	ADJ
ajlm-2912	120	21	sources	source	NOUN
ajlm-2912	120	22	.	.	PUNCT
ajlm-2912	121	1	the	the	DET
ajlm-2912	121	2	levels	level	NOUN
ajlm-2912	121	3	of	of	ADP
ajlm-2912	121	4	these	these	DET
ajlm-2912	121	5	markers	marker	NOUN
ajlm-2912	121	6	do	do	AUX
ajlm-2912	121	7	not	not	PART
ajlm-2912	121	8	indicate	indicate	VERB
ajlm-2912	121	9	the	the	DET
ajlm-2912	121	10	origin	origin	NOUN
ajlm-2912	121	11	of	of	ADP
ajlm-2912	121	12	their	their	PRON
ajlm-2912	121	13	production	production	NOUN
ajlm-2912	121	14	in	in	ADP
ajlm-2912	121	15	plasma.29	plasma.29	PROPN
ajlm-2912	121	16	in	in	ADP
ajlm-2912	121	17	the	the	DET
ajlm-2912	121	18	present	present	ADJ
ajlm-2912	121	19	study	study	NOUN
ajlm-2912	121	20	,	,	PUNCT
ajlm-2912	121	21	data	datum	NOUN
ajlm-2912	121	22	showed	show	VERB
ajlm-2912	121	23	that	that	SCONJ
ajlm-2912	121	24	patients	patient	NOUN
ajlm-2912	121	25	with	with	ADP
ajlm-2912	121	26	grade	grade	NOUN
ajlm-2912	121	27	4	4	NUM
ajlm-2912	121	28	acne	acne	NOUN
ajlm-2912	121	29	had	have	VERB
ajlm-2912	121	30	a	a	DET
ajlm-2912	121	31	strong	strong	ADJ
ajlm-2912	121	32	negative	negative	ADJ
ajlm-2912	121	33	association	association	NOUN
ajlm-2912	121	34	between	between	ADP
ajlm-2912	121	35	their	their	PRON
ajlm-2912	121	36	cat	cat	NOUN
ajlm-2912	121	37	and	and	CCONJ
ajlm-2912	121	38	mda	mda	PROPN
ajlm-2912	121	39	levels	level	NOUN
ajlm-2912	121	40	(	(	PUNCT
ajlm-2912	121	41	figure	figure	NOUN
ajlm-2912	121	42	5b	5b	NUM
ajlm-2912	121	43	)	)	PUNCT
ajlm-2912	121	44	,	,	PUNCT
ajlm-2912	121	45	whereas	whereas	SCONJ
ajlm-2912	121	46	patients	patient	NOUN
ajlm-2912	121	47	with	with	ADP
ajlm-2912	121	48	other	other	ADJ
ajlm-2912	121	49	grades	grade	NOUN
ajlm-2912	121	50	did	do	AUX
ajlm-2912	121	51	not	not	PART
ajlm-2912	121	52	show	show	VERB
ajlm-2912	121	53	this	this	DET
ajlm-2912	121	54	correlation	correlation	NOUN
ajlm-2912	121	55	.	.	PUNCT
ajlm-2912	122	1	furthermore	furthermore	ADV
ajlm-2912	122	2	,	,	PUNCT
ajlm-2912	122	3	regardless	regardless	ADV
ajlm-2912	122	4	of	of	ADP
ajlm-2912	122	5	the	the	DET
ajlm-2912	122	6	severity	severity	NOUN
ajlm-2912	122	7	of	of	ADP
ajlm-2912	122	8	the	the	DET
ajlm-2912	122	9	condition	condition	NOUN
ajlm-2912	122	10	,	,	PUNCT
ajlm-2912	122	11	no	no	DET
ajlm-2912	122	12	discernible	discernible	ADJ
ajlm-2912	122	13	relationship	relationship	NOUN
ajlm-2912	122	14	between	between	ADP
ajlm-2912	122	15	sod	sod	NOUN
ajlm-2912	122	16	activity	activity	NOUN
ajlm-2912	122	17	,	,	PUNCT
ajlm-2912	122	18	gsh	gsh	PROPN
ajlm-2912	122	19	levels	level	NOUN
ajlm-2912	122	20	,	,	PUNCT
ajlm-2912	122	21	and	and	CCONJ
ajlm-2912	122	22	mda	mda	PROPN
ajlm-2912	122	23	levels	level	NOUN
ajlm-2912	122	24	was	be	AUX
ajlm-2912	122	25	found	find	VERB
ajlm-2912	122	26	in	in	ADP
ajlm-2912	122	27	acne	acne	NOUN
ajlm-2912	122	28	patients	patient	NOUN
ajlm-2912	122	29	.	.	PUNCT
ajlm-2912	123	1	these	these	DET
ajlm-2912	123	2	results	result	NOUN
ajlm-2912	123	3	have	have	AUX
ajlm-2912	123	4	unequivocally	unequivocally	ADV
ajlm-2912	123	5	shown	show	VERB
ajlm-2912	123	6	that	that	SCONJ
ajlm-2912	123	7	oxidative	oxidative	ADJ
ajlm-2912	123	8	stress	stress	NOUN
ajlm-2912	123	9	contributes	contribute	VERB
ajlm-2912	123	10	to	to	ADP
ajlm-2912	123	11	acne	acne	NOUN
ajlm-2912	123	12	and	and	CCONJ
ajlm-2912	123	13	may	may	AUX
ajlm-2912	123	14	be	be	AUX
ajlm-2912	123	15	a	a	DET
ajlm-2912	123	16	significant	significant	ADJ
ajlm-2912	123	17	factor	factor	NOUN
ajlm-2912	123	18	in	in	ADP
ajlm-2912	123	19	its	its	PRON
ajlm-2912	123	20	aetiology	aetiology	NOUN
ajlm-2912	123	21	and	and	CCONJ
ajlm-2912	123	22	progression.30	progression.30	NOUN
ajlm-2912	123	23	however	however	ADV
ajlm-2912	123	24	,	,	PUNCT
ajlm-2912	123	25	the	the	DET
ajlm-2912	123	26	origin	origin	NOUN
ajlm-2912	123	27	of	of	ADP
ajlm-2912	123	28	these	these	DET
ajlm-2912	123	29	enzymes	enzyme	NOUN
ajlm-2912	123	30	can	can	AUX
ajlm-2912	123	31	not	not	PART
ajlm-2912	123	32	be	be	AUX
ajlm-2912	123	33	ascertained	ascertain	VERB
ajlm-2912	123	34	.	.	PUNCT
ajlm-2912	124	1	whether	whether	SCONJ
ajlm-2912	124	2	aberrant	aberrant	ADJ
ajlm-2912	124	3	antioxidant	antioxidant	ADJ
ajlm-2912	124	4	enzymes	enzyme	NOUN
ajlm-2912	124	5	are	be	AUX
ajlm-2912	124	6	the	the	DET
ajlm-2912	124	7	famous	famous	ADJ
ajlm-2912	124	8	‘	'	PUNCT
ajlm-2912	124	9	egg	egg	NOUN
ajlm-2912	124	10	or	or	CCONJ
ajlm-2912	124	11	chicken	chicken	NOUN
ajlm-2912	124	12	dilemma	dilemma	NOUN
ajlm-2912	124	13	’	'	PUNCT
ajlm-2912	124	14	in	in	ADP
ajlm-2912	124	15	acne	acne	NOUN
ajlm-2912	124	16	is	be	AUX
ajlm-2912	124	17	still	still	ADV
ajlm-2912	124	18	up	up	ADP
ajlm-2912	124	19	for	for	ADP
ajlm-2912	124	20	debate	debate	NOUN
ajlm-2912	124	21	.	.	PUNCT
ajlm-2912	125	1	it	it	PRON
ajlm-2912	125	2	is	be	AUX
ajlm-2912	125	3	likely	likely	ADJ
ajlm-2912	125	4	that	that	SCONJ
ajlm-2912	125	5	these	these	DET
ajlm-2912	125	6	alterations	alteration	NOUN
ajlm-2912	125	7	are	be	AUX
ajlm-2912	125	8	a	a	DET
ajlm-2912	125	9	result	result	NOUN
ajlm-2912	125	10	of	of	ADP
ajlm-2912	125	11	cutaneous	cutaneous	ADJ
ajlm-2912	125	12	inflammation	inflammation	NOUN
ajlm-2912	125	13	,	,	PUNCT
ajlm-2912	125	14	such	such	ADJ
ajlm-2912	125	15	as	as	ADP
ajlm-2912	125	16	acne	acne	NOUN
ajlm-2912	125	17	,	,	PUNCT
ajlm-2912	125	18	rather	rather	ADV
ajlm-2912	125	19	than	than	ADP
ajlm-2912	125	20	the	the	DET
ajlm-2912	125	21	cause	cause	NOUN
ajlm-2912	125	22	.	.	PUNCT
ajlm-2912	126	1	limitations	limitation	NOUN
ajlm-2912	126	2	of	of	ADP
ajlm-2912	126	3	the	the	DET
ajlm-2912	126	4	study	study	NOUN
ajlm-2912	126	5	the	the	DET
ajlm-2912	126	6	limitations	limitation	NOUN
ajlm-2912	126	7	of	of	ADP
ajlm-2912	126	8	the	the	DET
ajlm-2912	126	9	study	study	NOUN
ajlm-2912	126	10	were	be	AUX
ajlm-2912	126	11	as	as	SCONJ
ajlm-2912	126	12	follows	follow	VERB
ajlm-2912	126	13	:	:	PUNCT
ajlm-2912	126	14	the	the	DET
ajlm-2912	126	15	study	study	NOUN
ajlm-2912	126	16	design	design	NOUN
ajlm-2912	126	17	is	be	AUX
ajlm-2912	126	18	cross	cross	ADJ
ajlm-2912	126	19	-	-	ADJ
ajlm-2912	126	20	sectional	sectional	ADJ
ajlm-2912	126	21	,	,	PUNCT
ajlm-2912	126	22	which	which	PRON
ajlm-2912	126	23	limits	limit	VERB
ajlm-2912	126	24	the	the	DET
ajlm-2912	126	25	ability	ability	NOUN
ajlm-2912	126	26	to	to	PART
ajlm-2912	126	27	establish	establish	VERB
ajlm-2912	126	28	a	a	DET
ajlm-2912	126	29	causal	causal	ADJ
ajlm-2912	126	30	relationship	relationship	NOUN
ajlm-2912	126	31	between	between	ADP
ajlm-2912	126	32	biomarkers	biomarker	NOUN
ajlm-2912	126	33	and	and	CCONJ
ajlm-2912	126	34	acne	acne	NOUN
ajlm-2912	126	35	severity	severity	NOUN
ajlm-2912	126	36	.	.	PUNCT
ajlm-2912	127	1	the	the	DET
ajlm-2912	127	2	study	study	NOUN
ajlm-2912	127	3	does	do	AUX
ajlm-2912	127	4	not	not	PART
ajlm-2912	127	5	account	account	VERB
ajlm-2912	127	6	for	for	ADP
ajlm-2912	127	7	lifestyle	lifestyle	NOUN
ajlm-2912	127	8	and	and	CCONJ
ajlm-2912	127	9	environmental	environmental	ADJ
ajlm-2912	127	10	factors	factor	NOUN
ajlm-2912	127	11	,	,	PUNCT
ajlm-2912	127	12	such	such	ADJ
ajlm-2912	127	13	as	as	ADP
ajlm-2912	127	14	diet	diet	NOUN
ajlm-2912	127	15	,	,	PUNCT
ajlm-2912	127	16	stress	stress	NOUN
ajlm-2912	127	17	,	,	PUNCT
ajlm-2912	127	18	pollution	pollution	NOUN
ajlm-2912	127	19	exposure	exposure	NOUN
ajlm-2912	127	20	,	,	PUNCT
ajlm-2912	127	21	and	and	CCONJ
ajlm-2912	127	22	genetic	genetic	ADJ
ajlm-2912	127	23	predisposition	predisposition	NOUN
ajlm-2912	127	24	,	,	PUNCT
ajlm-2912	127	25	all	all	PRON
ajlm-2912	127	26	of	of	ADP
ajlm-2912	127	27	which	which	PRON
ajlm-2912	127	28	can	can	AUX
ajlm-2912	127	29	influence	influence	VERB
ajlm-2912	127	30	oxidative	oxidative	ADJ
ajlm-2912	127	31	stress	stress	NOUN
ajlm-2912	127	32	levels	level	NOUN
ajlm-2912	127	33	.	.	PUNCT
ajlm-2912	128	1	the	the	DET
ajlm-2912	128	2	effects	effect	NOUN
ajlm-2912	128	3	of	of	ADP
ajlm-2912	128	4	oxidative	oxidative	ADJ
ajlm-2912	128	5	stress	stress	NOUN
ajlm-2912	128	6	markers	marker	NOUN
ajlm-2912	128	7	after	after	ADP
ajlm-2912	128	8	treatment	treatment	NOUN
ajlm-2912	128	9	with	with	ADP
ajlm-2912	128	10	antioxidants	antioxidant	NOUN
ajlm-2912	128	11	were	be	AUX
ajlm-2912	128	12	not	not	PART
ajlm-2912	128	13	measured	measure	VERB
ajlm-2912	128	14	in	in	ADP
ajlm-2912	128	15	this	this	DET
ajlm-2912	128	16	study	study	NOUN
ajlm-2912	128	17	.	.	PUNCT
ajlm-2912	129	1	future	future	ADJ
ajlm-2912	129	2	scope	scope	NOUN
ajlm-2912	129	3	future	future	ADJ
ajlm-2912	129	4	research	research	NOUN
ajlm-2912	129	5	should	should	AUX
ajlm-2912	129	6	involve	involve	VERB
ajlm-2912	129	7	lesion	lesion	NOUN
ajlm-2912	129	8	-	-	PUNCT
ajlm-2912	129	9	level	level	NOUN
ajlm-2912	129	10	assays	assay	NOUN
ajlm-2912	129	11	–	–	PUNCT
ajlm-2912	129	12	such	such	ADJ
ajlm-2912	129	13	as	as	ADP
ajlm-2912	129	14	quantification	quantification	NOUN
ajlm-2912	129	15	of	of	ADP
ajlm-2912	129	16	squalene	squalene	NOUN
ajlm-2912	129	17	peroxides	peroxide	NOUN
ajlm-2912	129	18	in	in	ADP
ajlm-2912	129	19	sebum	sebum	NOUN
ajlm-2912	129	20	,	,	PUNCT
ajlm-2912	129	21	punch	punch	NOUN
ajlm-2912	129	22	biopsy	biopsy	NOUN
ajlm-2912	129	23	,	,	PUNCT
ajlm-2912	129	24	or	or	CCONJ
ajlm-2912	129	25	scraping	scraping	NOUN
ajlm-2912	129	26	of	of	ADP
ajlm-2912	129	27	skin	skin	NOUN
ajlm-2912	129	28	surface	surface	NOUN
ajlm-2912	129	29	by	by	ADP
ajlm-2912	129	30	a	a	DET
ajlm-2912	129	31	dermatologist	dermatologist	NOUN
ajlm-2912	129	32	for	for	ADP
ajlm-2912	129	33	correlating	correlate	VERB
ajlm-2912	129	34	serum	serum	NOUN
ajlm-2912	129	35	and	and	CCONJ
ajlm-2912	129	36	local	local	ADJ
ajlm-2912	129	37	cutaneous	cutaneous	ADJ
ajlm-2912	129	38	oxidative	oxidative	ADJ
ajlm-2912	129	39	stress	stress	NOUN
ajlm-2912	129	40	directly	directly	ADV
ajlm-2912	129	41	.	.	PUNCT
ajlm-2912	130	1	conclusion	conclusion	NOUN
ajlm-2912	130	2	according	accord	VERB
ajlm-2912	130	3	to	to	ADP
ajlm-2912	130	4	the	the	DET
ajlm-2912	130	5	present	present	ADJ
ajlm-2912	130	6	results	result	NOUN
ajlm-2912	130	7	,	,	PUNCT
ajlm-2912	130	8	statistically	statistically	ADV
ajlm-2912	130	9	high	high	ADJ
ajlm-2912	130	10	levels	level	NOUN
ajlm-2912	130	11	of	of	ADP
ajlm-2912	130	12	mda	mda	PROPN
ajlm-2912	130	13	in	in	ADP
ajlm-2912	130	14	patients	patient	NOUN
ajlm-2912	130	15	with	with	ADP
ajlm-2912	130	16	av	av	PROPN
ajlm-2912	130	17	is	be	AUX
ajlm-2912	130	18	evidence	evidence	NOUN
ajlm-2912	130	19	of	of	ADP
ajlm-2912	130	20	the	the	DET
ajlm-2912	130	21	existence	existence	NOUN
ajlm-2912	130	22	of	of	ADP
ajlm-2912	130	23	oxidative	oxidative	ADJ
ajlm-2912	130	24	stress	stress	NOUN
ajlm-2912	130	25	which	which	PRON
ajlm-2912	130	26	can	can	AUX
ajlm-2912	130	27	cause	cause	VERB
ajlm-2912	130	28	cell	cell	NOUN
ajlm-2912	130	29	injury	injury	NOUN
ajlm-2912	130	30	and	and	CCONJ
ajlm-2912	130	31	inflammation	inflammation	NOUN
ajlm-2912	130	32	.	.	PUNCT
ajlm-2912	131	1	furthermore	furthermore	ADV
ajlm-2912	131	2	,	,	PUNCT
ajlm-2912	131	3	low	low	ADJ
ajlm-2912	131	4	levels	level	NOUN
ajlm-2912	131	5	of	of	ADP
ajlm-2912	131	6	sod	sod	NOUN
ajlm-2912	131	7	,	,	PUNCT
ajlm-2912	131	8	cat	cat	NOUN
ajlm-2912	131	9	and	and	CCONJ
ajlm-2912	131	10	gsh	gsh	PROPN
ajlm-2912	131	11	enzyme	enzyme	NOUN
ajlm-2912	131	12	in	in	ADP
ajlm-2912	131	13	acne	acne	NOUN
ajlm-2912	131	14	clearly	clearly	ADV
ajlm-2912	131	15	indicate	indicate	VERB
ajlm-2912	131	16	that	that	SCONJ
ajlm-2912	131	17	the	the	DET
ajlm-2912	131	18	antioxidant	antioxidant	ADJ
ajlm-2912	131	19	defence	defence	NOUN
ajlm-2912	131	20	system	system	NOUN
ajlm-2912	131	21	is	be	AUX
ajlm-2912	131	22	damaged	damage	VERB
ajlm-2912	131	23	,	,	PUNCT
ajlm-2912	131	24	irrespective	irrespective	ADV
ajlm-2912	131	25	of	of	ADP
ajlm-2912	131	26	the	the	DET
ajlm-2912	131	27	degree	degree	NOUN
ajlm-2912	131	28	of	of	ADP
ajlm-2912	131	29	severity	severity	NOUN
ajlm-2912	131	30	,	,	PUNCT
ajlm-2912	131	31	and	and	CCONJ
ajlm-2912	131	32	thereby	thereby	ADV
ajlm-2912	131	33	antioxidant	antioxidant	ADJ
ajlm-2912	131	34	drugs	drug	NOUN
ajlm-2912	131	35	can	can	AUX
ajlm-2912	131	36	be	be	AUX
ajlm-2912	131	37	indicated	indicate	VERB
ajlm-2912	131	38	for	for	ADP
ajlm-2912	131	39	the	the	DET
ajlm-2912	131	40	treatment	treatment	NOUN
ajlm-2912	131	41	of	of	ADP
ajlm-2912	131	42	acne	acne	NOUN
ajlm-2912	131	43	.	.	PUNCT
ajlm-2912	132	1	however	however	ADV
ajlm-2912	132	2	,	,	PUNCT
ajlm-2912	132	3	it	it	PRON
ajlm-2912	132	4	is	be	AUX
ajlm-2912	132	5	still	still	ADV
ajlm-2912	132	6	unclear	unclear	ADJ
ajlm-2912	132	7	whether	whether	SCONJ
ajlm-2912	132	8	oxidative	oxidative	ADJ
ajlm-2912	132	9	stress	stress	NOUN
ajlm-2912	132	10	is	be	AUX
ajlm-2912	132	11	a	a	DET
ajlm-2912	132	12	cause	cause	NOUN
ajlm-2912	132	13	or	or	CCONJ
ajlm-2912	132	14	an	an	DET
ajlm-2912	132	15	outcome	outcome	NOUN
ajlm-2912	132	16	of	of	ADP
ajlm-2912	132	17	inflammation	inflammation	NOUN
ajlm-2912	132	18	.	.	PUNCT
ajlm-2912	133	1	combining	combine	VERB
ajlm-2912	133	2	antioxidants	antioxidant	NOUN
ajlm-2912	133	3	drugs	drug	NOUN
ajlm-2912	133	4	with	with	ADP
ajlm-2912	133	5	other	other	ADJ
ajlm-2912	133	6	treatment	treatment	NOUN
ajlm-2912	133	7	modalities	modality	NOUN
ajlm-2912	133	8	of	of	ADP
ajlm-2912	133	9	acne	acne	NOUN
ajlm-2912	133	10	might	might	AUX
ajlm-2912	133	11	be	be	AUX
ajlm-2912	133	12	beneficial	beneficial	ADJ
ajlm-2912	133	13	in	in	ADP
ajlm-2912	133	14	treating	treat	VERB
ajlm-2912	133	15	patients	patient	NOUN
ajlm-2912	133	16	,	,	PUNCT
ajlm-2912	133	17	especially	especially	ADV
ajlm-2912	133	18	those	those	PRON
ajlm-2912	133	19	with	with	ADP
ajlm-2912	133	20	inflammatory	inflammatory	ADJ
ajlm-2912	133	21	acne	acne	NOUN
ajlm-2912	133	22	lesions	lesion	NOUN
ajlm-2912	133	23	,	,	PUNCT
ajlm-2912	133	24	or	or	CCONJ
ajlm-2912	133	25	their	their	PRON
ajlm-2912	133	26	effects	effect	NOUN
ajlm-2912	133	27	may	may	AUX
ajlm-2912	133	28	be	be	AUX
ajlm-2912	133	29	mitigated	mitigate	VERB
ajlm-2912	133	30	.	.	PUNCT
ajlm-2912	134	1	acknowledgements	acknowledgement	NOUN
ajlm-2912	134	2	competing	compete	VERB
ajlm-2912	134	3	interests	interest	NOUN
ajlm-2912	134	4	the	the	DET
ajlm-2912	134	5	authors	author	NOUN
ajlm-2912	134	6	declare	declare	VERB
ajlm-2912	134	7	that	that	SCONJ
ajlm-2912	134	8	they	they	PRON
ajlm-2912	134	9	have	have	VERB
ajlm-2912	134	10	no	no	DET
ajlm-2912	134	11	financial	financial	ADJ
ajlm-2912	134	12	or	or	CCONJ
ajlm-2912	134	13	personal	personal	ADJ
ajlm-2912	134	14	relationships	relationship	NOUN
ajlm-2912	134	15	that	that	PRON
ajlm-2912	134	16	may	may	AUX
ajlm-2912	134	17	have	have	AUX
ajlm-2912	134	18	inappropriately	inappropriately	ADV
ajlm-2912	134	19	influenced	influence	VERB
ajlm-2912	134	20	them	they	PRON
ajlm-2912	134	21	in	in	ADP
ajlm-2912	134	22	writing	write	VERB
ajlm-2912	134	23	this	this	DET
ajlm-2912	134	24	article	article	NOUN
ajlm-2912	134	25	.	.	PUNCT
ajlm-2912	135	1	authors	author	NOUN
ajlm-2912	135	2	’	'	PUNCT
ajlm-2912	135	3	contributions	contribution	NOUN
ajlm-2912	135	4	astha	astha	PROPN
ajlm-2912	135	5	goyal	goyal	PROPN
ajlm-2912	135	6	conceived	conceive	VERB
ajlm-2912	135	7	and	and	CCONJ
ajlm-2912	135	8	designed	design	VERB
ajlm-2912	135	9	the	the	DET
ajlm-2912	135	10	study	study	NOUN
ajlm-2912	135	11	,	,	PUNCT
ajlm-2912	135	12	collected	collect	VERB
ajlm-2912	135	13	and	and	CCONJ
ajlm-2912	135	14	analysed	analyse	VERB
ajlm-2912	135	15	the	the	DET
ajlm-2912	135	16	data	datum	NOUN
ajlm-2912	135	17	and	and	CCONJ
ajlm-2912	135	18	drafted	draft	VERB
ajlm-2912	135	19	the	the	DET
ajlm-2912	135	20	manuscript	manuscript	NOUN
ajlm-2912	135	21	.	.	PUNCT
ajlm-2912	136	1	dr	dr	PROPN
ajlm-2912	136	2	.	.	PROPN
ajlm-2912	136	3	sanjiv	sanjiv	PROPN
ajlm-2912	136	4	k.	k.	PROPN
ajlm-2912	136	5	bansal	bansal	PROPN
ajlm-2912	136	6	reviewed	review	VERB
ajlm-2912	136	7	and	and	CCONJ
ajlm-2912	136	8	revised	revise	VERB
ajlm-2912	136	9	the	the	DET
ajlm-2912	136	10	final	final	ADJ
ajlm-2912	136	11	article	article	NOUN
ajlm-2912	136	12	and	and	CCONJ
ajlm-2912	136	13	contributed	contribute	VERB
ajlm-2912	136	14	to	to	ADP
ajlm-2912	136	15	the	the	DET
ajlm-2912	136	16	visualization	visualization	NOUN
ajlm-2912	136	17	of	of	ADP
ajlm-2912	136	18	the	the	DET
ajlm-2912	136	19	manuscript	manuscript	NOUN
ajlm-2912	136	20	.	.	PUNCT
ajlm-2912	137	1	dr	dr	PROPN
ajlm-2912	137	2	.	.	PROPN
ajlm-2912	137	3	shikhar	shikhar	PROPN
ajlm-2912	137	4	ganjoo	ganjoo	PROPN
ajlm-2912	137	5	contributed	contribute	VERB
ajlm-2912	137	6	to	to	ADP
ajlm-2912	137	7	the	the	DET
ajlm-2912	137	8	study	study	NOUN
ajlm-2912	137	9	methodology	methodology	NOUN
ajlm-2912	137	10	,	,	PUNCT
ajlm-2912	137	11	and	and	CCONJ
ajlm-2912	137	12	assisted	assist	VERB
ajlm-2912	137	13	in	in	ADP
ajlm-2912	137	14	manuscript	manuscript	NOUN
ajlm-2912	137	15	editing	editing	NOUN
ajlm-2912	137	16	.	.	PUNCT
ajlm-2912	138	1	sources	source	NOUN
ajlm-2912	138	2	of	of	ADP
ajlm-2912	138	3	support	support	NOUN
ajlm-2912	138	4	this	this	DET
ajlm-2912	138	5	research	research	NOUN
ajlm-2912	138	6	received	receive	VERB
ajlm-2912	138	7	no	no	DET
ajlm-2912	138	8	specific	specific	ADJ
ajlm-2912	138	9	grant	grant	NOUN
ajlm-2912	138	10	from	from	ADP
ajlm-2912	138	11	any	any	DET
ajlm-2912	138	12	funding	funding	NOUN
ajlm-2912	138	13	agency	agency	NOUN
ajlm-2912	138	14	in	in	ADP
ajlm-2912	138	15	the	the	DET
ajlm-2912	138	16	public	public	ADJ
ajlm-2912	138	17	,	,	PUNCT
ajlm-2912	138	18	commercial	commercial	ADJ
ajlm-2912	138	19	,	,	PUNCT
ajlm-2912	138	20	or	or	CCONJ
ajlm-2912	138	21	not	not	PART
ajlm-2912	138	22	-	-	PUNCT
ajlm-2912	138	23	for	for	ADP
ajlm-2912	138	24	-	-	PUNCT
ajlm-2912	138	25	profit	profit	NOUN
ajlm-2912	138	26	sectors	sector	NOUN
ajlm-2912	138	27	.	.	PUNCT
ajlm-2912	139	1	data	datum	NOUN
ajlm-2912	139	2	availability	availability	NOUN
ajlm-2912	139	3	the	the	DET
ajlm-2912	139	4	data	datum	NOUN
ajlm-2912	139	5	that	that	PRON
ajlm-2912	139	6	support	support	VERB
ajlm-2912	139	7	the	the	DET
ajlm-2912	139	8	findings	finding	NOUN
ajlm-2912	139	9	of	of	ADP
ajlm-2912	139	10	this	this	DET
ajlm-2912	139	11	study	study	NOUN
ajlm-2912	139	12	are	be	AUX
ajlm-2912	139	13	available	available	ADJ
ajlm-2912	139	14	on	on	ADP
ajlm-2912	139	15	request	request	NOUN
ajlm-2912	139	16	from	from	ADP
ajlm-2912	139	17	the	the	DET
ajlm-2912	139	18	corresponding	corresponding	ADJ
ajlm-2912	139	19	author	author	NOUN
ajlm-2912	139	20	,	,	PUNCT
ajlm-2912	139	21	astha	astha	PROPN
ajlm-2912	139	22	goyal	goyal	PROPN
ajlm-2912	139	23	upon	upon	SCONJ
ajlm-2912	139	24	reasonable	reasonable	ADJ
ajlm-2912	139	25	request	request	NOUN
ajlm-2912	139	26	.	.	PUNCT
ajlm-2912	140	1	disclaimer	disclaimer	VERB
ajlm-2912	140	2	the	the	DET
ajlm-2912	140	3	views	view	NOUN
ajlm-2912	140	4	and	and	CCONJ
ajlm-2912	140	5	opinions	opinion	NOUN
ajlm-2912	140	6	expressed	express	VERB
ajlm-2912	140	7	in	in	ADP
ajlm-2912	140	8	this	this	DET
ajlm-2912	140	9	article	article	NOUN
ajlm-2912	140	10	are	be	AUX
ajlm-2912	140	11	those	those	PRON
ajlm-2912	140	12	of	of	ADP
ajlm-2912	140	13	the	the	DET
ajlm-2912	140	14	authors	author	NOUN
ajlm-2912	140	15	and	and	CCONJ
ajlm-2912	140	16	are	be	AUX
ajlm-2912	140	17	the	the	DET
ajlm-2912	140	18	product	product	NOUN
ajlm-2912	140	19	of	of	ADP
ajlm-2912	140	20	professional	professional	ADJ
ajlm-2912	140	21	research	research	NOUN
ajlm-2912	140	22	.	.	PUNCT
ajlm-2912	141	1	the	the	DET
ajlm-2912	141	2	article	article	NOUN
ajlm-2912	141	3	does	do	AUX
ajlm-2912	141	4	not	not	PART
ajlm-2912	141	5	necessarily	necessarily	ADV
ajlm-2912	141	6	reflect	reflect	VERB
ajlm-2912	141	7	the	the	DET
ajlm-2912	141	8	official	official	ADJ
ajlm-2912	141	9	policy	policy	NOUN
ajlm-2912	141	10	or	or	CCONJ
ajlm-2912	141	11	position	position	NOUN
ajlm-2912	141	12	of	of	ADP
ajlm-2912	141	13	any	any	DET
ajlm-2912	141	14	affiliated	affiliated	ADJ
ajlm-2912	141	15	institution	institution	NOUN
ajlm-2912	141	16	,	,	PUNCT
ajlm-2912	141	17	funder	funder	NOUN
ajlm-2912	141	18	,	,	PUNCT
ajlm-2912	141	19	agency	agency	NOUN
ajlm-2912	141	20	,	,	PUNCT
ajlm-2912	141	21	or	or	CCONJ
ajlm-2912	141	22	that	that	PRON
ajlm-2912	141	23	of	of	ADP
ajlm-2912	141	24	the	the	DET
ajlm-2912	141	25	publisher	publisher	NOUN
ajlm-2912	141	26	.	.	PUNCT
ajlm-2912	142	1	the	the	DET
ajlm-2912	142	2	authors	author	NOUN
ajlm-2912	142	3	are	be	AUX
ajlm-2912	142	4	responsible	responsible	ADJ
ajlm-2912	142	5	for	for	ADP
ajlm-2912	142	6	this	this	DET
ajlm-2912	142	7	article	article	NOUN
ajlm-2912	142	8	’s	’s	PART
ajlm-2912	142	9	results	result	NOUN
ajlm-2912	142	10	,	,	PUNCT
ajlm-2912	142	11	findings	finding	NOUN
ajlm-2912	142	12	,	,	PUNCT
ajlm-2912	142	13	and	and	CCONJ
ajlm-2912	142	14	content	content	NOUN
ajlm-2912	142	15	.	.	PUNCT
ajlm-2912	143	1	references	reference	NOUN
ajlm-2912	143	2	dabash	dabash	VERB
ajlm-2912	144	1	d	d	NOUN
ajlm-2912	144	2	,	,	PUNCT
ajlm-2912	144	3	salahat	salahat	ADJ
ajlm-2912	144	4	h	h	NOUN
ajlm-2912	144	5	,	,	PUNCT
ajlm-2912	144	6	awawdeh	awawdeh	X
ajlm-2912	144	7	s	s	PRON
ajlm-2912	144	8	,	,	PUNCT
ajlm-2912	144	9	et	et	PROPN
ajlm-2912	144	10	al	al	PROPN
ajlm-2912	144	11	.	.	PUNCT
ajlm-2912	145	1	prevalence	prevalence	NOUN
ajlm-2912	145	2	of	of	ADP
ajlm-2912	145	3	acne	acne	NOUN
ajlm-2912	145	4	and	and	CCONJ
ajlm-2912	145	5	its	its	PRON
ajlm-2912	145	6	impact	impact	NOUN
ajlm-2912	145	7	on	on	ADP
ajlm-2912	145	8	quality	quality	NOUN
ajlm-2912	145	9	of	of	ADP
ajlm-2912	145	10	life	life	NOUN
ajlm-2912	145	11	and	and	CCONJ
ajlm-2912	145	12	practices	practice	NOUN
ajlm-2912	145	13	regarding	regard	VERB
ajlm-2912	145	14	self	self	NOUN
ajlm-2912	145	15	-	-	PUNCT
ajlm-2912	145	16	treatment	treatment	NOUN
ajlm-2912	145	17	among	among	ADP
ajlm-2912	145	18	medical	medical	ADJ
ajlm-2912	145	19	students	student	NOUN
ajlm-2912	145	20	.	.	PUNCT
ajlm-2912	146	1	sci	sci	PROPN
ajlm-2912	146	2	rep	rep	PROPN
ajlm-2912	146	3	.	.	PROPN
ajlm-2912	146	4	2024;14(1	2024;14(1	NUM
ajlm-2912	146	5	):	):	PUNCT
ajlm-2912	146	6	4351	4351	NUM
ajlm-2912	146	7	.	.	PUNCT
ajlm-2912	147	1	https://doi.org/10.1038/s41598-024-55094-6	https://doi.org/10.1038/s41598-024-55094-6	PROPN
ajlm-2912	147	2	febyan	febyan	PROPN
ajlm-2912	147	3	wk	wk	PROPN
ajlm-2912	147	4	.	.	PROPN
ajlm-2912	147	5	acne	acne	PROPN
ajlm-2912	147	6	vulgaris	vulgaris	NOUN
ajlm-2912	147	7	in	in	ADP
ajlm-2912	147	8	adults	adult	NOUN
ajlm-2912	147	9	:	:	PUNCT
ajlm-2912	147	10	a	a	DET
ajlm-2912	147	11	brief	brief	ADJ
ajlm-2912	147	12	review	review	NOUN
ajlm-2912	147	13	on	on	ADP
ajlm-2912	147	14	diagnosis	diagnosis	NOUN
ajlm-2912	147	15	and	and	CCONJ
ajlm-2912	147	16	management	management	NOUN
ajlm-2912	147	17	.	.	PUNCT
ajlm-2912	148	1	int	int	PROPN
ajlm-2912	148	2	j	j	PROPN
ajlm-2912	148	3	res	res	PROPN
ajlm-2912	148	4	rev	rev	PROPN
ajlm-2912	148	5	.	.	PROPN
ajlm-2912	148	6	2020;7(5):246–252	2020;7(5):246–252	NUM
ajlm-2912	148	7	.	.	PUNCT
ajlm-2912	149	1	costa	costa	PROPN
ajlm-2912	149	2	cs	cs	PROPN
ajlm-2912	149	3	,	,	PUNCT
ajlm-2912	149	4	bagatin	bagatin	NOUN
ajlm-2912	149	5	e	e	PROPN
ajlm-2912	149	6	,	,	PUNCT
ajlm-2912	149	7	yang	yang	PROPN
ajlm-2912	149	8	z	z	PROPN
ajlm-2912	149	9	,	,	PUNCT
ajlm-2912	149	10	et	et	PROPN
ajlm-2912	149	11	al	al	PROPN
ajlm-2912	149	12	.	.	PUNCT
ajlm-2912	149	13	systemic	systemic	ADJ
ajlm-2912	149	14	pharmacological	pharmacological	ADJ
ajlm-2912	149	15	treatments	treatment	NOUN
ajlm-2912	149	16	for	for	ADP
ajlm-2912	149	17	acne	acne	NOUN
ajlm-2912	149	18	:	:	PUNCT
ajlm-2912	149	19	an	an	DET
ajlm-2912	149	20	overview	overview	NOUN
ajlm-2912	149	21	of	of	ADP
ajlm-2912	149	22	systematic	systematic	ADJ
ajlm-2912	149	23	reviews	review	NOUN
ajlm-2912	149	24	(	(	PUNCT
ajlm-2912	149	25	protocol	protocol	NOUN
ajlm-2912	149	26	)	)	PUNCT
ajlm-2912	149	27	.	.	PUNCT
ajlm-2912	150	1	cochrane	cochrane	PROPN
ajlm-2912	150	2	database	database	PROPN
ajlm-2912	150	3	syst	syst	PROPN
ajlm-2912	150	4	rev	rev	PROPN
ajlm-2912	150	5	.	.	PROPN
ajlm-2912	150	6	2021;2021(11):1	2021;2021(11):1	NUM
ajlm-2912	150	7	.	.	PUNCT
ajlm-2912	150	8	https://doi.org/10.1002/14651858.cd014917	https://doi.org/10.1002/14651858.cd014917	PROPN
ajlm-2912	150	9	özçelik	özçelik	PROPN
ajlm-2912	150	10	s	s	PROPN
ajlm-2912	150	11	,	,	PUNCT
ajlm-2912	150	12	kulaç	kulaç	PROPN
ajlm-2912	150	13	i̇	i̇	PROPN
ajlm-2912	150	14	,	,	PUNCT
ajlm-2912	150	15	yazıcı	yazıcı	NOUN
ajlm-2912	150	16	m	m	PROPN
ajlm-2912	150	17	,	,	PUNCT
ajlm-2912	150	18	öcal	öcal	ADJ
ajlm-2912	150	19	e.	e.	NOUN
ajlm-2912	150	20	distribution	distribution	NOUN
ajlm-2912	150	21	of	of	ADP
ajlm-2912	150	22	childhood	childhood	NOUN
ajlm-2912	150	23	skin	skin	NOUN
ajlm-2912	150	24	diseases	disease	NOUN
ajlm-2912	150	25	according	accord	VERB
ajlm-2912	150	26	to	to	ADP
ajlm-2912	150	27	age	age	NOUN
ajlm-2912	150	28	and	and	CCONJ
ajlm-2912	150	29	gender	gender	NOUN
ajlm-2912	150	30	,	,	PUNCT
ajlm-2912	150	31	a	a	DET
ajlm-2912	150	32	single	single	ADJ
ajlm-2912	150	33	institution	institution	NOUN
ajlm-2912	150	34	experience	experience	NOUN
ajlm-2912	150	35	.	.	PUNCT
ajlm-2912	151	1	turk	turk	PROPN
ajlm-2912	151	2	archiv	archiv	PROPN
ajlm-2912	151	3	pediatr	pediatr	PROPN
ajlm-2912	151	4	.	.	PUNCT
ajlm-2912	152	1	2018;53(2):105	2018;53(2):105	NUM
ajlm-2912	152	2	.	.	PUNCT
ajlm-2912	153	1	https://doi.org/10.5152/turkpediatriars.2018.6431	https://doi.org/10.5152/turkpediatriars.2018.6431	PROPN
ajlm-2912	153	2	baldwin	baldwin	PROPN
ajlm-2912	153	3	h	h	PROPN
ajlm-2912	153	4	,	,	PUNCT
ajlm-2912	153	5	farberg	farberg	PROPN
ajlm-2912	153	6	a	a	PROPN
ajlm-2912	153	7	,	,	PUNCT
ajlm-2912	153	8	frey	frey	PROPN
ajlm-2912	153	9	c	c	PROPN
ajlm-2912	153	10	,	,	PUNCT
ajlm-2912	153	11	et	et	PROPN
ajlm-2912	154	1	al	al	PROPN
ajlm-2912	154	2	.	.	PROPN
ajlm-2912	154	3	unmet	unmet	PROPN
ajlm-2912	154	4	needs	need	VERB
ajlm-2912	154	5	in	in	ADP
ajlm-2912	154	6	the	the	DET
ajlm-2912	154	7	management	management	NOUN
ajlm-2912	154	8	of	of	ADP
ajlm-2912	154	9	acne	acne	NOUN
ajlm-2912	154	10	vulgaris	vulgaris	NOUN
ajlm-2912	154	11	:	:	PUNCT
ajlm-2912	154	12	a	a	DET
ajlm-2912	154	13	consensus	consensus	NOUN
ajlm-2912	154	14	statement	statement	NOUN
ajlm-2912	154	15	.	.	PUNCT
ajlm-2912	155	1	j	j	PROPN
ajlm-2912	155	2	drugs	drug	NOUN
ajlm-2912	155	3	dermatol	dermatol	NOUN
ajlm-2912	155	4	.	.	PUNCT
ajlm-2912	156	1	2023;22(6):582–587	2023;22(6):582–587	NUM
ajlm-2912	156	2	.	.	PUNCT
ajlm-2912	157	1	https://doi.org/10.36849/jdd.7587	https://doi.org/10.36849/jdd.7587	PROPN
ajlm-2912	157	2	assiri	assiri	PROPN
ajlm-2912	157	3	a	a	PRON
ajlm-2912	157	4	,	,	PUNCT
ajlm-2912	157	5	alameer	alameer	NOUN
ajlm-2912	157	6	m	m	PROPN
ajlm-2912	157	7	,	,	PUNCT
ajlm-2912	157	8	zogel	zogel	PROPN
ajlm-2912	157	9	b	b	PROPN
ajlm-2912	157	10	,	,	PUNCT
ajlm-2912	157	11	et	et	PROPN
ajlm-2912	157	12	al	al	PROPN
ajlm-2912	157	13	.	.	PUNCT
ajlm-2912	158	1	prevalence	prevalence	NOUN
ajlm-2912	158	2	of	of	ADP
ajlm-2912	158	3	acne	acne	NOUN
ajlm-2912	158	4	vulgaris	vulgaris	NOUN
ajlm-2912	158	5	and	and	CCONJ
ajlm-2912	158	6	its	its	PRON
ajlm-2912	158	7	association	association	NOUN
ajlm-2912	158	8	with	with	ADP
ajlm-2912	158	9	lifestyle	lifestyle	NOUN
ajlm-2912	158	10	among	among	ADP
ajlm-2912	158	11	the	the	DET
ajlm-2912	158	12	general	general	ADJ
ajlm-2912	158	13	population	population	NOUN
ajlm-2912	158	14	of	of	ADP
ajlm-2912	158	15	jazan	jazan	PROPN
ajlm-2912	158	16	city	city	PROPN
ajlm-2912	158	17	,	,	PUNCT
ajlm-2912	158	18	saudi	saudi	PROPN
ajlm-2912	158	19	arabia	arabia	PROPN
ajlm-2912	158	20	:	:	PUNCT
ajlm-2912	158	21	a	a	DET
ajlm-2912	158	22	cross	cross	ADJ
ajlm-2912	158	23	-	-	ADJ
ajlm-2912	158	24	sectional	sectional	ADJ
ajlm-2912	158	25	study	study	NOUN
ajlm-2912	158	26	.	.	PUNCT
ajlm-2912	159	1	int	int	PROPN
ajlm-2912	159	2	j	j	PROPN
ajlm-2912	159	3	med	med	PROPN
ajlm-2912	159	4	dev	dev	PROPN
ajlm-2912	159	5	countr	countr	PROPN
ajlm-2912	159	6	.	.	PUNCT
ajlm-2912	160	1	2023;7(10):1305–1312	2023;7(10):1305–1312	NUM
ajlm-2912	160	2	.	.	PUNCT
ajlm-2912	161	1	https://doi.org/10.24911/ijmdc.51-1683495519	https://doi.org/10.24911/ijmdc.51-1683495519	INTJ
ajlm-2912	161	2	sutaria	sutaria	PROPN
ajlm-2912	161	3	ah	ah	INTJ
ajlm-2912	161	4	,	,	PUNCT
ajlm-2912	161	5	masood	masood	PROPN
ajlm-2912	161	6	s	s	PROPN
ajlm-2912	161	7	,	,	PUNCT
ajlm-2912	161	8	saleh	saleh	PROPN
ajlm-2912	161	9	hm	hm	INTJ
ajlm-2912	161	10	,	,	PUNCT
ajlm-2912	161	11	schlessinger	schlessinger	PROPN
ajlm-2912	161	12	j.	j.	PROPN
ajlm-2912	161	13	acne	acne	PROPN
ajlm-2912	161	14	vulgaris	vulgaris	PROPN
ajlm-2912	161	15	.	.	PUNCT
ajlm-2912	162	1	treasure	treasure	NOUN
ajlm-2912	162	2	island	island	NOUN
ajlm-2912	162	3	,	,	PUNCT
ajlm-2912	162	4	fl	fl	PROPN
ajlm-2912	162	5	:	:	PUNCT
ajlm-2912	162	6	statpearls	statpearls	PROPN
ajlm-2912	162	7	publishing	publishing	NOUN
ajlm-2912	162	8	;	;	PUNCT
ajlm-2912	162	9	2023	2023	NUM
ajlm-2912	162	10	.	.	PUNCT
ajlm-2912	163	1	simpson	simpson	PROPN
ajlm-2912	163	2	rc	rc	PROPN
ajlm-2912	163	3	,	,	PUNCT
ajlm-2912	163	4	grindlay	grindlay	NOUN
ajlm-2912	163	5	dj	dj	PROPN
ajlm-2912	163	6	,	,	PUNCT
ajlm-2912	163	7	williams	williams	PROPN
ajlm-2912	163	8	hc	hc	PROPN
ajlm-2912	163	9	.	.	PUNCT
ajlm-2912	164	1	what	what	PRON
ajlm-2912	164	2	’s	’	VERB
ajlm-2912	164	3	new	new	ADJ
ajlm-2912	164	4	in	in	ADP
ajlm-2912	164	5	acne	acne	NOUN
ajlm-2912	164	6	?	?	PUNCT
ajlm-2912	165	1	an	an	DET
ajlm-2912	165	2	analysis	analysis	NOUN
ajlm-2912	165	3	of	of	ADP
ajlm-2912	165	4	systematic	systematic	ADJ
ajlm-2912	165	5	reviews	review	NOUN
ajlm-2912	165	6	and	and	CCONJ
ajlm-2912	165	7	clinically	clinically	ADV
ajlm-2912	165	8	significant	significant	ADJ
ajlm-2912	165	9	trials	trial	NOUN
ajlm-2912	165	10	published	publish	VERB
ajlm-2912	165	11	in	in	ADP
ajlm-2912	165	12	2010–11	2010–11	NUM
ajlm-2912	165	13	.	.	PUNCT
ajlm-2912	166	1	clin	clin	PROPN
ajlm-2912	166	2	exp	exp	NOUN
ajlm-2912	166	3	dermatol	dermatol	NOUN
ajlm-2912	166	4	.	.	PUNCT
ajlm-2912	167	1	2011;36(8):840–844	2011;36(8):840–844	NUM
ajlm-2912	167	2	.	.	PROPN
ajlm-2912	167	3	https://doi.org/10.1111/j.1365-2230.2011.04218.x	https://doi.org/10.1111/j.1365-2230.2011.04218.x	PROPN
ajlm-2912	167	4	johnson	johnson	PROPN
ajlm-2912	167	5	ba	ba	PROPN
ajlm-2912	167	6	,	,	PUNCT
ajlm-2912	167	7	nunley	nunley	PROPN
ajlm-2912	167	8	jr	jr	PROPN
ajlm-2912	167	9	.	.	PUNCT
ajlm-2912	167	10	use	use	NOUN
ajlm-2912	167	11	of	of	ADP
ajlm-2912	167	12	systemic	systemic	ADJ
ajlm-2912	167	13	agents	agent	NOUN
ajlm-2912	167	14	in	in	ADP
ajlm-2912	167	15	the	the	DET
ajlm-2912	167	16	treatment	treatment	NOUN
ajlm-2912	167	17	of	of	ADP
ajlm-2912	167	18	acne	acne	NOUN
ajlm-2912	167	19	vulgaris	vulgaris	NOUN
ajlm-2912	167	20	.	.	PUNCT
ajlm-2912	167	21	am	be	AUX
ajlm-2912	167	22	fam	fam	NOUN
ajlm-2912	167	23	phys	phy	NOUN
ajlm-2912	167	24	.	.	PUNCT
ajlm-2912	168	1	2000;62(8):1823–1830	2000;62(8):1823–1830	PROPN
ajlm-2912	168	2	.	.	PUNCT
ajlm-2912	169	1	akamatsu	akamatsu	PROPN
ajlm-2912	169	2	h	h	NOUN
ajlm-2912	169	3	,	,	PUNCT
ajlm-2912	169	4	horio	horio	ADP
ajlm-2912	169	5	t.	t.	PROPN
ajlm-2912	169	6	the	the	DET
ajlm-2912	169	7	possible	possible	ADJ
ajlm-2912	169	8	role	role	NOUN
ajlm-2912	169	9	of	of	ADP
ajlm-2912	169	10	reactive	reactive	ADJ
ajlm-2912	169	11	oxygen	oxygen	NOUN
ajlm-2912	169	12	species	specie	NOUN
ajlm-2912	169	13	generated	generate	VERB
ajlm-2912	169	14	by	by	ADP
ajlm-2912	169	15	neutrophils	neutrophil	NOUN
ajlm-2912	169	16	in	in	ADP
ajlm-2912	169	17	mediating	mediate	VERB
ajlm-2912	169	18	acne	acne	NOUN
ajlm-2912	169	19	inflammation	inflammation	NOUN
ajlm-2912	169	20	.	.	PUNCT
ajlm-2912	170	1	dermatology	dermatology	NOUN
ajlm-2912	170	2	.	.	PUNCT
ajlm-2912	171	1	1998;196(1):82–85	1998;196(1):82–85	X
ajlm-2912	171	2	.	.	PUNCT
ajlm-2912	172	1	https://doi.org/10.1159/000017876	https://doi.org/10.1159/000017876	PROPN
ajlm-2912	172	2	basak	basak	PROPN
ajlm-2912	172	3	py	py	PROPN
ajlm-2912	172	4	,	,	PUNCT
ajlm-2912	172	5	gultekin	gultekin	PROPN
ajlm-2912	172	6	fa	fa	PROPN
ajlm-2912	172	7	,	,	PUNCT
ajlm-2912	172	8	kilinc	kilinc	PROPN
ajlm-2912	172	9	i	i	PROPN
ajlm-2912	172	10	,	,	PUNCT
ajlm-2912	172	11	delibas	delibas	PROPN
ajlm-2912	172	12	n.	n.	VERB
ajlm-2912	172	13	the	the	DET
ajlm-2912	172	14	effect	effect	NOUN
ajlm-2912	172	15	of	of	ADP
ajlm-2912	172	16	benzoyl	benzoyl	ADJ
ajlm-2912	172	17	peroxide	peroxide	NOUN
ajlm-2912	172	18	and	and	CCONJ
ajlm-2912	172	19	benzoyl	benzoyl	ADJ
ajlm-2912	172	20	peroxide	peroxide	NOUN
ajlm-2912	172	21	/	/	SYM
ajlm-2912	172	22	erythromycin	erythromycin	NOUN
ajlm-2912	172	23	combination	combination	NOUN
ajlm-2912	172	24	on	on	ADP
ajlm-2912	172	25	the	the	DET
ajlm-2912	172	26	antioxidative	antioxidative	ADJ
ajlm-2912	172	27	defence	defence	NOUN
ajlm-2912	172	28	system	system	NOUN
ajlm-2912	172	29	in	in	ADP
ajlm-2912	172	30	papulopustular	papulopustular	ADJ
ajlm-2912	172	31	acne	acne	NOUN
ajlm-2912	172	32	.	.	PUNCT
ajlm-2912	173	1	eur	eur	PROPN
ajlm-2912	173	2	j	j	PROPN
ajlm-2912	173	3	dermatol	dermatol	NOUN
ajlm-2912	173	4	.	.	PUNCT
ajlm-2912	174	1	2002;12(1):53–57	2002;12(1):53–57	NUM
ajlm-2912	174	2	.	.	PUNCT
ajlm-2912	175	1	bickers	bickers	PROPN
ajlm-2912	175	2	dr	dr	PROPN
ajlm-2912	175	3	,	,	PUNCT
ajlm-2912	175	4	athar	athar	PROPN
ajlm-2912	175	5	m.	m.	NOUN
ajlm-2912	175	6	oxidative	oxidative	ADJ
ajlm-2912	175	7	stress	stress	NOUN
ajlm-2912	175	8	in	in	ADP
ajlm-2912	175	9	the	the	DET
ajlm-2912	175	10	pathogenesis	pathogenesis	NOUN
ajlm-2912	175	11	of	of	ADP
ajlm-2912	175	12	skin	skin	NOUN
ajlm-2912	175	13	disease	disease	NOUN
ajlm-2912	175	14	.	.	PUNCT
ajlm-2912	176	1	j	j	PROPN
ajlm-2912	176	2	investig	investig	NOUN
ajlm-2912	176	3	dermatol	dermatol	NOUN
ajlm-2912	176	4	.	.	PUNCT
ajlm-2912	177	1	2006;126(12):2565–2575	2006;126(12):2565–2575	NUM
ajlm-2912	177	2	.	.	PUNCT
ajlm-2912	178	1	https://doi.org/10.1038/sj.jid.5700340	https://doi.org/10.1038/sj.jid.5700340	PROPN
ajlm-2912	178	2	kardeh	kardeh	PROPN
ajlm-2912	178	3	s	s	PART
ajlm-2912	178	4	,	,	PUNCT
ajlm-2912	178	5	ashkani	ashkani	NOUN
ajlm-2912	178	6	-	-	PUNCT
ajlm-2912	178	7	esfahani	esfahani	PROPN
ajlm-2912	178	8	s	s	PROPN
ajlm-2912	178	9	,	,	PUNCT
ajlm-2912	178	10	alizadeh	alizadeh	PROPN
ajlm-2912	178	11	am	be	AUX
ajlm-2912	178	12	.	.	PUNCT
ajlm-2912	179	1	paradoxical	paradoxical	ADJ
ajlm-2912	179	2	action	action	NOUN
ajlm-2912	179	3	of	of	ADP
ajlm-2912	179	4	reactive	reactive	ADJ
ajlm-2912	179	5	oxygen	oxygen	NOUN
ajlm-2912	179	6	species	specie	NOUN
ajlm-2912	179	7	in	in	ADP
ajlm-2912	179	8	creation	creation	NOUN
ajlm-2912	179	9	and	and	CCONJ
ajlm-2912	179	10	therapy	therapy	NOUN
ajlm-2912	179	11	of	of	ADP
ajlm-2912	179	12	cancer	cancer	NOUN
ajlm-2912	179	13	.	.	PUNCT
ajlm-2912	180	1	eur	eur	PROPN
ajlm-2912	180	2	j	j	PROPN
ajlm-2912	180	3	pharmacol	pharmacol	PROPN
ajlm-2912	180	4	.	.	PUNCT
ajlm-2912	181	1	2014;735:150–168	2014;735:150–168	NOUN
ajlm-2912	181	2	.	.	PUNCT
ajlm-2912	182	1	https://doi.org/10.1016/j.ejphar.2014.04.023	https://doi.org/10.1016/j.ejphar.2014.04.023	NUM
ajlm-2912	182	2	el	el	PROPN
ajlm-2912	182	3	garem	garem	VERB
ajlm-2912	182	4	yf	yf	PROPN
ajlm-2912	182	5	,	,	PUNCT
ajlm-2912	182	6	ahmed	ahmed	PROPN
ajlm-2912	182	7	ra	ra	PROPN
ajlm-2912	182	8	,	,	PUNCT
ajlm-2912	182	9	ragab	ragab	VERB
ajlm-2912	182	10	ma	ma	PROPN
ajlm-2912	182	11	,	,	PUNCT
ajlm-2912	182	12	abouzeid	abouzeid	ADJ
ajlm-2912	182	13	aa	aa	NOUN
ajlm-2912	182	14	.	.	PUNCT
ajlm-2912	183	1	study	study	NOUN
ajlm-2912	183	2	of	of	ADP
ajlm-2912	183	3	oxidative	oxidative	ADJ
ajlm-2912	183	4	stress	stress	NOUN
ajlm-2912	183	5	in	in	ADP
ajlm-2912	183	6	different	different	ADJ
ajlm-2912	183	7	clinical	clinical	ADJ
ajlm-2912	183	8	severities	severity	NOUN
ajlm-2912	183	9	of	of	ADP
ajlm-2912	183	10	acne	acne	NOUN
ajlm-2912	183	11	vulgaris	vulgaris	NOUN
ajlm-2912	183	12	.	.	PUNCT
ajlm-2912	184	1	egypt	egypt	PROPN
ajlm-2912	184	2	j	j	PROPN
ajlm-2912	184	3	dermat	dermat	PROPN
ajlm-2912	184	4	venerol	venerol	PROPN
ajlm-2912	184	5	.	.	PUNCT
ajlm-2912	185	1	2014;34(1):53–57	2014;34(1):53–57	X
ajlm-2912	185	2	.	.	PUNCT
ajlm-2912	186	1	https://doi.org/10.4103/1110-6530.137313	https://doi.org/10.4103/1110-6530.137313	PROPN
ajlm-2912	186	2	del	del	PROPN
ajlm-2912	186	3	rio	rio	PROPN
ajlm-2912	186	4	d	d	PROPN
ajlm-2912	186	5	,	,	PUNCT
ajlm-2912	186	6	stewart	stewart	PROPN
ajlm-2912	186	7	aj	aj	PROPN
ajlm-2912	186	8	,	,	PUNCT
ajlm-2912	186	9	pellegrini	pellegrini	PROPN
ajlm-2912	186	10	n.	n.	PROPN
ajlm-2912	186	11	a	a	DET
ajlm-2912	186	12	review	review	NOUN
ajlm-2912	186	13	of	of	ADP
ajlm-2912	186	14	recent	recent	ADJ
ajlm-2912	186	15	studies	study	NOUN
ajlm-2912	186	16	on	on	ADP
ajlm-2912	186	17	malondialdehyde	malondialdehyde	PROPN
ajlm-2912	186	18	as	as	ADP
ajlm-2912	186	19	toxic	toxic	ADJ
ajlm-2912	186	20	molecule	molecule	NOUN
ajlm-2912	186	21	and	and	CCONJ
ajlm-2912	186	22	biological	biological	ADJ
ajlm-2912	186	23	marker	marker	NOUN
ajlm-2912	186	24	of	of	ADP
ajlm-2912	186	25	oxidative	oxidative	ADJ
ajlm-2912	186	26	stress	stress	NOUN
ajlm-2912	186	27	.	.	PUNCT
ajlm-2912	187	1	nutr	nutr	PROPN
ajlm-2912	187	2	metab	metab	PROPN
ajlm-2912	187	3	cardiovasc	cardiovasc	PROPN
ajlm-2912	187	4	dis	dis	PROPN
ajlm-2912	187	5	.	.	PUNCT
ajlm-2912	188	1	2005;15(4):316–328	2005;15(4):316–328	X
ajlm-2912	188	2	.	.	PUNCT
ajlm-2912	189	1	https://doi.org/10.1016/j.numecd.2005.05.003	https://doi.org/10.1016/j.numecd.2005.05.003	PROPN
ajlm-2912	189	2	matés	matés	PROPN
ajlm-2912	189	3	jm	jm	PROPN
ajlm-2912	189	4	,	,	PUNCT
ajlm-2912	189	5	pérez	pérez	NOUN
ajlm-2912	189	6	-	-	PUNCT
ajlm-2912	189	7	gómez	gómez	NOUN
ajlm-2912	189	8	c	c	NOUN
ajlm-2912	189	9	,	,	PUNCT
ajlm-2912	189	10	de	de	X
ajlm-2912	189	11	castro	castro	NOUN
ajlm-2912	189	12	in	in	ADP
ajlm-2912	189	13	.	.	PUNCT
ajlm-2912	190	1	antioxidant	antioxidant	ADJ
ajlm-2912	190	2	enzymes	enzyme	NOUN
ajlm-2912	190	3	and	and	CCONJ
ajlm-2912	190	4	human	human	ADJ
ajlm-2912	190	5	diseases	disease	NOUN
ajlm-2912	190	6	.	.	PUNCT
ajlm-2912	191	1	clin	clin	PROPN
ajlm-2912	191	2	biochem	biochem	PROPN
ajlm-2912	191	3	.	.	PUNCT
ajlm-2912	192	1	1999;32(8):595–603	1999;32(8):595–603	NUM
ajlm-2912	192	2	.	.	PUNCT
ajlm-2912	192	3	https://doi.org/10.1016/s0009-9120(99)00075-2	https://doi.org/10.1016/s0009-9120(99)00075-2	PROPN
ajlm-2912	192	4	farag	farag	PROPN
ajlm-2912	192	5	rm	rm	PROPN
ajlm-2912	192	6	,	,	PUNCT
ajlm-2912	192	7	ahmed	ahmed	PROPN
ajlm-2912	192	8	mb	mb	PROPN
ajlm-2912	192	9	,	,	PUNCT
ajlm-2912	192	10	el	el	PROPN
ajlm-2912	192	11	-	-	PROPN
ajlm-2912	192	12	gendy	gendy	PROPN
ajlm-2912	192	13	ma	ma	PROPN
ajlm-2912	192	14	,	,	PUNCT
ajlm-2912	192	15	mohamed	mohamed	PROPN
ajlm-2912	192	16	is	be	AUX
ajlm-2912	192	17	.	.	PUNCT
ajlm-2912	193	1	evaluation	evaluation	NOUN
ajlm-2912	193	2	of	of	ADP
ajlm-2912	193	3	oxidative	oxidative	ADJ
ajlm-2912	193	4	stress	stress	NOUN
ajlm-2912	193	5	and	and	CCONJ
ajlm-2912	193	6	apoptosis	apoptosis	NOUN
ajlm-2912	193	7	in	in	ADP
ajlm-2912	193	8	breast	breast	NOUN
ajlm-2912	193	9	cancer	cancer	NOUN
ajlm-2912	193	10	.	.	PUNCT
ajlm-2912	194	1	egypt	egypt	PROPN
ajlm-2912	194	2	j	j	PROPN
ajlm-2912	194	3	biochem	biochem	PROPN
ajlm-2912	194	4	mol	mol	ADP
ajlm-2912	194	5	biol	biol	PROPN
ajlm-2912	194	6	.	.	PUNCT
ajlm-2912	195	1	2009;27(2):63–82	2009;27(2):63–82	X
ajlm-2912	195	2	.	.	NOUN
ajlm-2912	195	3	https://doi.org/10.4314/ejbmb.v27i2.49254	https://doi.org/10.4314/ejbmb.v27i2.49254	X
ajlm-2912	195	4	pugliese	pugliese	PROPN
ajlm-2912	195	5	pt	pt	NOUN
ajlm-2912	195	6	.	.	PUNCT
ajlm-2912	196	1	the	the	DET
ajlm-2912	196	2	skin	skin	NOUN
ajlm-2912	196	3	’s	’s	PART
ajlm-2912	196	4	antioxidant	antioxidant	ADJ
ajlm-2912	196	5	systems	system	NOUN
ajlm-2912	196	6	.	.	PUNCT
ajlm-2912	197	1	dermatol	dermatol	NOUN
ajlm-2912	197	2	nurs	nur	VERB
ajlm-2912	197	3	.	.	PUNCT
ajlm-2912	198	1	1998;10(6):401–402	1998;10(6):401–402	X
ajlm-2912	198	2	.	.	PUNCT
ajlm-2912	198	3	https://doi.org/10.1016/s0950-7051(98)00033-1	https://doi.org/10.1016/s0950-7051(98)00033-1	PROPN
ajlm-2912	198	4	sarici	sarici	PROPN
ajlm-2912	198	5	g	g	PROPN
ajlm-2912	198	6	,	,	PUNCT
ajlm-2912	198	7	cinar	cinar	PROPN
ajlm-2912	198	8	s	s	PROPN
ajlm-2912	198	9	,	,	PUNCT
ajlm-2912	198	10	armutcu	armutcu	PROPN
ajlm-2912	198	11	f	f	X
ajlm-2912	198	12	,	,	PUNCT
ajlm-2912	198	13	altınyazar	altınyazar	NOUN
ajlm-2912	198	14	c	c	PROPN
ajlm-2912	198	15	,	,	PUNCT
ajlm-2912	198	16	koca	koca	PROPN
ajlm-2912	198	17	r	r	PROPN
ajlm-2912	198	18	,	,	PUNCT
ajlm-2912	198	19	tekin	tekin	X
ajlm-2912	198	20	ns	ns	NUM
ajlm-2912	198	21	.	.	PROPN
ajlm-2912	198	22	oxidative	oxidative	ADJ
ajlm-2912	198	23	stress	stress	NOUN
ajlm-2912	198	24	in	in	ADP
ajlm-2912	198	25	acne	acne	NOUN
ajlm-2912	198	26	vulgaris	vulgaris	NOUN
ajlm-2912	198	27	.	.	PUNCT
ajlm-2912	199	1	j	j	PROPN
ajlm-2912	199	2	eur	eur	PROPN
ajlm-2912	199	3	acad	acad	PROPN
ajlm-2912	199	4	dermatol	dermatol	NOUN
ajlm-2912	199	5	venereol	venereol	NOUN
ajlm-2912	199	6	.	.	PUNCT
ajlm-2912	200	1	2010;24(7):763–767	2010;24(7):763–767	X
ajlm-2912	200	2	.	.	PUNCT
ajlm-2912	201	1	https://doi.org/10.1111/j.1468-3083.2009.03505.x	https://doi.org/10.1111/j.1468-3083.2009.03505.x	PROPN
ajlm-2912	201	2	arican	arican	PROPN
ajlm-2912	201	3	o	o	PROPN
ajlm-2912	201	4	,	,	PUNCT
ajlm-2912	201	5	kurutas	kurutas	PROPN
ajlm-2912	201	6	eb	eb	PROPN
ajlm-2912	201	7	,	,	PUNCT
ajlm-2912	201	8	sasmaz	sasmaz	PROPN
ajlm-2912	201	9	s.	s.	PROPN
ajlm-2912	201	10	oxidative	oxidative	VERB
ajlm-2912	201	11	stress	stress	NOUN
ajlm-2912	201	12	in	in	ADP
ajlm-2912	201	13	patients	patient	NOUN
ajlm-2912	201	14	with	with	ADP
ajlm-2912	201	15	acne	acne	NOUN
ajlm-2912	201	16	vulgaris	vulgaris	NOUN
ajlm-2912	201	17	.	.	PUNCT
ajlm-2912	202	1	mediators	mediator	NOUN
ajlm-2912	202	2	inflamm	inflamm	NOUN
ajlm-2912	202	3	.	.	PUNCT
ajlm-2912	203	1	2005;2005(6):380–384	2005;2005(6):380–384	NUM
ajlm-2912	203	2	.	.	PUNCT
ajlm-2912	204	1	https://doi.org/10.1155/mi.2005.380	https://doi.org/10.1155/mi.2005.380	VERB
ajlm-2912	204	2	tutakne	tutakne	PROPN
ajlm-2912	204	3	ma	ma	PROPN
ajlm-2912	204	4	,	,	PUNCT
ajlm-2912	204	5	chari	chari	PROPN
ajlm-2912	204	6	kv	kv	PROPN
ajlm-2912	204	7	.	.	PUNCT
ajlm-2912	205	1	acne	acne	PROPN
ajlm-2912	205	2	,	,	PUNCT
ajlm-2912	205	3	rosacea	rosacea	NOUN
ajlm-2912	205	4	and	and	CCONJ
ajlm-2912	205	5	perioral	perioral	ADJ
ajlm-2912	205	6	dermatitis	dermatitis	NOUN
ajlm-2912	205	7	.	.	PUNCT
ajlm-2912	206	1	in	in	ADP
ajlm-2912	206	2	:	:	PUNCT
ajlm-2912	206	3	valia	valia	PROPN
ajlm-2912	206	4	rg	rg	PROPN
ajlm-2912	206	5	,	,	PUNCT
ajlm-2912	206	6	valia	valia	PROPN
ajlm-2912	206	7	ar	ar	PROPN
ajlm-2912	206	8	,	,	PUNCT
ajlm-2912	206	9	editors	editor	NOUN
ajlm-2912	206	10	.	.	PUNCT
ajlm-2912	207	1	iadvl	iadvl	ADJ
ajlm-2912	207	2	textbook	textbook	NOUN
ajlm-2912	207	3	and	and	CCONJ
ajlm-2912	207	4	atlas	atlas	PROPN
ajlm-2912	207	5	of	of	ADP
ajlm-2912	207	6	dermatology	dermatology	NOUN
ajlm-2912	207	7	.	.	PUNCT
ajlm-2912	208	1	2nd	2nd	ADJ
ajlm-2912	208	2	ed	ed	NOUN
ajlm-2912	208	3	.	.	PUNCT
ajlm-2912	208	4	vol	vol	NOUN
ajlm-2912	208	5	.	.	PROPN
ajlm-2912	209	1	2	2	X
ajlm-2912	209	2	.	.	X
ajlm-2912	209	3	mumbai	mumbai	PROPN
ajlm-2912	209	4	:	:	PUNCT
ajlm-2912	209	5	bhalani	bhalani	PROPN
ajlm-2912	209	6	publishing	publishing	PROPN
ajlm-2912	209	7	house	house	PROPN
ajlm-2912	209	8	,	,	PUNCT
ajlm-2912	209	9	2003	2003	NUM
ajlm-2912	209	10	;	;	PUNCT
ajlm-2912	209	11	p.	p.	NOUN
ajlm-2912	209	12	689–710	689–710	NUM
ajlm-2912	209	13	.	.	PUNCT
ajlm-2912	210	1	agarwal	agarwal	PROPN
ajlm-2912	210	2	d	d	PROPN
ajlm-2912	210	3	,	,	PUNCT
ajlm-2912	210	4	mathur	mathur	PROPN
ajlm-2912	210	5	dk	dk	PROPN
ajlm-2912	210	6	,	,	PUNCT
ajlm-2912	210	7	paliwal	paliwal	NOUN
ajlm-2912	210	8	v.	v.	ADP
ajlm-2912	210	9	psychological	psychological	ADJ
ajlm-2912	210	10	morbidity	morbidity	NOUN
ajlm-2912	210	11	in	in	ADP
ajlm-2912	210	12	young	young	ADJ
ajlm-2912	210	13	adults	adult	NOUN
ajlm-2912	210	14	with	with	ADP
ajlm-2912	210	15	acne	acne	NOUN
ajlm-2912	210	16	vulgaris	vulgaris	NOUN
ajlm-2912	210	17	:	:	PUNCT
ajlm-2912	210	18	a	a	DET
ajlm-2912	210	19	hospital	hospital	NOUN
ajlm-2912	210	20	-	-	PUNCT
ajlm-2912	210	21	based	base	VERB
ajlm-2912	210	22	study	study	NOUN
ajlm-2912	210	23	.	.	PUNCT
ajlm-2912	211	1	j	j	PROPN
ajlm-2912	211	2	clin	clin	PROPN
ajlm-2912	211	3	diagn	diagn	PROPN
ajlm-2912	211	4	res	re	NOUN
ajlm-2912	211	5	.	.	PUNCT
ajlm-2912	212	1	2023;17(2):wc01	2023;17(2):wc01	NUM
ajlm-2912	212	2	–	–	PUNCT
ajlm-2912	212	3	wc04	wc04	PROPN
ajlm-2912	212	4	.	.	PUNCT
ajlm-2912	213	1	https://doi.org/10.7860/jcdr/2023/61797.17483	https://doi.org/10.7860/jcdr/2023/61797.17483	PROPN
ajlm-2912	213	2	mybiosource	mybiosource	PROPN
ajlm-2912	213	3	.	.	PUNCT
ajlm-2912	214	1	human	human	ADJ
ajlm-2912	214	2	superoxide	superoxide	NOUN
ajlm-2912	214	3	dismutase	dismutase	NOUN
ajlm-2912	214	4	(	(	PUNCT
ajlm-2912	214	5	sod	sod	NOUN
ajlm-2912	214	6	)	)	PUNCT
ajlm-2912	214	7	elisa	elisa	NOUN
ajlm-2912	214	8	kit	kit	NOUN
ajlm-2912	215	1	[	[	X
ajlm-2912	215	2	homepage	homepage	NOUN
ajlm-2912	215	3	on	on	ADP
ajlm-2912	215	4	the	the	DET
ajlm-2912	215	5	internet	internet	NOUN
ajlm-2912	215	6	]	]	PUNCT
ajlm-2912	215	7	.	.	PUNCT
ajlm-2912	216	1	catalog	catalog	NOUN
ajlm-2912	216	2	no	no	PROPN
ajlm-2912	216	3	.	.	PROPN
ajlm-2912	216	4	mbs005068	mbs005068	NOUN
ajlm-2912	216	5	.	.	PUNCT
ajlm-2912	217	1	research	research	NOUN
ajlm-2912	217	2	use	use	NOUN
ajlm-2912	217	3	only	only	ADV
ajlm-2912	217	4	.	.	PUNCT
ajlm-2912	218	1	san	san	PROPN
ajlm-2912	218	2	diego	diego	PROPN
ajlm-2912	218	3	,	,	PUNCT
ajlm-2912	218	4	ca	ca	NOUN
ajlm-2912	218	5	:	:	PUNCT
ajlm-2912	218	6	mybiosource	mybiosource	ADJ
ajlm-2912	218	7	;	;	PUNCT
ajlm-2912	218	8	2020	2020	NUM
ajlm-2912	219	1	[	[	X
ajlm-2912	219	2	cited	cite	VERB
ajlm-2912	219	3	n.d	n.d	PROPN
ajlm-2912	219	4	.	.	PROPN
ajlm-2912	219	5	]	]	PUNCT
ajlm-2912	219	6	.	.	PUNCT
ajlm-2912	220	1	available	available	ADJ
ajlm-2912	220	2	from	from	ADP
ajlm-2912	220	3	:	:	PUNCT
ajlm-2912	220	4	https://www.mybiosource.com/sod-human-elisa-kits/superoxide-dismutase/5068	https://www.mybiosource.com/sod-human-elisa-kits/superoxide-dismutase/5068	PROPN
ajlm-2912	220	5	abbexa	abbexa	PROPN
ajlm-2912	220	6	.	.	PUNCT
ajlm-2912	221	1	human	human	ADJ
ajlm-2912	221	2	catalase	catalase	NOUN
ajlm-2912	221	3	(	(	PUNCT
ajlm-2912	221	4	cat	cat	NOUN
ajlm-2912	221	5	)	)	PUNCT
ajlm-2912	221	6	elisa	elisa	NOUN
ajlm-2912	221	7	kit	kit	NOUN
ajlm-2912	221	8	(	(	PUNCT
ajlm-2912	221	9	catalogue	catalogue	NOUN
ajlm-2912	221	10	no	no	INTJ
ajlm-2912	221	11	.	.	NOUN
ajlm-2912	221	12	abx572370	abx572370	NOUN
ajlm-2912	221	13	)	)	PUNCT
ajlm-2912	222	1	[	[	X
ajlm-2912	222	2	product	product	NOUN
ajlm-2912	222	3	datasheet	datasheet	VERB
ajlm-2912	222	4	]	]	PUNCT
ajlm-2912	223	1	[	[	X
ajlm-2912	223	2	homepage	homepage	NOUN
ajlm-2912	223	3	on	on	ADP
ajlm-2912	223	4	the	the	DET
ajlm-2912	223	5	internet	internet	NOUN
ajlm-2912	223	6	]	]	PUNCT
ajlm-2912	223	7	.	.	PUNCT
ajlm-2912	224	1	abbexa	abbexa	PROPN
ajlm-2912	224	2	ltd	ltd	PROPN
ajlm-2912	224	3	;	;	PUNCT
ajlm-2912	224	4	2022	2022	NUM
ajlm-2912	224	5	[	[	X
ajlm-2912	224	6	cited	cite	VERB
ajlm-2912	224	7	n.d	n.d	PROPN
ajlm-2912	224	8	.	.	PROPN
ajlm-2912	224	9	]	]	PUNCT
ajlm-2912	224	10	.	.	PUNCT
ajlm-2912	225	1	available	available	ADJ
ajlm-2912	225	2	from	from	ADP
ajlm-2912	225	3	:	:	PUNCT
ajlm-2912	225	4	https://www.abbexa.com/human-catalase-cat-elisa-kit?srsltid=afmboopps1-	https://www.abbexa.com/human-catalase-cat-elisa-kit?srsltid=afmboopps1-	PROPN
ajlm-2912	225	5	&	&	CCONJ
ajlm-2912	225	6	abbexa	abbexa	PROPN
ajlm-2912	225	7	.	.	PUNCT
ajlm-2912	226	1	human	human	ADJ
ajlm-2912	226	2	glutathione	glutathione	NOUN
ajlm-2912	226	3	(	(	PUNCT
ajlm-2912	226	4	gsh	gsh	PROPN
ajlm-2912	226	5	)	)	PUNCT
ajlm-2912	226	6	elisa	elisa	PROPN
ajlm-2912	226	7	kit	kit	NOUN
ajlm-2912	226	8	(	(	PUNCT
ajlm-2912	226	9	catalogue	catalogue	NOUN
ajlm-2912	226	10	no	no	PROPN
ajlm-2912	226	11	.	.	PROPN
ajlm-2912	226	12	abx573700	abx573700	PROPN
ajlm-2912	226	13	)	)	PUNCT
ajlm-2912	227	1	[	[	X
ajlm-2912	227	2	product	product	NOUN
ajlm-2912	227	3	datasheet	datasheet	VERB
ajlm-2912	227	4	]	]	PUNCT
ajlm-2912	228	1	[	[	X
ajlm-2912	228	2	homepage	homepage	NOUN
ajlm-2912	228	3	on	on	ADP
ajlm-2912	228	4	the	the	DET
ajlm-2912	228	5	internet	internet	NOUN
ajlm-2912	228	6	]	]	PUNCT
ajlm-2912	228	7	.	.	PUNCT
ajlm-2912	229	1	abbexa	abbexa	PROPN
ajlm-2912	229	2	ltd	ltd	PROPN
ajlm-2912	229	3	;	;	PUNCT
ajlm-2912	229	4	2022	2022	NUM
ajlm-2912	229	5	[	[	X
ajlm-2912	229	6	cited	cite	VERB
ajlm-2912	229	7	n.d	n.d	PROPN
ajlm-2912	229	8	.	.	PROPN
ajlm-2912	229	9	]	]	PUNCT
ajlm-2912	229	10	.	.	PUNCT
ajlm-2912	230	1	available	available	ADJ
ajlm-2912	230	2	from	from	ADP
ajlm-2912	230	3	:	:	PUNCT
ajlm-2912	230	4	https://www.abbexa.com/human-glutathione-gsh-elisa-kit	https://www.abbexa.com/human-glutathione-gsh-elisa-kit	PROPN
ajlm-2912	230	5	mybiosource	mybiosource	PROPN
ajlm-2912	230	6	.	.	PUNCT
ajlm-2912	231	1	human	human	PROPN
ajlm-2912	231	2	malondialdehyde	malondialdehyde	PROPN
ajlm-2912	231	3	(	(	PUNCT
ajlm-2912	231	4	mda	mda	PROPN
ajlm-2912	231	5	)	)	PUNCT
ajlm-2912	231	6	elisa	elisa	PROPN
ajlm-2912	231	7	kit	kit	NOUN
ajlm-2912	231	8	(	(	PUNCT
ajlm-2912	231	9	catalog	catalog	NOUN
ajlm-2912	231	10	no	no	NOUN
ajlm-2912	231	11	.	.	PUNCT
ajlm-2912	231	12	mbs263626	mbs263626	ADJ
ajlm-2912	231	13	)	)	PUNCT
ajlm-2912	232	1	[	[	X
ajlm-2912	232	2	product	product	NOUN
ajlm-2912	232	3	manual	manual	NOUN
ajlm-2912	232	4	]	]	PUNCT
ajlm-2912	233	1	[	[	X
ajlm-2912	233	2	homepage	homepage	NOUN
ajlm-2912	233	3	on	on	ADP
ajlm-2912	233	4	the	the	DET
ajlm-2912	233	5	internet	internet	NOUN
ajlm-2912	233	6	]	]	PUNCT
ajlm-2912	233	7	.	.	PUNCT
ajlm-2912	234	1	mybiosource	mybiosource	NOUN
ajlm-2912	234	2	;	;	PUNCT
ajlm-2912	234	3	2021	2021	NUM
ajlm-2912	234	4	[	[	X
ajlm-2912	234	5	cited	cite	VERB
ajlm-2912	234	6	n.d	n.d	PROPN
ajlm-2912	234	7	.	.	PROPN
ajlm-2912	234	8	]	]	PUNCT
ajlm-2912	234	9	.	.	PUNCT
ajlm-2912	235	1	available	available	ADJ
ajlm-2912	235	2	from	from	ADP
ajlm-2912	235	3	:	:	PUNCT
ajlm-2912	235	4	https://www.mybiosource.com/mda-elisa-kits/human/263626	https://www.mybiosource.com/mda-elisa-kits/human/263626	PROPN
ajlm-2912	235	5	maccarrone	maccarrone	PROPN
ajlm-2912	235	6	m	m	PROPN
ajlm-2912	235	7	,	,	PUNCT
ajlm-2912	235	8	catani	catani	PROPN
ajlm-2912	235	9	mv	mv	PROPN
ajlm-2912	235	10	,	,	PUNCT
ajlm-2912	235	11	iraci	iraci	NOUN
ajlm-2912	235	12	s	s	NOUN
ajlm-2912	235	13	,	,	PUNCT
ajlm-2912	235	14	melino	melino	NOUN
ajlm-2912	235	15	g	g	NOUN
ajlm-2912	235	16	,	,	PUNCT
ajlm-2912	235	17	agrò	agrò	PROPN
ajlm-2912	235	18	af	af	PROPN
ajlm-2912	235	19	.	.	PUNCT
ajlm-2912	236	1	a	a	DET
ajlm-2912	236	2	survey	survey	NOUN
ajlm-2912	236	3	of	of	ADP
ajlm-2912	236	4	reactive	reactive	ADJ
ajlm-2912	236	5	oxygen	oxygen	NOUN
ajlm-2912	236	6	species	specie	NOUN
ajlm-2912	236	7	and	and	CCONJ
ajlm-2912	236	8	their	their	PRON
ajlm-2912	236	9	role	role	NOUN
ajlm-2912	236	10	in	in	ADP
ajlm-2912	236	11	dermatology	dermatology	NOUN
ajlm-2912	236	12	.	.	PUNCT
ajlm-2912	237	1	j	j	PROPN
ajlm-2912	237	2	eur	eur	PROPN
ajlm-2912	237	3	acad	acad	PROPN
ajlm-2912	237	4	dermatol	dermatol	NOUN
ajlm-2912	237	5	venereol	venereol	NOUN
ajlm-2912	237	6	.	.	PUNCT
ajlm-2912	238	1	1997;8(3):185–202	1997;8(3):185–202	X
ajlm-2912	238	2	.	.	PUNCT
ajlm-2912	239	1	https://doi.org/10.1111/j.1468-3083.1997.tb00478.x	https://doi.org/10.1111/j.1468-3083.1997.tb00478.x	PROPN
ajlm-2912	239	2	mahmoud	mahmoud	PROPN
ajlm-2912	239	3	a	a	PROPN
ajlm-2912	239	4	,	,	PUNCT
ajlm-2912	239	5	gaber	gaber	PROPN
ajlm-2912	239	6	mae	mae	PROPN
ajlm-2912	239	7	,	,	PUNCT
ajlm-2912	239	8	dawood	dawood	PROPN
ajlm-2912	239	9	aae	aae	PROPN
ajlm-2912	239	10	.	.	PUNCT
ajlm-2912	240	1	oxidants	oxidant	NOUN
ajlm-2912	240	2	and	and	CCONJ
ajlm-2912	240	3	antioxidants	antioxidant	NOUN
ajlm-2912	240	4	role	role	NOUN
ajlm-2912	240	5	in	in	ADP
ajlm-2912	240	6	acne	acne	NOUN
ajlm-2912	240	7	vulgaris	vulgaris	NOUN
ajlm-2912	240	8	.	.	PUNCT
ajlm-2912	241	1	menoufia	menoufia	PROPN
ajlm-2912	241	2	med	med	PROPN
ajlm-2912	241	3	.	.	PUNCT
ajlm-2912	242	1	j.	j.	PROPN
ajlm-2912	242	2	2014;27(2):465–468	2014;27(2):465–468	PROPN
ajlm-2912	242	3	.	.	PUNCT
ajlm-2912	243	1	https://doi.org/10.4103/1110-2098.141728	https://doi.org/10.4103/1110-2098.141728	PROPN
ajlm-2912	243	2	kurutas	kurutas	PROPN
ajlm-2912	243	3	eb	eb	PROPN
ajlm-2912	243	4	,	,	PUNCT
ajlm-2912	243	5	arican	arican	PROPN
ajlm-2912	243	6	o	o	NOUN
ajlm-2912	243	7	,	,	PUNCT
ajlm-2912	243	8	sasmaz	sasmaz	PROPN
ajlm-2912	243	9	s.	s.	PROPN
ajlm-2912	243	10	superoxide	superoxide	NOUN
ajlm-2912	243	11	dismutase	dismutase	NOUN
ajlm-2912	243	12	and	and	CCONJ
ajlm-2912	243	13	myeloperoxidase	myeloperoxidase	NOUN
ajlm-2912	243	14	activities	activity	NOUN
ajlm-2912	243	15	in	in	ADP
ajlm-2912	243	16	polymorphonuclear	polymorphonuclear	NOUN
ajlm-2912	243	17	leukocytes	leukocyte	NOUN
ajlm-2912	243	18	in	in	ADP
ajlm-2912	243	19	acne	acne	NOUN
ajlm-2912	243	20	vulgaris	vulgaris	NOUN
ajlm-2912	243	21	.	.	PUNCT
ajlm-2912	244	1	acta	acta	PROPN
ajlm-2912	244	2	dermatovenerol	dermatovenerol	PROPN
ajlm-2912	244	3	alp	alp	PROPN
ajlm-2912	244	4	panonica	panonica	PROPN
ajlm-2912	244	5	adriat	adriat	PROPN
ajlm-2912	244	6	,	,	PUNCT
ajlm-2912	244	7	2005;14:39–42	2005;14:39–42	NUM
ajlm-2912	244	8	.	.	PUNCT
ajlm-2912	245	1	akamatsu	akamatsu	PROPN
ajlm-2912	245	2	h	h	PROPN
ajlm-2912	245	3	,	,	PUNCT
ajlm-2912	245	4	horio	horio	PROPN
ajlm-2912	245	5	t	t	PROPN
ajlm-2912	245	6	,	,	PUNCT
ajlm-2912	245	7	hattori	hattori	PROPN
ajlm-2912	245	8	k.	k.	PROPN
ajlm-2912	245	9	increased	increase	VERB
ajlm-2912	245	10	hydrogen	hydrogen	NOUN
ajlm-2912	245	11	peroxide	peroxide	NOUN
ajlm-2912	245	12	generation	generation	NOUN
ajlm-2912	245	13	by	by	ADP
ajlm-2912	245	14	neutrophils	neutrophil	NOUN
ajlm-2912	245	15	from	from	ADP
ajlm-2912	245	16	patients	patient	NOUN
ajlm-2912	245	17	with	with	ADP
ajlm-2912	245	18	acne	acne	NOUN
ajlm-2912	245	19	inflammation	inflammation	NOUN
ajlm-2912	245	20	.	.	PUNCT
ajlm-2912	246	1	int	int	NOUN
ajlm-2912	246	2	j	j	PROPN
ajlm-2912	246	3	dermatol	dermatol	NOUN
ajlm-2912	246	4	.	.	PUNCT
ajlm-2912	247	1	2003;42(5):366–369	2003;42(5):366–369	NUM
ajlm-2912	247	2	.	.	PUNCT
ajlm-2912	247	3	https://doi.org/10.1046/j.1365-4362.2003.01540.x	https://doi.org/10.1046/j.1365-4362.2003.01540.x	VERB